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Summary
The aim o f the thesis was threefold. Firstly, to undertake a retrospective analysis for the presence 
o f ‘dissociating factors' in a longitudinal study designed to investigate the relationship between 
progressive structural and functional damage in open angle glaucoma (OAG). Secondly, to 
evaluate, in a prospective cross-sectional study, the diagnostic precision o f current promising 
techniques for the detection o f OAG. namely : Optical Coherence Tomography (OCT). Confocal 
Scanning Laser Ophthalmoscopy (CSLO) and the M ultifocal Visual Evoked Potential (mtVEP). 
Thirdly, to investigate the validity o f RNFL thickness measurements obtained using novel 
software (OCTAnalyse) against those obtained using a commercially available OCT 
(StratusOCT).
The longitudinal study (follow-up 78.4 +9.5 months) was concerned with the concordance 
between progressive damage identified using Fleidelberg Retina Tomograph (F1RT) Topographic 
Change Analysis (TCA) and the Humphrey Field Analyzer (HFA) Glaucoma Probability Analysis 
(GPA) in patients with OAG or ‘high risk* ocular-hypertension (OHT). Seventeen out o f 23 
patients exhibited progressive damage by TCA and/or by GPA: however, only 4 patients exhibited 
progressive damage by both techniques. In a majority (70%) o f the eyes progressing by only one 
technique, one o f three ‘dissociating factors' explained the discordance.
The prospective cross-sectional study evaluated the diagnostic precision o f retinal nerve fibre 
layer (RNFL) thickness using StratusOCT. neuroretinal rim area using the HRT and the mfVEP 
using the Visual Evoked Response Imaging System (VERIS) in a cohort o f 20 normal individuals 
and 23 individuals with OAG. OAG was defined in terms o f the subjective assessment o f the 
digital stereoscopic image (DSI) o f the ONH by each o f 3 masked observers. The sensitivity and 
specificity o f OCT. CSLO. mlVEP for OAG was 91.3% and 65.0%. 43.5% and 95.0%, 69.6% and 
60.0%. respectively. In the same cohort. Standard Automated Perimetry (SAP) achieved 
sensitivity and specificity o f 47.8% and 95%. respectively. The best combination of tests for the 
detection o f OAG was OCT and CSLO. which yielded a sensitivity and specificity o f 82.6% and 
80%. respectively. The topographical correspondence o f the ONH abnormality identified by DSI 
was greatest using CSLO (100%).
The final study utilised custom-derived software. OCTAnalyse. designed for use in instances 
where StratusOCT yielded erroneous RNFL thickness measurements (such as with a detatched 
internal limiting membrane and/or in a retina exhibiting poor reflectivity). The validity o f the 
RNFL thickness measurements collected in the cross-sectional study and analysed using 
OCTAnalyse were compared against those obtained using the standard StratusOCT analysis 
software. OCTAnalyse RNFL thickness measurements were greater (by approximately 9pm) and 
exhibited poorer within-session repeatability than those obtained using the StratusOCT.
The overall findings from the three studies provide important information for clinicians 
implementing the current promising techniques for the routine management o f patients with OAG.
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Chapter 1: Structural and functional relationships in open 
angle glaucoma (OAG)
1.1 Introduction
The generic term 'glaucoma' refers to a group o f ocular disorders characterised by 
progressive damage to the optic nerve head (ONH) and visual field loss. The 
pathogenesis o f the disease is unclear (Anderson DR 1989. Drance SM 1992. 1997) and 
the detection o f OAG requires the ability to accurately differentiate an ONH that is 
diseased from one that is healthy. The clinical investigation o f glaucoma employs a 
number o f diagnostic techniques to determine abnormality in the structural and/or 
functional integrity o f the eve and/or identify risk factors for the development o f the 
disease.
1.2 Epidemiology
Open-angle glaucoma (OAG) is the most prevalent form o f the disease and is the leading 
cause o f  blindness in the developed world (R esnikoff S. et al. 2004. Saw S. et al. 2004) 
affecting between 1.5-8.5% o f the population over the age o f 40 (Anton A. et al. 2004. 
Iwase A. et al. 2004. Mitchell P. et al. 2004. Ntim-Amponsah CT. et al. 2004. Tuck MW 
and Crick RP 1998. Varma R. et al. 2004). Unlike other chronic diseases. OAG is 
asymptomatic until later stages o f the disease; therefore, case finding in groups 
considered 'at risk' is vital for early detection.
By definition, in OAG. the optic neuropathy manifests in the presence o f open anterior 
chamber angles and is a chronic form o f the disease. An acute form o f glaucoma, referred 
to as angle closure glaucoma (ACG). occurs when the anterior chamber angle becomes 
closed and can occur with (primary) or without (secondary) an anatomical predisposition. 
Unlike OAG. ACG is associated with a rapid increase in IOP. a painful red eye and a 
reduction in visual acuity. Angle closure glaucoma is considered a true ophthalmic 
emergency requiring immediate, appropriate therapy to prevent vision loss. 
Glaucomatous optic neuropathy can develop in the presence o f seemingly normal IOP. 
This is a condition referred to as normal-tension glaucoma (NTG) and accounts for 25- 
30% o f all open angle glaucoma cases (Klein BE. et al. 1992. Sommer A 1996). 
Conversely. IOP can be elevated with no evidence o f  associated ONH damage. This 
condition is referred to as ocular-hypertension (OHT). Approximately 97% of individuals 
with IOP between 21mmHg and 25mmHg. and just under 50% o f individuals with IOP 
greater than 35mmHg never develop ONH damage (Kass MA. et al. 1980, Pohjanpelto 
PE and PalvaJ 1974).
Risk factors for OAG include: elevated intra-ocular pressure (IOP) (Armaly MF 1969, 
Kass MA, et al. 1980). older age (Armaly MF. et al. 1980). ethnic origin (Afro- 
Caribbean's are likely to develop OAG at an earlier age. progress more rapidly, be more 
resistant to therapy and are more likely to go blind from the disease) (Quigley HA 1996. 
Tielsch JM. et al. 1991). a family history o f the disease (Miller SJ 1978. Tielsch JM, et al. 
1994) and moderate to high myopia (>3DS) (Chihara E. et al. 1997. Mitchell P. et al.
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1999. Phelps CD 1982). There is much debate as to whether a positive correlation exists 
between diabetes and OAG. and between systemic hypertension and OAG. Several 
studies have reported no statistically significant association between diabetes and OAG 
(Leske MC. et al. 1995. Tielsch JM. et al. 1995). Others, however, report a three-fold 
increase in the prevalence o f OAG (Dielemans I. et al. 1996) and a two-fold increase in 
the prevalence o f  OHT (Mitchell P. et al. 1997) in patients with diabetes. Several authors 
report no association between systemic hypertension and OAG (Jonas JB and Grundler 
AE 1998. Schulzer M and Drance SM 1987) whilst others report evidence to the contrary 
(Tielsch JM. et al. 1995).
1.3 Pathophysiology o f OAG
The pathological change underlying OAG is atrophy o f  the retinal ganglion cells (retinal 
ganglion cells) and neural tissue within the retina. Retinal ganglion cell death manifests 
as a thinning o f the retinal nerve fibre layer (RNFL) and reduction in the width o f the 
neuroretinal rim (NRR) o f the ONH with concomitant enlargement o f the optic cup. 
Neuronal death in OAG is not. however, limited to the retina as neurons in the lateral 
geniculate nucleus (LGN) (Yucel YH. et al. 2000. Yucel YH. et al. 2001. 2003) and 
visual cortex (Crawford ML. et al. 2001. Yucel YH. et al. 2003) are also lost through 
retrograde degeneration. The aetiology o f glaucomatous optic neuro-degeneration is not 
fully understood. Elevated IOP is the principal risk factor and is associated with the 
degeneration o f the retinal ganglion cells and optic nerve fibres in a majority o f patients 
with OAG. Elevation o f IOP above physiological levels results in an increase in the
3
pressure gradient across the lamina cribrosa. This, in turn, causes deformation and 
mechanical stress to the lamina cribrosa and retinal ganglion cell axons (Bellezza AJ. et 
al. 2003). In addition, mechanical com pression o f the retinal ganglion cell axons due to 
elevated IOP. impairs transport o f axonal factors supporting a mechanism o f cell death 
that is due to trophic insufficiency (Krishnamoorthy RR. et al. 2001. Pease ME. et al.
2000. Quigley HA. et al. 2000).
Independently, or in addition to elevated IOP. other factors can individually, or 
collectively , contribute to the death o f the retinal ganglion cells and ON fibres in OAG. 
Localised ischaemia o f retinal tissues due to dysfunction o f retinal blood flow 
autoregulation has been implicated as one o f these factors (Weinreb RN. et al. 1997). 
Excessive stimulation o f the glutamatergic system, specifically the N-methyl-D-aspartate 
(NMDA) subtypes, has also been proposed as a contributory factor to the death o f retinal 
ganglion cells in OAG (Dreyer EB. et al. 1996. Lipton SA 2003. Yoles E and Schwartz 
M 1998). However, it is still unknown whether excess glutamate has a positive or a 
negative effect on the retinal ganglion cells and whether various sub-classes o f retinal 
ganglion cells respond to glutamate in different ways (Honkanen RA. et al. 2003). Other 
proposed aetiologies for glaucomatous neuro-degeneration include: poorly functioning 
cellular pumps and glutamate transporters (M artin KR. et al. 2002), oxidative stress and 
formation o f free radicals (Geiger LK. et al. 2002. Schlieve CR. et al. 2006). 
autoimmunity (Grus FH. et al. 2004. Schwartz M 2003. Tezel G. et al. 1999. Wax MB
2000) and the effects o f  inflammatory cytokines such as tumour necrosis factor (TNF) 
and nitric oxide (NO) (Chiou GC 2001. Dawson VL and Dawson TM 1996. Dreyer EB
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1998. Liu B and Neufeld AH 2001. M organ J. et al. 1999. Yan X. et al. 2000). Evidence 
also exists suggesting that an initial response to ON insult can lead to a secondary 
cascade o f events causing neuro-degeneration among surviving retinal ganglion cells and 
their fibres (Liu B and Neufeld AH 2001. Schwartz M 2003). Thus, although primary 
nerve injury may not directly affect all retinal ganglion cells, it may increase the 
vulnerability o f spared neurones due to subsequent alterations in their environment (Liu 
B and Neufeld AH 2001. Schwartz M 2003).
1.4 Clinical examination for OAG
The management o f  OAG principally involves evaluation o f the ONH. examination o f 
the visual field and the measurement o f IOP.
1.4.1 Evaluation o f the Optic Nerve Head (ONH)
Evaluation o f the ONH appearance is presently the most sensitive technique for the 
identification o f the earliest pathological changes that occur in OAG (American Academy 
o f Ophthalmology 2000. European Glaucoma Prevention Study (EGPS) Group 2002. 
Gordon MO and Kass MA - The Ocular Hypertension Treatment Study Group 1999. 
Leske CM. et al. 1999). Clinically, the ONH is examined stereoscopically and under 
magnification by slit-lamp binocular indirect ophthalmoscopy (BIO). Slit-lamp BIO 
provides a quick, simple and non-invasive method to assess the ONH for changes 
characteristic o f OAG. Subjective evaluation o f stereoscopic ONH photographs is the 
recommended standard technique for identifying glaucomatous structural damage
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(American Academy o f Ophthalmology 2000. European Glaucoma Prevention Study 
(EGPS) Group 2002. Gordon MO and Kass MA - The Ocular Hypertension Treatment 
Study Group 1999. Leske CM. et al. 1999).
The neuroretinal rim (NRR) is the intrapapillarv projection of the RNFL. The shape o f 
the NRR is governed by the angle at which the optic nerve meets the globe and the size o f 
the ONH relative to the number o f retinal ganglion cell axons. As a result, the appearance 
o f the NRR shows great variability between normal individuals (Jonas JB and Grundler 
AE 1997).
Loss o f retinal ganglion cells and neural tissue in OAG reduces the width o f the NRR and 
the size o f the optic cup increases, relative to the ONH (Fingeret M. et al. 2005) (Figure 
1.0). Attenuation o f the NRR and enlargement o f the optic cup. referred to as ‘cupping', 
most frequently occurs at the superior and inferior regions o f the ONH. Cupping may 
also manifest as a concentric expansion o f the cup due to diffuse loss o f retinal ganglion 
cells (Burgoyne CF. et al. 2005). or as a notch in the regular contour o f the NRR due to 
localised loss o f retinal ganglion cells (Javitt JC. et al. 1990. Quigley HA and Addicks 
EM 1981) (Figure 1.1). A topographical relationship has been shown between regions o f 
the NRR and the visual field (Garway-Heath DF. et al. 2000. Hudson CJ. et al. 2007. 
Johnson CA. et al. 2003. Strouthidis NG. et al. 2006). Localised retinal ganglion cell 
death and subsequent focal attenuation o f the NRR width is nearly always associated with 
a corresponding visual field abnormality (Anderson DR 1983).
Neuroretinal nm
Scleral ring of Elschnig 
surrounding the optic 
disc
Optic Cup (the pale 
depression within the 
neuroretinal rim)
The margin of the optic nerve head is delineated 
by the inside edge of the scleral ring of Elschnig 
As shown, the healthy optic nerve head obeys the 
ISNT rule
Diffude loss of the 
neuroretinal nm.lt may 
be difficult to distinguish 
diffuse loss of the 
neuroretinal rim from a 
normal physiologically 
large optic cup
Localised loss of the 
inferior neuroretinal rim. 
Localised loss (notch) 
can be identified as 
pathological since the 
neuroretinal rim 
configuration no longer 
obeys the ISNT rule
Inferior neuroretinal rim thinning
Figure 1.1 -  Schematic representation o f  the appearance o f  the ONH in the normal eye 
(top) and in diffuse (bottom left) and localised (bottom right) neuroretinal rim 
attenuation from  OAG.
The appearance o f an ONH haemorrhage is highly indicative o f OAG (Fingeret M. et al. 
2005, Soares AS, et al. 2004). The aetiology o f ONH haemorrhages is unclear; however, 
it is postulated that they represent acute ischaemic changes in the retina and/or collapse o f 
small blood vessels at the ONH margin (Sonnsjo B. et al. 1991) and/or disruption o f the 
blood retinal barrier (Grieshaber MC. et al. 2006). Optic nerve head haemorrhages appear
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as small, localised flame shaped, or less commonly, round haemorrhages within one disc 
diameter o f the ONH. Their characteristic 'flam e' shape is created by virtue o f their 
occurrence in the superficial RNFL. Optic nerve head haemorrhages occur transiently in 
some, but not all. cases o f OAG and NTG and thus their prevalence is difficult to 
determine. Optic nerve head haemorrhage prevalence estimates vary between 2% and 
37% in OAG (Drance SM 1989. Hendrickx KH. et al. 1994. Kitazawa Y. et al. 1986) and 
are up to four times more likely in NTG (Gloster J 1981. Healey PR. et al. 1998. Siegner 
SW and Netland PA 1996. Tuulonen A. et al. 1992).
The location o f an ONH haemorrhage shows good topographical correspondence with the 
subsequent development and location o f visual field loss (Kono Y. et al. 2003) and their 
presence is associated with progressive damage to the RNFL (Ahn JK and Park KH 2002. 
Airaksinen PJ. et al. 1981. Airaksinen PJ and Tuulonen A 1984. Jonas JB and Xu L 1994. 
Siegner SW and Netland PA 1996. Sugiyama K. et al. 1997. Sugiyama K. et al. 1999) 
and visual field (Rasker MT. et al. 1997. Siegner SW and Netland PA 1996).
Peripapillary atrophy (PPA) describes a region o f  cellular degeneration affecting the 
retinal photoreceptor layer, retinal pigment epithelium (RPE) and chorioretinal tissue 
adjacent to the ONH. The presence o f PPA is non-specific to OAG and is also a 
physiological effect with ageing; however, the extent o f atrophic area is statistically 
significantly larger in eyes with OAG compared to age-matched normal eyes (Jonas JB 
2005. Jonas JB. et al. 1999. Jonas JB. et al. 1992. Jonas JB. et al. 1989. Law SK. et al.
2001). Peripapillary atrophy is divisible ophthalmoscopically and histopathologically into
two distinct regions, namely: the alpha (a )  and the beta (P) zones (Figure 1.2). The 13- 
zone occurs at the peripheral edge o f the scleral rim of Elshnig and is characterised by 
complete loss of the RPE and a marked atrophy of the photoreceptor layer and the 
choriocapillaris. The a -  zone borders the peripheral edge of the p-zone and is visible as 
irregular RPE hypo- and hyperpigmentation and chorioretinal thinning.
Expansion o f the PPA regions have been observed in progressive OAG (Heltzer JM
1999. Jonas JB 2005, Uchida H. et al. 1998). patients with OHT converting to OAG and 
in patients with OAG exhibiting progressive damage to the visual field (Heltzer JM 
1999). However. PPA shows large inter-individual variation and the pattern of PPA 
varies in different types o f OAG. Peripapillary atrophy is more common in NTG than 
OAG, for reasons that are unknown (Wang L, et al. 1998). Similarly, the precise 
aetiology of PPA is also unknown although vascular ischaemic changes to the choroid 
have been proposed (Wang L, et al. 1998).
Figure 1.2 -  The alpha (a) and beta (p) zones o f  peripappilary atrophy (PPA) at the 
ONH margin.
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Stereoscopic imaging is the current gold standard technique used to assess the ONH in 
OAG (American Academy o f Ophthalmology 2000. European Glaucoma Prevention 
Study (EGPS) Group 2002). The technique derives objective and archiveable images o f 
the ONH and peripapillary retina useful both in cross-sectional and longitudinal 
evaluations.
During the last two decades, a number o f  computer-assisted techniques for evaluating 
ONH morphometry have evolved for the identification o f OAG. These techniques include 
digital planimetry (Morgan JE. et al. 2005). confocal scanning laser ophthalmoscopy 
(CSLO) (Bowd C. et al. 2004. Chauhan BC. et al. 2001. Wollstein G. et al. 1998). optical 
coherence tomography (OCT) (Guedes V. et al. 2003. Wollstein G. et al. 2004). retinal 
thickness analysis (RTA) (Zeimer R. et al. 1998) and nerve fibre layer polarimetry (GDx) 
(Medeiros FA. et al. 2004. Reus NJ and Lemij HG 2004). The objective nature o f these 
techniques generally confers high test-retest repeatability o f measurements and facilitates 
their use in the identification o f progressive structural damage. Each of these techniques 
is discussed in section 1.6.
1.4.2 Examination o f the visual field
Glaucomatous damage to the retinal ganglion cells results in a functional impairment to 
vision that is most frequently identified by examination o f the visual field. Clinically, the 
visual field is assessed under standardised recording conditions by a process known as 
standard automated perimetry (SAP). Standard automated perimetry evaluates the 
differential light sensitivity at a number o f specific and pre-determined locations
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throughout the central visual field. The lowest detectable stimulus luminance at each 
location within the visual field is termed the threshold luminance. The differential light 
sensitivity, expressed in decibels (dB). is the reciprocal of the threshold luminance. The 
Humphrey Field Analyzer (HFA. Carl Zeiss Meditec. CA) is the automated perimeter 
that is most commonly employed in the clinical setting and is therefore the 'gold 
standard* for visual field examination in OAG.
Evaluation o f the visual field by SAP. clinically, is made taking into account any 
apparent correspondence that exists between the location o f the visual field loss and the 
location o f the ONH abnormality. Retinal nerve fibres from the nasal retina project into 
the ONH in a radial fashion, whereas retinal nerve fibres from temporal retina enter the 
ONH at the supero-temporal and infero-temporal regions. This asymmetry is due to the 
relatively large number o f retinal nerve fibres originating from the papillomacular region. 
Retinal nerve fibres from the temporal retina must pass around these nerve fibres and thus 
enter the ONH closer to the superior and inferior poles. In OAG. damage to the temporal 
retinal fibres is a common manifestation o f the disease and subsequently produces 
attenuation o f the NRR in the supero-temporal and/or infero-temporal regions and a 
corresponding visual field defect.
Retinal nerve fibres from the temporal retina do not cross the horizontal midline o f the 
retina (Horizontal line o f Raphe). This anatomical feature means that in the early stages 
o f OAG. visual field loss can manifest as a marked difference in the differential light 
sensitivity between the superior and inferior hemifields. The horizontal line o f Raphe is
also responsible for the ‘nasal step' visual field defect, which occurs due to localised loss 
o f nerve fibres originating from the nasal periphery (Drance SM 1969). The nasal step 
more commonly manifests in the superior hemifield (Hart WM and Becker B 1982) and 
is present in up to 40% o f OAG patients with visual field loss (Caprioli J and Spaeth GL 
1985).
Paracentral visual field defects are also prevalent in OAG and account for approximately 
70% o f all glaucomatous field loss (Chauhan BC. et al. 1989). Paracentral visual field 
defects are more commonly found in the superior hemifield between 10° and 20° 
eccentricity (Hart WM and Becker B 1982. Mickelberg FS and Drance SM 1984).
With progressive damage to the visual field, new regions o f field loss appear and/or 
existing defects become larger, deeper or coalesce. In advanced visual field loss, both 
hemifields are affected and the extent o f the visual field loss can become so profound that 
the condition drastically impairs mobility and quality o f  life.
With increasing age. the differential light sensitivity gradually reduces due to the effects 
of: senile pupil miosis, reduced light transmission o f  the ocular media, and reduction in 
the neural integrity o f the retina and visual pathway (Johnson CA. et al. 1989). Thus, 
reduction in the differential light sensitivity that is due to OAG must be separated from 
that which is due to age.
In the retina, a number o f retinal ganglion cell sub-populations exist that comprise
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broadly two groups, those that project to the magnocellular layers (M-cells) in the lateral 
geniculate nucleus (LGN) and those projecting to the parvocellular layers (P-cells) (Perry 
V. et al. 1984. Silveira L and Perry V 1991). The M. or parasol cells, are widely 
distributed in the retina and have relatively large cell bodies, axonal diameters and 
receptive fields (Silveira L and Perry V 1991). The P. or midget cells, tend to be 
concentrated within the fovea region, and decline rapidly with increase in eccentricity 
(Dacey D 1993). The P-cells have small cell bodies, axonal diameters and receptive fields 
and account for about 80-90% o f the total retinal ganglion cell population (Curcio CA 
and Allen KA 1990).
A second group o f retinal ganglion cells project to the parvocellular layers o f the LGN. 
namely the K. or small bi-stratified cells. These K-cells have larger cell bodies and larger 
receptive fields than P-cells and are more sparsely distributed across the retina (Curcio 
CA and Allen KA 1990). The K-cells receive input from the short-wavelength sensitive 
(SWS) cone cells, opposed by the combined input from the medium-wavelength sensitive 
(MWS) cones and long-wavelength sensitive (LW S) cones and convey the SWS cone 
excitatory signals to the parvocellular layers o f the LGN (Dacey D 1993).
Numerous studies have implicated selective damage to retinal ganglion cell sub­
populations as the pathological mechanism underlying OAG (Anderson RS and O'Brien 
C 1997. Glovinsky Y. et al. 1991. Quigley HA. et al. 1988. Quigley HA. et al. 1987). 
Identifying the mechanism o f retinal ganglion cell death is important in terms o f our 
understanding o f the disease process and in designing psychophysical tests that exploit
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the properties o f these cells to identify early disease.
O ptic nerve axon counts in monkey and human OAG show a greater loss o f  the larger 
than average diameter axons compared to those o f  the normal optic nerve (Quigley HA. 
et al. 1988. Quigley HA. et al. 1987). A scarcity o f larger diameter axons has also been 
observed in prepared sections o f retinal tissue from glaucomatous eyes (Glovinsky Y. et 
al. 1991). These observations suggest that large diameter axons may be more susceptible 
to damage in OAG and supports the use o f psychophysical tests that are sensitive to and 
specific for M-cell properties in the detection o f pre-perimetric OAG.
However, some doubts exist as to the interpretation o f the histological findings arising 
from such factors as: cell shrinkage, cell labelling errors, small sample sizes, large 
between-individual variation in retinal ganglion cell size and differences in tissue 
preparation (Curcio CA and Allen KA 1990. Morgan JE 1994).
Damage to both magno- and parvocellular pathways is reported in OAG (Weber AJ. et al. 
1998). Thus, whether retinal ganglion cell death in OAG is truly selective, or not. has yet 
to be fully elucidated; however, it is conceivable that there is overlap in the susceptibility 
o f  different retinal ganglion cell sub-populations to glaucomatous damage.
Selective and non-selective losses o f  retinal ganglion cells may be occurring at different 
locations within the visual field and at different times throughout the course o f the 
disease dependent upon the pathogenesis and stage o f glaucomatous damage. Utilizing
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this view, some investigators have put forward the hypothesis that sparsely represented 
retinal ganglion cells, with lower degrees o f overlap between adjacent receptive fields, 
are more likely to exhibit functional deficits not necessarily due to selective damage but 
because only a small number o f  cells must be lost before the integrity o f the pathway is 
compromised (the reduced redundancy theory) (Johnson C 1994. Johnson CA 1995).
Evidence for selective loss o f retinal ganglion cells and/or the reduced redundancy theory 
has prompted the development o f psychophysical tests that exploit various function- 
specific retino-cortical pathways. Several o f these tests exhibit clinically useful levels o f 
sensitivity and specificity for the identification o f early OAG and include: short- 
wavelength automated perimetry (SWAP) (Bayer AU and Erb C 2002. Bayer AU, et al. 
2002. Demirel S and Johnson CA 2001). Frequency Doubling Technology Perimetry 
(FDT) (Kogure S. et al. 2003. Landers J. et al. 2006. Wadood AC. et al. 2002) and High- 
pass Resolution Perimetry (HRP) (Birt CM. et al. 1998. Iester M. et al. 1999. 
Kalaboukhova L and Lindblom B 2003).
1.4.3 Measurement of intra-ocular pressure (/OP)
Elevated intra-ocular pressure (IOP) is the primary treatable risk factor for OAG (Heijl A, 
et al. 2002. Kass MA. et al. 2002. Lee BL and W ilson MR 2003); however, the precise 
role o f IOP in the pathophysiology o f the disease is unknown (Gordon MO. et al. 2002. 
Leske MC. et al. 2003).
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Treatment o f OAG is aimed prim arily at lowering IOP. either by therapeutic or by 
surgical or laser intervention, to prevent progressive damage and thus improve the 
prognosis for the maintenance o f  ‘good’ vision (Cioffi GA and Leibmann JM 2002. 
Leske MC. et al. 2004).
The Goldmann applanation tonometer (GAT) is the internationally accepted standard for 
IOP measurement. The principal o f the technique is based upon the Imbert-Fick Law. 
which assumes that the cornea is a dry surface that is infinitely thin and behaves as a 
membrane where by the applanating pressure is equal to the IOP (Gloster J and Perkins 
ES 1963). In reality, the cornea fulfils none o f these criteria; however, the surface tension 
force created by the tear film and the resistance force created by virtue of corneal 
thickness are approximately equal and opposite when an applanation area of 7.35mm2 
(diameter 3.06mm) is applied to a cornea o f 520pm in thickness (Ehlers N. et al. 1975). 
Central corneal thickness (CCT) and corneal curvature affect IOP measurements obtained 
with the GAT (Brandt JD 2004. Brandt JD. et al. 2001. Whitacre MM. et al. 1993). The 
effect o f CCT on GAT measurements has been apparent since the introduction o f laser 
refractive surgery where there is an iatrogenic thinning o f the cornea and a reported 
underestimation o f IOP post surgery (Agudelo LM. et al. 2002. Chatterjee A. et al. 1997). 
Central corneal thickness affects the pressure m easurements obtained with the GAT such 
that IOP may be overestimated or underestim ated in thick or thin corneas, respectively 
(Doughty MJ and Zaman ML 2000. Ehlers N. et al. 1975). The extent o f the 
underestimation and overestimation by GAT has received mixed reviews (Doughty MJ 
and Zaman ML 2000. Singh RP. et al. 2001. Whitacre MM. et al. 1993). Some authors
report that GAT IOP measurements may span a range o f up to llm m H g in patients 
normally encountered clinically (Doughty MJ and Zaman ML 2000. Whitacre MM. et al. 
1993). whilst others suggest that the effect o f CCT on IOP is small and does not need 
correction in the majority o f patients (Singh RP. et al. 2001).
The clinical utility o f CCT-corrected IOP measurements lies in the identification o f 
elevated IOP in eyes with thin corneas and o f  normal eyes falsely classified as OHT. 
Several correction factors for GAT IOP measurements have been proposed (Doughty MJ 
and Zaman ML 2000. Gunvant P. et al. 2005. W hitacre MM. et al. 1993) and typically 
adjust measurements by between 0.19-0.37mmHg for each + 10pm of thickness variation 
from the normal CCT o f 520pm (Doughty MJ and Zaman ML 2000. Gunvant P. et al.
2005. Whitacre MM. et al. 1993). However, none o f these correction factors consider the 
stiffening o f the cornea that is thought to occur with age (Friedenwald JS 1937). Age 
induced stiffening o f the cornea results from ultrastructural changes in the collagen fibrils 
o f the corneal stroma (Daxer A. et al. 1998. Malik NS. et al. 1992); thus, a ‘one size fits 
all* correction factor may be unsuitable for patients o f different ages.
1.5 Current approaches to OAG detection and management
Throughout the last decade, technological advances have led to the development o f new 
techniques for the investigation o f OAG. Many o f these techniques appear to exhibit 
clinically useful levels o f diagnostic precision for OAG. and are seemingly useful in the 
detection o f pre-perimetric disease. The techniques which show the greatest level o f
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promise for the early detection o f OAG are reviewed in the following sections and can be 
classified under the headings: ocular imaging (Section 1.6). ocular electrophysiological 
techniques (Section 1.7) or psychophysical (Section 1.8) techniques.
1.6 Ocular imaging
It is well established that structural damage to the ONH and RNFL precedes detectable 
visual field loss by SAP (Harwerth RS. et al. 2004. Quigley HA. et al. 1982). As a result, 
a number o f quantitative ocular imaging techniques have evolved that are capable o f 
identifying structural changes that are believed to represent the earliest pathological 
changes o f the glaucomatous disease process. These techniques include: digital 
stereoscopic imaging (DSI). optical coherence tomography (OCT), confocal scanning 
laser ophthalmoscopy (CSLO). retinal thickness analysis (RTA) and scanning laser 
polarimetery (SLP).
These devices each exhibit clinical utility for the detection o f OAG (Bagga H. et al. 2005. 
Bathija R. et al. 1998. Budenz DL. et al. 2005. Da Pozzo S. et al. 2005. De Leon-Ortega 
JE. et al. 2006. Garway-Heath DF and Hitchings RA 1998. Hougaard JL. et al. 2004. 
Huang ML and Chen HY 2005. Iester M. et al. 2000. Jeoung JW. et al. 2005. Kanadani 
FN. et al. 2006. Kanamori A. et al. 2006. Kanamori A. et al. 2003. Leung CK. et al. 2005. 
Leung CK. et al. 2005. Mardin CY. et al. 1999. Medeiros FA and Susanna R Jr 2003. 
Medeiros FA. et al. 2005. Medeiros FA. et al. 2004. Mikelberg FS. et al. 1995. Morgan 
JE. et al. 2005. Nouri-Mahdavi K. et al. 2004. O'Connor DJ, et al. 1993. Sihota R. et al.
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2006. Uchida H. et al. 1996. W ollstein G. et al. 1998. Wollstein G. et al. 2005) and 
demonstrate topographical correspondence between the location o f structural damage and 
visual field loss in eyes with OAG (Garwav-Heath DF. et al. 2000. Sommer A. et al. 
1991). However, since in a majority o f these studies OAG was defined on the basis o f 
visual field loss, the appreciation o f their clinical utility in detecting early/pre-perimetric 
OAG is limited. The diagnostic ability o f the most promising novel imaging techniques in 
correctly identifying pre-perimetric OAG has yet to be established. In addition, the 
chronology o f structural damage as assessed by each o f the different techniques is also 
unknown.
The application and limitation o f the current commercially available imaging techniques 
for the detection o f glaucomatous structural damage is discussed in the following 
sections.
1.6.1 Stereoscopic ONH-imaging and planimetry
Subjective evaluation o f stereoscopic photographic images o f the ONH is an effective 
and recommended standard technique for the evaluation o f  the glaucomatous optic 
neuropathy (Abrams LS. et al. 1994. American Academy o f Ophthalmology 2000. 
European Glaucoma Prevention Study (EGPS) Group 2002. Gordon MO and Kass MA - 
The Ocular Hypertension Treatment Study Group 1999. Leske CM. et al. 1999. Musch 
DC. et al. 1997). The technique utilises pairs o f  photographic images, which when 
viewed together in a specialised stereo-viewer. allows the observer to appreciate depth. A 
small amount o f disparity between two images, created by a lateral displacement in the
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axis o f image capture between the two acquisitions, is required to create the appreciation 
o f depth when the images are viewed simultaneously.
In order to achieve ‘good quality* stereoscopic images, patients should have dilated 
pupils and have relatively clear media. A skilled ophthalmic photographer is also 
important.
Stereoscopic imaging provides a permanent and archiveable record of the appearance o f 
the ONH and peripapillary retina at any given time point. Specifically, digital 
stereoscopic imaging (DSI) is the preferred form o f this technique owing to advances in 
photographic methods and the greater versatility o f  images in this medium.
Viewing the ONH in three-dimensions improves the discrimination o f the NRR. the 
appreciation o f the depth o f the optic cup. and provides better visualisation o f blood 
vessel changes. These factors, in combination, enhance the observer's ability to assess 
characteristics o f the ONH with respect to OAG. including; the intra-papillary projection 
o f the retinal nerve fibres; localised and/or generalised attenuation o f the NRR; the extent 
o f cupping and/or bowing o f the lamina cribrosa; the presence o f an acquired pit o f the 
optic nerve (APON); and alterations in the course o f retinal blood vessels (Broadway DC, 
et al. 1999. Piette SD and Sergott RC 2006).
A number o f stereo-cameras designed for ophthalmologic application are currently 
commercially available, including the NIDEK 3-Dx (NIDEK Co., Ltd, Tokyo. Japan) and
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Topcon TRC-50EX (Topcon Medical Systems. Inc. [TMS]. Paramus. NJ). These two 
cameras acquire digital stereo-im age pairs in different ways. The NIDEK 3-Dx stereo- 
camera obtains pairs o f digital stereo-images simultaneously, whereas the Topcon TRC- 
50EX stereo-camera obtains the pair o f  digital stereoscopic images sequentially. Whilst 
both simultaneous and sequential imaging techniques are capable o f obtaining high 
quality digital stereoscopic images, sequentially acquired digital images are more 
susceptible to artefacts due to eye movements and to blinking between the first and 
second successive image. Simultaneously acquired digital stereoscopic images exhibit 
superior reproducibility to those obtained sequentially and are therefore recommended for 
use in the detection of progressive structural damage (Varma R. et al. 1992).
Technological advances in digital display equipment have facilitated the evaluation of 
digital stereoscopic ONH images. In its simplest form, a standard computer monitor with 
a device capable o f dissociating the view (for example, a monitor Z-Screen overlay 
[StereoGraphics Corp.. San Rafael. CA] and passive polarizing eyewear) to each eye is 
all that is required.
The qualitative assessment o f digital ONH images by trained observers exhibits moderate 
to excellent levels o f sensitivity (72-78%) and specificity (60-95%) for the detection o f 
OAG (Abrams LS. et al. 1994. O 'Connor DJ. et al. 1993, Wollstein G, et al. 2000).
Digital planimetry is a method for analysing stereoscopic images that permits 
quantification o f the ONH morphometry. At present, there is no established standard
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planimetric technique to assess the ONH and studies utilizing digital planimetry have 
primarily employed custom software (Garway-Heath DF. et al. 1999. Hatch WV. et al. 
1999. Kono Y. et al. 1999. Morgan JE. et al. 2005. Shen SY. et al. 2006). Planimetry is 
capable o f measuring parameters o f the ONH including the ONH size. ONH area, optic 
cup area, optic cup to ONH area ratio, cx-zone PPA area and p-zone PPA area etc. Such 
measurements are derived from the area within a boundary that is positioned around the 
given structure. Therefore, the actual measurement obtained by this technique for any 
given structure, is subject to between-observer variability (Hatch WV. et al. 1999. Kono 
Y. et al. 1999).
Digital planimetry can be used to identify an ONH structure that is statistically 
significantly different from the expected value based upon a distribution o f the value 
found in a population o f normal individuals. In this way. planimetry can be applied cross- 
sectionally provided that differences in refractive error and corneal curvature between 
patients are corrected. Digital planimetry yields values o f specificity and sensitivity o f 
between 67-94.3% and 62-94.4%. respectively for the detection o f  OAG (Garway-Heath 
DF. et al. 1998. Morgan JE. et al. 2005. O 'Connor DJ. et al. 1993) and typically exceeds 
that o f alternative objective digital imaging devices when compared in a single cohort 
(Correnti AJ. et al. 2003. Greaney MJ. et al. 2002. Jonas JB. et al. 1998. Wollstein G. et 
al. 2000).
DSI and digital planimetry exhibit large amounts o f within- (Kappa = 0.69-0.96) and 
between-observer (Kappa = 0.20-0.84) variability (Coleman AL. et al. 1996). Despite the
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inherent variability. DS1 is clinically appropriate for the evaluation o f glaucomatous 
structural damage since it is offers direct visualisation of the structural status o f the 
neuro-retina (Jonas JB. et al. 1998). In addition, the objective nature by which digital 
stereo ONH images are obtained results in high repeatability of images between sessions. 
Thus. DSI is suitable for the identification in progressive structural damage. Although the 
absence o f longitudinal data currently precludes this assumption, statistically significant 
reductions in manual planimetrically derives rim area measurements were evident over a 
10 year follow-up (Airaksinen PJ. et al. 1992).
1.6.2 Confocal Scanning Laser Ophthalmoscopy (CSLO)
The confocal scanning laser ophthalmoscope (CSLO) is an objective imaging device used 
for in vivo topographical mapping o f the ONH and peripapillary retina. The procedure is 
non-invasive and negates the need for pupil dilation in a majority o f patients owing to the 
low intensity, long-wavelength diode laser used to obtain the images. The Heidelberg 
Retina Tomograph (HRT. Heidelberg Engineering GmbH. Dossenheim. Germany) is a 
commercially available CSLO. that has demonstrated clinical utility in detecting early 
and progressive structural damage in OAG (Artes PH and Chauhan BC 2005. Bathija R. 
et al. 1998. Bowd C. et al. 2004. Chauhan BC. et al. 2000. Chauhan BC, et al. 2001. Ford 
BA. et al. 2003. Kamal DS. et al. 2000. Kesen MR. et al. 2002, Miglior S. et al. 2003. 
Uchida H. et al. 1996).
The current version o f the HRT. the HRT III. employs a rapid scanning 670nm diode 
laser to obtain images o f  the posterior segment. The emitted beam is projected through a
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pinhole, a raster scanning system and an objective lens onto the retina. Laser light that is 
reflected from the retina is then re-directed through a second pinhole and onto a light 
sensitive detector. The confocal aperture limits the depth from which reflected light 
reaches the detector to a narrow range centred around the location o f a set focal plane on 
the retinal or ONH surface. Reflected light from structures in front o f or behind the focal 
plane o f interest is blocked by the detector pinhole producing an optical section o f  the 
posterior pole corresponding to the focal plane. The depth of the focal plane is 
automatically adjusted by shifting the confocal aperture to acquire multiple image 
sections through the tissue, creating a layered three-dimensional structure. The HRT III 
acquires 16 to 64 imaging planes to a depth o f up to 4mm. depending on the depth o f the 
optic cup. The sections are then combined to create a three-dimensional topographical 
map o f the ONH surface. The amount o f reflected laser light at each point in the image at 
each point in the z-axis forms the z-profile. The peak o f the z-profile is used to determine 
the retinal surface height at each point in the image, which is presumed to correspond 
with the internal limiting membrane. The product o f this process is a topographic height 
map containing independent retinal surface height measurements o f the ONH and 
peripapillary retina.
After an initial * pre-scan*. which determines the depth o f the optic cup. the HRT III 
automatically obtains a further three scans for the analysis. Automated quality control 
measures detect scans that are o f inadequate quality due to blinking and/or fixation shifts, 
and repeat any faulty scans to ensure that three ‘adequate* scans are obtained. The scans 
are then automatically aligned and averaged to create a mean topography image for the
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scan session. Heidelberg Retina Tomograph measurements with the current and previous 
versions o f the instrument exhibit high repeatability (Janknecht P and Funk J 1994. 
Rohschneider K. et al. 1994. W einreb RN. et al. 1993. Zangwill L. et al. 1997). Once the 
image is processed and saved, the topography standard deviation (SD) provides a 
measure o f image quality. Standard deviations below 20pm indicate excellent image 
quality; 20 to 30pm. very good image quality, and 30 to 40pm. acceptable image quality 
(Schuerle AF and Schmidt E 2004).
The reflectance image is a false-colour image that is similar in appearance to a 
photograph o f the ONH. The image is created by summating the two-dimensional 
reflectance images and is presented as a 384x384 pixel map illustrating the intensity o f 
the reflections at sites within the ONH and peripapillary retina. Darker areas represent 
regions o f lower reflectance whereas lighter areas indicate higher reflectance.
The topography image provides information regarding the height o f the surface contour 
o f the ONH and peripapillary retina. The topography image is derived from the height 
measurement matrix constructed from the depth o f maximal reflection in the z-axis 
intensity profile. The image is false-colour coded, whereby brighter areas correspond to 
deeper surfaces and darker areas lie more superficially.
A number o f stereometric parameters that describe the morphometry o f the ONH are 
generated by HRT III software following the delineation o f the ONH margin. The ONH 
margin is defined as the inner edge o f the scleral ring o f Elshnig. The ONH itself usually
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appears a slightly pink in colour with a slightly depressed central portion (cup) that is 
pale pinkish-white in colour. The position o f the ONH margin is determined using the 
same general procedure for all version o f the HRT and takes into account both the 
topography and the reflectance images. Six or more points are placed along the 
circumference o f the ONH margin using a mouse controlled cursor; the HRT automated 
software then constructs a roughly circular contour line connecting adjacent points. Fine 
adjustments to the position o f the ONH contour line are then made to ensure that it 
corresponds with the ONH margin throughout the entirety o f its circumference. Where 
evidence o f peripapillary atrophy (PPA) and/or a myopic crescent is apparent, extra care 
is required in order not to confuse the ONH margin with the edge o f the atrophic region. 
Once correctly aligned, the contour line is used during cross-sectional and longitudinal 
analysis o f scans.
The location o f the ONH margin dictates the position o f  a ‘reference plane', against 
which most o f the stereometric parameters are derived. The ‘standard reference plane' 
(SRP) lies 50pm below a 6° wide section o f the ONH margin corresponding to the site of 
the papillomacular bundle. This region o f the ONH is considered to remain relatively 
stable throughout the course o f OAG such that the position o f the SRP is stable 
throughout the course o f the disease. The SRP is positioned below the retinal surface 
height at this location to account for the inter-individual variability in ONH topography 
(Burk RO. et al. 2000) (Figure 1.3). However, since demarcation of the ONH margin is a 
subjective task, the shape, size and location o f the ONH contour exhibits considerable 
between- and within-observer variability (Iester M. et al. 2001).
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Figure 1.3 - Position o f  the standard reference plane (SRP)
Owing to the considerable between-individual variability in the size, shape and tilt etc, o f 
the ONH, the distinction between a normal and abnormal ONH appearance, the HRT II 
stereometric parameters can provide limited/misleading information in cases o f large 
(>3.0mm2), small (<1.9mm2) and/or tilted ONHs (Schuerle AF and Schmidt E 2004).
Within these constraints, a number o f different mathematical approaches have been 
applied to the problem o f deriving a suitable algorithm that can make use of all the HRT 
data to distinguish between normal and OAG eyes (Bowd C, et al. 2002, Ford BA, et al. 
2003, Swindale NV. et al. 2000. Wollstein G, et al. 2000).
Linear discriminant function (LDF) analysis o f  combinations of optimally weighted 
stereometric parameters is a method widely used for the detection o f glaucomatous ONH 
abnormalities (Bathija R. et al. 1998. Mardin CY. et al. 1999, Mikelberg FS, et al. 1995).
27
Analysis o f HRT data by LDF analysis exhibits moderate to good levels o f  sensitivity 
(62-87%) and good to excellent levels o f specificity (80-96%) for the detection o f OAG 
(Bathija R. et al. 1998. Iester M. et al. 2000. Mardin CY. et al. 1999. Uchida H. et al. 
1996. Wollstein G. et al. 1998). This approach makes no assumptions about the 
parameters that are most likely to be useful; however, it does assume that distributions 
representing different populations are linearly separable. If this assumption is not well 
met. the performance of the LDF becomes degraded.
The Moorfields Regression Analysis (MRA) is a linear discriminant function that is 
incorporated into the software o f the commercially available HRT II and III. The MRA 
differs from most other LDFs by incorporating prior knowledge o f the physiological 
dependence o f NNR area on ONH size. The MRA algorithm is derived from linear 
regression o f sectoral and global ONH area against the log o f the NRR area. Due to 
increase in the variability o f NRR area measurements with increasing NRR area. (Jonas 
JB. et al. 1988) log scaling o f NRR. helps to normalize the observed size o f the ONH. 
With respect to the detection o f abnormality, log scaling o f NRR area makes the 
prediction intervals more appropriate for both small and large ONHs.
The first version o f the MRA algorithm available with the HRT II employs measurements 
obtained from 110 normal eyes to determine 95.0%. 99.0% and 99.9% confidence limits 
for the normal population. The latest software version (3.0) for the HRT III includes a 
larger and ethnicity-specific normative database. The Heidelberg Retina Tomograph III 
includes two databases, one o f  733 healthy Caucasian eyes and one o f 215 healthy
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African-American eyes. Based on the enlarged database, the equations o f the MRA have 
been modified. Both for HRT II and HRT III. an ONH is classified as ‘within normal 
limits' if  the global and sectoral NRR areas are all within the 95% confidence interval. 
Where the NRR area lies between the 95% and 99.9% confidence intervals for normality, 
the ONH is classified to be ‘borderline'. If the rim area of any segment falls outside the 
99.9% confidence interval then it is deemed to be ‘outside normal limits'.
The MRA (Version 1.0) exhibits sensitivity o f 74-84% and specificity of 41-96% in 
detecting glaucoma eyes with glaucomatous field loss by SAP (Miglior S. et al. 2003. 
Wollstein G. et al. 1998). This, and several other studies have demonstrated that 
sensitivities and specificities o f MRA reduce if  the ‘borderline' outcomes are considered 
to be normal (Ford BA. et al. 2003. Miglior S. et al. 2003). The diagnostic performance 
o f the HRT III MRA has not yet been extensively evaluated: although, one study has 
reported improved diagnostic performance by the HRT III MRA (Area under receiver 
operating characteristic. AROC 0.934) compared to the HRT II MRA (AROC 0.927) 
(Burgansky-Eliash Z. et al. 2007).
Several, automated classification systems have employed neural networks to classify eyes 
as normal or glaucomatous based upon the HRT II stereometric parameters (Bowd C. et 
al. 2002. Brigatti L. et al. 1996. Uchida H. et al. 1996). Neural networks, or specifically, 
multilayer perceptrons (MLPs) with back-propagated learning, can be trained to detect a 
relationship between input data and a pre-defined ‘gold standard* diagnosis by comparing 
its prediction with the labelled diagnosis, and learning from its mistakes (Rumelhart DE.
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et al. 1986). In general, neural networks differ from basic statistical techniques, such as 
LDFs. because they are able to adapt to the distribution of the variable rather than assume 
a predefined distribution. Neural network classification techniques appear to outperform 
conventional LDF techniques, including the MRA. in the detection o f OAG; however, 
studies comparing the two methods are scant (Bowd C. et al. 2002. Uchida H. et al. 
1996). Neural network classification systems provide good to excellent sensitivity (83%- 
92%) and excellent specificity (around 90%) for the detection of OAG (Bowd C. et al.
2002. Uchida H. et al. 1996).
Both the HRT III and HRT II are accurate (Dreher AW and Weinreb RN 1991. Janknecht 
P and Funk J 1994. 1995) and reproducible (Garway-Heath DF. et al. 1999) techniques 
for the quantification o f progressive damage.
To date, there are two general methods that have been used to identify progressive 
damage to the ONH; one based upon linear regression o f stereometric parameters and the 
other based upon evaluation o f longitudinal topographic height change.
Detection o f progressive damage by linear regression o f stereometric parameters permits 
quantification o f the extent o f the progressive damage, but provides little information 
regarding its location. Conversely, detection o f  progressive damage by localised 
reduction in topographic height is a better method for determining the location o f 
progressive damage but is unable to quantify the extent in real terms.
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The HRT III and HRT II software uses an automated algorithm to align consecutive 
images obtained from a series o f  follow-up examinations. This process ensures that 
corresponding locations o f consecutive images are compared for evidence o f progressive 
damage. The ONH margin contour from the base-line image is then replicated onto the 
follow-up images and stereometric param eters generated for each image. Due to the 
heterogeneity o f the stereometric param eters, evidence o f progressive damage is based 
upon normalized parameter values. If  no detectable damage occurs between consecutive 
images then normalized parameter values are equal to 0. Where a normal ONH is deemed 
to progress to advance disease, the normalised values are equal to -1 (Schuerle AF and 
Schmidt E 2004). The HRT II displays normalised stereometric values for global and 
three different sector combinations (Schuerle AF and Schmidt E 2004) for evidence of 
progressive damage.
Topographic change analysis (TCA) is a statistical method, which is incorporated into the 
standard HRT II software, to compare topographic height values from discrete regions 
called superpixels (4x4 pixels). Following the alignment o f the image series, evidence o f 
statistically significant change in topographic height, from the mean topographical height 
o f two baseline examinations, is determined for each superpixel using standard statistical 
procedures (Chauhan BC. et al. 2000). The probability that any observed change in 
topographic height occurring within a superpixel exceeds between-examination 
variability is evaluated by ANOVA and expressed in the form o f a probability map. 
Regions within the ONH and peripapillary retina that exhibit statistically significant 
reduction in topographic height from baseline (p<0.05) are highlighted by the
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superimposition o f magenta superpixels in the corresponding region o f the HRT II 
reflectance image. Regions within the ONH and peripapillary retina that exhibit 
statistically significant elevation in topographic height from baseline (p<0.05) are 
highlighted by the superimposition o f  green superpixels in the corresponding region o f 
the HRT II reflectance image. The TCA identifies statistically significant progressive 
damage when a cluster o f at least 20 magenta superpixels is present at each o f three 
consecutive follow-up examinations (Chauhan BC. et al. 2001). The clinical utility o f 
TCA has been investigated by a number o f  studies (Artes PH and Chauhan BC 2005. 
Chauhan BC. et al. 2001). In addition, topographic correspondence between progressive 
structural damage by the HRT II TCA and functional progression by SAP is often present 
when progressive damage is demonstrable by both techniques (Artes PH and Chauhan 
BC 2005. Chauhan BC. et al. 2001). However, a poor level o f agreement generally exists 
between HRT II TCA and SAP progression analyses (Artes PH and Chauhan BC 2005. 
Chauhan BC. et al. 2001).
A number o f factors that are related to the stage o f the glaucomatous disease and/or 
inherent to the test procedures are believed to be the source o f the poor association (Jonas 
JB. et al. 1988).
1.6.3 Optical Coherence Tomography (OCT)
The first optical coherence tom ographer for imaging the retina was demonstrated in 1991 
(Huang D. et al. 1991). Optical coherence tomography (OCT) is a non-invasive imaging 
technique capable o f providing sectional imaging in many biomedical situations
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especially imaging o f the retinal structures. The current generation o f the clinical 
standard OCT used in ophthalmology. StratusOCT (Carl Zeiss Meditec Inc.. Dublin. CA) 
has recently been surpassed by the fourth generation, which exhibits an axial resolution 
o f between 5 and 7pm. Other com mercially available instruments include: Niris (Imalux. 
Clevelend. OH). RT VuelOO (Optovue. Fremont. CA). LightLab (LightLab Imaging. 
Westford. MA). Bioptigen (Bioptigen Inc.. Research Triangle Park. NC). Spectral 
OCT/SLO (OTI. Ophthalmic Technologies Inc.. Toronto. Ontario. Canada) and 
Spectralis (Heidelberg Engineering GmbH. Dossenheim. Germany).
The principle o f OCT is based on low-coherence interferometry (Huang D, et al. 1991). 
Using broadband light sources generated by using superluminescent diodes or 
femtosecond lasers. OCT uses the properties o f reflected light from the tissue of regard, 
in the context o f this thesis, the retina, to construct a two- or three-dimensional model of 
the cytoarchitecture. The time-delay o f reflected light between points o f reflection is used 
to determine the thickness o f the tissues.
The light source in an OCT system is split into two arms: a sample arm (for example, 
containing the retina) and a reference arm (in most cases, a mirror). The combination o f 
reflected light from the sample arm and from the reference arm gives rise to an 
interference pattern. Areas o f the sample/retina that reflect back a lot o f light will create 
greater interference than areas that don 't. This reflectivity profile, called an A-scan 
contains information about the spatial dimensions and location o f structure within the
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sample/retina. A cross-sectional tomography (B-scan) is achieved by laterally combining 
a series o f axial depth scans (A-scan).
The lateral resolution o f the StratusOCT can be manually varied between 128. 256 and 
512 scans per record. The device has a scan rate o f 400 scans/second, thus acquisition 
time can also be controlled between approximately 25ms and 130ms.
The StratusOCT employs a false-colour image to represent the layered retinal 
architecture. The current StratusOCT software (Version 4.0) incorporates 19 scanning 
and 18 analysis protocols. Radial scans, along any vector, and circular scans, o f varying 
diameter, can be customised for a range o f applications.
Good agreement exists between OCT (StratusOCT and OCT) and histologically derived 
retinal thickness measurements in post-mortem eyes (Hee MR. et al. 1995. Huang D, et 
al. 1991. Schuman JS. et al. 2007. Toth CA. et al. 1997); although StratusOCT 
measurements are typically thinner (Dichtl A. et al. 1999. Varma R, et al. 1996).
The StratusOCT has an axial resolution o f  around 10pm  and yields structural images and 
measurements that are highly repeatable (SD ±5-8pm ) (Blumenthal EZ. et al. 2000. 
Budenz DL. et al. 2005. Carpineto P. et al. 2003. Paunescu LA. et al. 2004). The 
StratusOCT has been applied to range o f vitreoretinal and retinal disorders; however, 
given the topic o f this thesis the description o f its utility will be restricted to retinal 
applications related to OAG. Due to the very recent arrival o f the fourth generation
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instrument (Cirus high-definition OCT) this review is limited to versions up to 
StratusOCT.
The clinical application o f OCT/StratusOCT in the detection of OAG has been widely 
investigated (Bagga H. et al. 2005. Budenz DL. et al. 2005. Burgansky-Eliash Z. et al. 
2005. De Leon-Ortega JE. et al. 2006. Huang ML and Chen HY 2005. Jeoung JW. et al. 
2005. Kanadani FN. et al. 2006. Kanamori A. et al. 2006. Nouri-Mahdavi K. et al. 2004. 
Sihota R. et al. 2006). Several o f the standard StratusOCT scan protocols exhibit 
clinically useful levels o f sensitivity and specificity for the detection of OAG (Bourne 
RR. et al. 2005. Bowd C. et al. 2001. Burgansky-Eliash Z. et al. 2005. Kanadani FN. et 
al. 2006. Leung CK. et al. 2005. Medeiros FA. et al. 2005. Sihota R. et al. 2006. 
Wollstein G. et al. 2005). However, the RNFL thickness (3.4) protocol yields the highest 
levels o f diagnostic precision for the detection o f OAG with (AROC 0.91-0. 93) (Bourne 
RR. et al. 2005. Bowd C. et al. 2001. Leung CK. et al. 2005. Medeiros FA, et al. 2005. 
Sihota R. et al. 2006. Wollstein G. et al. 2005) and without visual field loss by SAP 
(AROC 0.87-0.89) (Bowd C. et al. 2001. Kanamori A. et al. 2006).
Whilst OAG is traditionally associated with structural alterations to the ONH and 
peripapillary retina. StratusOCT exhibits diagnostic precision for the detection o f OAG 
based upon measurements obtained from the macula region (Burgansky-Eliash Z, et al. 
2005. Leung CK. et al. 2005). Anatomically, the macula is defined as the region o f the 
retina where the ganglion cell layer is more than one ganglion cell thick. Since the 
photoreceptor layer is not considered to decrease in thickness in OAG, it is likely that a
35
reduction in retinal thickness in the macula region in OAG can be attributed to loss o f 
retinal ganglion cells and the RNFL.
The density o f ganglion cells at the macula is greater than at any other region o f the retina 
and accounts for up to 30% o f the total retinal thickness (Giovannini A. et al. 2002. 
Greenfield DS. et al. 2003). This observation lends favour to the hypothesis that the 
attenuation in retinal thickness at the macula can be used to detect OAG before 
substantial functional abnormality manifests. Scans obtained from the macula region also 
have the practical advantage o f easier image acquisition and less between-operator and 
between-session variability (Gurses-Ozden R. et al. 2004).
StratusOCT macula thickness and macula volume protocols exhibit moderate to excellent 
discriminatory power for the detection o f OAG suspect eyes (AROC 0.61) (Leung CK. et 
al. 2005) and in eyes with advanced OAG (AROC 0.89) (Burgansky-Eliash Z. et al. 
2005). respectively. However, the presence o f maculopathy. for example, age-related 
macula degeneration (AMD) and/or diabetic maculopathy. limits the utility o f macula 
scanning across the typical OAG population.
Longitudinal evaluation o f eyes with OAG and o f  eyes o f OAG suspects, during a 4.7 
year follow-up. shows that twice the number patients exhibited structural progression o f 
the RNFL by StratusOCT (22%) than o f  the visual field recorded by SAP (9%) 
(Wollstein G. et al. 2005). However, the lack o f an established criterion o f what 
constitutes a statistically significant reduction in RNFL thickness limits the validity o f
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this finding. The clinical utility o f  StratusOCT in longitudinal evaluation o f OAG by 
many research groups is ongoing and the results are eagerly awaited. Such studies will 
determine the true clinical utility o f  StratusOCT in the detection o f progressive structural 
damage.
1.6.4 Retina/ Thickness Analysis (RTA)
The retinal thickness analyser (RTA; Talia Technology Ltd. Neve-IIan. Israel) is a 
commercially available objective retinal-imaging device for measurement o f retinal 
thickness and retinal surface topography. Unlike OCT. which analyses retinal thickness 
as a single section. RTA is able to compile a series o f rapidly and consecutively acquired 
sections, within a small area, to produce a three-dimensional retinal thickness map. This 
facilitates measurement o f both the degree and size o f the affected area o f atrophy or 
oedema.
The principal o f the technique is similar to slit lamp bio-microscopy (optical 
triangulation) (Zeimer R. et al. 1998) in that a thin vertical slit of green laser light (540 
nm) is projected obliquely onto the retina. The reflected laser light enters an offset, closed 
circuit digital (CCD), camera and is analysed by software. During a single scan, 500 
points along the scan section are obtained. The shape o f the back-scatter profile can then 
be determined and is synonymous with retinal thickness (Zeimer R. et al. 1998). The 
RTA acquires 16 adjacent sectional scans covering an area o f 9mm2 (approximately 10° x 
10°) in approximately 320ms and combines the two-dimensional scan data from each 
profile to derive the three-dimensional model o f retinal topography. Five such scans are
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obtained at the macula, three scans at the ONH and an additional 5 scans over the 
peripapillary region.
The RTA then performs morphom etric analysis o f the data using automated algorithms. 
These algorithms divide each optical section into 20 segments with each segment 100 pm 
in length. The segment information is converted into a light-intensity profile (Zeimer R. 
et al. 1998) from which the separation between the vitreoretinal interface and the 
chorioretinal interface can be determined. These provisional thickness estimates are then 
corrected for erroneous results, arising from fixation instability, media opacity etc using a 
quality check algorithm. The corrected thickness data from adjacent and surrounding 
segments are then combined and smoothed using a specialised two-dimensional filter to 
create an 'un-calibrated' retinal thickness map. The un-calibrated map is sufficient to 
determine whether there are changes in thickness occurring within an individual over 
time: however, in order that measurements are comparable cross-sectionally. the effects 
o f the patient's axial length and the refractive error must be accounted for.
The latter two parameters are determined prior to scanning using a built in ultrasound A- 
scan (axial length), and the spherical focus adjustment necessary to acquire the image 
(spherical refractive error). A conversion factor is then applied to the un-calibrated data 
to derive measurements o f  retinal thickness in micrometers (pm).
The RTA has clinical application in the diagnosis and management o f a range o f posterior 
segment abnormalities, particularly those affecting the macula, such as age-related
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macula degeneration (Shahidi M. et al. 2002) and diabetic macula oedema (Oshima Y. et 
al. 1999. Weinberger D. et al. 1998).
The RTA provides a range o f com prehensive reports covering the posterior pole, 
peripapillary and ONH regions. The 'glaucom a complete' protocol analyses the posterior 
pole, peripapillary retina and ONH regions and is used in the detection and follow-up o f 
OAG. The RTA is able to derive a print-out detailing the rim/cup area map; a colour 
coded two-dimensional thickness map o f the posterior pole and an accompanying 
deviation probability map: the retinal surface height profile along an operator defined 
ONH margin contour and indices defining disc area, rim area, cup area, cup volume, rim 
volume and cup/disc area ratio measurements.
Statistically significant reductions in RTA derived macula thickness (P<0.05) in early 
OAG have been found compared to age-matched normal individuals (Asrani S, et al.
2003. Mori M. et al. 1999. Zeimer R. et al. 1998). The RTA is also able to detect 
perimacula retinal thinning in corresponding regions o f  the visual field where the 
measured sensitivity is beyond the dynamic range o f  SAP using a size III stimulus 
(Zeimer R. et al. 1998).
Despite its theoretical advantages, the RTA has failed to receive widespread clinical 
acceptance. This is principally due to several inherent limitations. Firstly, the accuracy o f 
the RTA measurements is reduced to a greater extent than most other imaging techniques 
where patients have unclear media and/or a pupil diameter less than 5 mm (Zeimer R. et
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al. 1998). Secondly, it is not known how the presence of co-existing maculopathy. such 
as diabetic maculopathy or age-related macula degeneration, which are also prevalent 
amongst the glaucomatous population, affects the diagnostic performance o f the 
technique.
Interestingly, no variation in retinal thickness with age is reported with the RTA (Asrani 
S. et al. 1999. Cvenkel B 2002). which is contrary to observations made using 
StratusOCT (Alamouti B and Funk J 2003). The most likely explanation for these 
disparate findings lies in the difference in the axial resolution o f the two devices. The 
axial resolution o f the RTA is approximately 5 times that o f the StratusOCT, being 50pm 
and 10pm respectively.
Until the RTA is capable o f  achieving a level o f resolution comparable with other 
commercially available imaging devices such as the fourth generation o f OCT, its 
application to the early detection o f OAG will remain limited.
1.6.5 Scanning Laser Polarimetry (SLP)
Scanning laser polarimetery (SLP) is an optical imaging technique for measuring the 
RNFL thickness (Bagga H and Greenfield DS 2004. Bagga H. et al. 2003. Weinreb RN. 
et al. 1990). The principal o f the technique is similar to CSLO but, instead, uses a longer 
wavelength laser (780nm) and an integrated polarimeter. The technique utilises the 
parallel architecture o f the axonal tubules o f the RNFL and their birefringence properties 
to measure the amount o f retardation o f  re fected  polarised light. Polarised light passing
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through the RNFL parallel to the axonal tubules is retarded to a greater extent than 
polarised light passing through the RNFL perpendicular to the axonal tubules. The net 
amount o f retardation is proportional to the RNFL thickness, whereby approximately 1° 
o f retardation is equivalent to 7.4pm o f thickness (Weinreb RN. et al. 1990).
Flowever. the birefringent properties o f  the eye do not originate solely from the RNFL. 
The cornea, lens and sclera also produce birefringence and their combined effects must 
be overcome in order to determine the amount o f light retardation that is due to the RNFL 
(Bowd C. et al. 2003. Greenfield DS. et al. 2000. Greenfield DS. et al. 2003. Weinreb 
RN, et al. 2002, Weinreb RN. et al. 2003). Early versions o f SLP (NFL Analyzer, I and
II. GDx and GDx Access [Laser Diagnostic Technology. San Diego, CA]) used a fixed 
corneal compensation (FCC) factor, derived from median values obtained from a normal 
population, to correct for anterior segment birefringence. Current versions o f SLP. such 
as the commercially available GDx-VCC (Variable Corneal Compensation) (Carl Zeiss 
Meditec Inc.. Dublin. CA) quantify the amount o f anterior segment birefringence 
compensation (ASBC) prior to determining the RNFL thickness (Weinreb RN, et al. 
2002). The ASBC is determined from the axis and magnitude (brightness) o f the macula 
‘bow tie ' that appears in the uncompensated SLP image. The ‘bow tie’ appearance arises 
from the interaction o f the linear birefringence o f  the anterior segment with the radial 
birefringence o f H enle's RNFL.
The GDx-VCC scan area covers an image field o f  40° horizontally and 20° vertically and 
image are obtained in approximately 0.7 seconds. By virtue of the long wavelength light
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(780-798nm) source the procedure is relatively unaffected by mild/moderate media 
opacity (Hollo G. et al. 1997).
The GDX-VCC printout includes a retardation map o f the ONH and peripapillary RNFL 
and summary statistics o f the measured RNFL thickness. The image o f the peripapillary 
retina is superimposed with colour-coded pixels to denote the significance o f any 
reduction in RNFL thickness below an expected level based on the distribution o f normal 
thicknesses contained within the database o f  the polarimeter. Pixels appear blue if the 
RNFL thickness falls between a probability for normality o f between 2% and 5%; light 
blue, between 2% and 1%; yellow, between 1.0% and 0.5% and red if the average RNFL 
thickness is less than the 0.5% prediction limit.
The GDx-VCC also generates six parameters that are based upon segment analysis o f the 
ONH and peripapillary retina nerve fibre layer thickness. The parameter with the highest 
discriminatory power for OAG is the Nerve Fibre Index (NFI) (AROC 0.89-0.98) (Bowd 
C. et al. 2001. Medeiros FA. et al. 2004, Reus NJ and Lemij HG 2004, 2004). This 
parameter represents the output o f a support vector machine that has been trained based 
upon the measurements taken from normal and OAG eyes. The Nerve Fibre Index values 
range between 0 (normal) and 100 (advanced OAG) and are proportionally related to the 
stage/severity o f OAG. Nerve fibre indicator values between 35 and 44 are considered 
borderline.
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Retinal nerve fibre layer thickness measurements derived by the GDx-VCC exhibit a 
curvilinear relationship with differential light sensitivity obtained with SAP (r2 = 0.640) 
(Leung CK. et al. 2005. Reus NJ and Lemij HG 2005). The diagnostic precision o f the 
StratusOCT and GDx-VCC for the detection OAG is approximately equal and generally 
yield AROCs between 0.85 and 0.94 (Kanamori A. et al. 2006. Leung CK. et al. 2005).
Limitations o f GDx-VCC include a reduction in the reliability o f RNFL thickness 
measurements in eyes with large peripapillary atrophic areas and a difficulty in 
determining ASBC in eyes with moderate to advanced maculopathy and/or a history o f 
corneal refractive surgery (Kook MS. et al. 2002). An alternative algorithm for individual 
compensation o f  corneal birefringence, the Enhanced Corneal Compensation (ECC). has 
been developed for the GDx (Reus NJ. et al. 2006). which appears to exhibit improved 
diagnostic precision for OAG than the GDx-VCC (M edeiros FA. et al. 2007) although 
further studies are warranted to confirm this observation.
1.7 Electrophysiology o f vision
Electrophysiological assessment o f visual function assesses the integrity o f specific visual 
areas and pathways. The clinical appeal o f  electrophysiology assessment o f vision, as 
with ocular imaging, lies in the objective nature o f  the procedures. Thus, they are 
relatively robust to the effects o f patient induced variables, such as learning and fatigue. 
In addition, electrophysiological procedures provide a unique assessment o f the electrical 
and chemical processes underlying vision.
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The visual evoked potential (VEP) and electroretinogram (ERG) evaluate the functional 
integrity o f the visual pathway at the level o f the visual cortex and retina, respectively. 
Since the VEP and ERG are typically small (mV). the recording conditions under which 
these tests are conducted must be carefully standardised and controlled (Marmour MF. et 
al. 2004. Odom JV. et al. 2004). This ensures that electrophysiological recordings can be 
more easily replicated and directly compared between institutions.
Several modifications o f the standard VEP and ERG techniques have evolved which offer 
improved spatial resolution o f functional abnormality and/or better sensitivity for specific 
visual pathway damage in OAG. with consequent improved diagnostic precision. These 
techniques, include the multifocal VEP (mfVEP). pattern electroretinogram (PERG). 
photopic negative response (PHNR) and the multifocal ERG (mfERG), and are described 
in further detail in the following sections.
1.7.1 The Visual Evoked Potential (VEP)
The visual evoked potential (VEP) is a small electrical signal that is produced by the 
primary visual processing area o f  the Occipital Cortex (V I) in response to a retinal 
stimulus (Carr RE and Siegel IM 1982). The VEP is typically between 3 and 25pv in 
magnitude and is embedded within the electroencephalogram (EEG). which is much 
greater in amplitude (around lOOpv). The EEG represents non-specific brain activity that 
is recorded simultaneously with the VEP. As a result, specialist filtering and 
amplification procedures are required to separate the VEP from the EEG.
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The VEP is recorded using electrodes that are placed in contact with the scalp overlying 
the visual cortex (Area V I). Specifically, two silver chloride or two gold plated 
electrodes are positioned above and below each other along the vertical midline of the 
cranium constitute the active and a reference channels, respectively. This configuration is 
referred to as a bipolar occipital straddle (BOS). A third channel, or ‘ground' electrode, is 
attached to the centre o f the forehead or to an ear lobe.
The VEP can be generated either in response to a Ganzfeld stimulus that is controlled for 
luminance, presentation rate and/or wavelength, or in response to a patterned stimulus 
that is controlled for field size, pattern size, contrast, retinal location, presentation rate 
and wavelength (Odom JV. et al. 2004).
Although the VEP is a mass response from the entire retina it is primarily used as a 
measure o f macula function. This is due to the anatomical arrangement o f the visual 
cortex. The posterior surface o f the occipital cortex is responsible for processing 
information derived from the central retina. Activity within this region is more easily 
detected by the recording electrodes than activity in the medial aspect o f the occipital 
cortex, deep within the calcarine fissure, that is responsible for processing o f information 
from the peripheral retinal locations. In addition, cortical magnification means that a 
larger proportion o f the visual cortex is responsible for the processing o f information 
derived from the macula than would be expected on the basis of the relative amount o f 
the retina occupied by this region (Duncan RO and Boynton RM 2003). A third reason.
which applies only to patterned stimuli, relates to the fact that only the macula region can 
resolve high spatial frequency stimuli.
The VEP has traditionally been utilised during the assessment of gross macula function in 
paediatric and learning-disabled patients by virtue o f its non-invasive and objective 
nature. The VEP has also been applied to a number o f diseases including; demyelinating 
optic neuropathies (Halliday AM. et al. 1972. Nemerow NS and Enns N 1972. Richey 
ET. et al. 1971) such as optic neuritis, retrobulbar optic neuritis and multiple sclerosis; 
the investigation o f macular disease (Johnson LN. et al. 1986). such as central serous 
maculopathy. macular holes and macular cysts; and in the investigation of more diffusely 
occurring optic neuropathies, such as OAG (Kubova Z. et al. 1996-97. Towle VL. et al. 
1983). However, the principal limitation o f  the VEP is the large between-individual 
variability o f the response both in terms o f magnitude and waveform. This arises from the 
physiological variation in cortical anatomy (Steinmetz H. et al. 1989, Stensaas SS, et al. 
1972). the magnitude o f the EEG. and the thickness and density o f bone, skin and fat 
tissue (Carr RE and Siegel IM 1982).
1.7.2 The Multifocal Visual Evoked Potential (m/VEP)
A major advancement to the VEP technique is the multifocal VEP technique (mfVEP). 
The mfVEP is a technique that derives multiple and discrete VEPs from localised areas of 
the retina. The mfVEP occurs in response to a specialised, computer-controlled stimulus 
that is subdivided into a number o f sectors, each o f which is responsible for generating a 
VEP. Each sector contains an array o f high contrast black and white checks. The VEP
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derived from each sector occurs in response to pattern reversal, as the black and white 
checks reverse in polarity. The reversal o f polarity within each sector is controlled by a 
computer-driven binary m-sequence. which allows VEPs corresponding to each o f the 
sectors to be recorded simultaneously.
Similar to the VEP. the mfVEP exhibits considerable between-individual variability both 
in amplitude and in waveform. Consequently, the clinical utility o f the procedure has 
been put under scrutiny (Baseler HA. et al. 1994). However, due to the homogeneity of 
the mfVEP obtained from the right and left eyes o f a normal individual, inter-ocular 
comparison o f mfVEPs is advocated in the uni-ocular and/or asymmetrical conditions 
including OAG (Hood DC 2000. Hood DC. et al. 2004).
The mfVEP represents a promising objective method for identifying functional deficits in 
glaucoma (Baseler HA. et al. 1994. Goldberg I. et al. 2002. Graham SL. et al. 2005, 
Graham SL. et al. 2000. Hasegawa S and Abe H 2001. Hood DC, et al. 2004, Hood DC 
and Zhang X 2000. Hood DC. et al. 2000, Klistorner Al and Graham SL 2000, Klistorner 
AL et al. 1998. Thienprasiddhi P. et al. 2003. Thienprasiddhi P, et al. 2006). 
Improvements to the technique (see following sections), such as multiple channel 
recording (Hood DC. et al. 2002. K listorner AL et al. 2000), inter-ocular analysis 
(Graham SL. et al. 2000. Hood DC. et al. 2000) and signal-to-noise amplitude assessment 
(Klistorner Al and Graham SL 2001. Zhang X. et al. 2002) have helped to increase the 
clinical utility of the mfVEP.
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The mfVEP can accurately discriminate between persons with glaucomatous visual field 
loss and those with normal vision (Baseler HA. et al. 1994. Goldberg I. et al. 2002. 
Graham SL. et al. 2005. Graham SL. et al. 2000. Hasegawa S and Abe H 2001. Hood 
DC. et al. 2004. Hood DC and Zhang X 2000. Hood DC. et al. 2000. Klistorner Al and 
Graham SL 2000. Klistorner AL et al. 1998. Thienprasiddhi P. et al. 2003. 
Thienprasiddhi P. et al. 2006). The mfVEP can identify as abnormal, perimetrically 
normal areas o f the glaucomatous visual field by SAP (Hood DC. et al. 2003. 
Thienprasiddhi P. et al. 2003). and even in eyes suspected o f having OAG with normal 
visual fields by SAP (Goldberg I. et al. 2002. Graham SL. et al. 2000. Klistorner Al and 
Graham SL 2000. Thienprasiddhi P. et al. 2006).
The mfVEP stimulus, employed by the clinical "gold standard* device for measuring the 
mfVEP. the Visual Evoked Response Imaging System (VERIS. EDI. San Mateo. CA) 
(Figure 1.4). is a checkerboard style array o f checks and is divided into 60 sectors. Each 
sector contains 16 checks, o f  which 8 are black and 8 are white (Balachandran C, et al. 
2003. Hood DC and Greenstein VC 2003). The luminance o f the white checks typically 
falls between 100-200cd/m2 and the black checks are typically < lcd/m 2 (Hood DC 2003). 
depending upon the stimulus delivery system used. The sectors progressively increase in 
size from the centre to the periphery o f  the checker-board and are scaled to be 
approximately equal in their representation in the cortex (Baseler HA, et al. 1994). 
Modified versions o f the stimulus spatial array are available for use with alternative 
systems, such as the AccuMap (ObjectiVision Pty. Ltd.. Sydney, Australia). The typical 
mfVEP is capable o f examining the functional integrity o f the central visual field out to
48
25° eccentricity (Baseler HA, et al. 1994. Goldberg I, et al. 2002, Graham SL. et al. 2005. 
Graham SL, et al. 2000. Hasegawa S and Abe H 2001. Hood DC. et al. 2004, Hood DC 
and Zhang X 2000. Hood DC. et al. 2000. Hood DC. et al. 2003. Klistorner Al and 
Graham SL 2000. Klistorner Al. et al. 1998, Thienprasiddhi P. et al. 2003, 
Thienprasiddhi P. et al. 2006).
F igure 1.4 - The typical checkerboard style o f  the multifocal Visual Evoked Potential 
(mfVEP) Stimulus.
A major factor governing the ‘quality’ o f  the mfVEP response is the magnitude o f the 
EEG (Klistorner Al and Graham SL 2001). Multifocal VEP recordings must be 
normalised for the effects o f the EEG in order that the mfVEP can be determined. The
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established method for this utilises two discrete recording ‘windows', o f equal duration; 
one containing the EEG and the m tVEP (signal window) and a second containing only 
the EEG (noise window) (Hasegawa S and Abe H 2001. Hood DC. et al. 2002. Zhang X. 
et al. 2002). From these two recordings, the magnitude of the signal window relative to 
the noise w indow s is expressed in term s o f  their root mean squared (RMS) signal-to- 
noise ratio (SNR). Root mean squared values are a traditional way of representing the 
magnitude o f  a waveform. Root mean squared values are derived from the difference 
between th e  amplitude (pv) at each time interval (ms) during the recording window and 
the mean am plitude o f the waveform. These values are then squared and averaged. The 
square root o f  this average is the RMS value (Hood DC and Greenstein VC 2003. Zhang 
X. et al. 2002). Since the signal window contains both the signal (VEP) and the noise 
(EEG). the RMS SNR for mfVEP recordings with very little signal will approach 1. 
rather than 0 (Hood DC and Greenstein VC 2003. Zhang X. et al. 2002).
In most individuals. VEPs originating from the superior and inferior visual field are 
opposed in polarity i.e. appear counter-phased (Harding GF. et al. 1996. Zhang X, et al. 
2002). T h is observation is consistent with the known anatomy o f the visual cortex (V I) 
(Clark VP. et al. 1995. Jeffreys DA and Axford JG 1972). Most o f area VI lies within the 
calcarine fissure, the upper and lower banks o f which represent the lower and upper 
visual field, respectively. The cells in the calcarine fissure generating mfVEP responses 
are thus oriented in opposite directions and generate dipoles o f opposing polarity. The 
distance o f  the calcarine fissure varies between 1.5cm below and 3.5cm above the inion 
(Hood DC and Zhang X 2000). To ensure that the calcarine fissure is below the active
electrode, in a majority o f patients the active electrode is mounted between 3 and 4cm 
above the inion (Hood DC and Zhang X 2000).
The conventional BOS electrode configuration (single vertical midline channel) has a 
tendency to derive smaller responses in the superior visual field relative to those from the 
inferior visual field. This is due to the angle between the calcarine sulcus and the 
reference electrode, which when placed at the inion. favours responses from the upper 
banks o f the calcarine sulcus (lower visual field) (Hood DC and Greenstein VC 2003). 
One method to overcome this effect is to place the active electrode below the reference 
electrode (Graham SL. et al. 2000. Klistorner Al and Graham SL 2000. Klistorner AL et 
al. 1998): however. mfVEPs recorded in this fashion exhibit only a marginal 
improvement in superior field response amplitudes in a minority o f patients (Hood DC, et 
al. 2002). In addition, this electrode configuration creates problems associated with 
attaching the electrodes to the nape o f the neck and is contaminated with extra noise from 
the neck muscles.
The single channel BOS electrode configuration is also limited in its representation o f 
m fVEPs from the lower horizontal region o f  the visual field (Klistorner Al and Graham 
SL 2000). At the level o f the cortex, this region o f the visual field is represented deep 
within the calcarine fissure at its base. The dipoles in this region o f the cortex are 
generated perpendicular to the vertically oriented BOS electrodes and thus little or no 
signal is detected (Klistorner Al and Graham SL 2000). The SNR from these regions is 
improved by utilizing two additional active electrodes, with a common reference, placed
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lcm  above and 4cm laterally to the Inion on either side (Hood DC. et al. 2002. Klistorner 
Al and Graham SL 2000). By collating the responses with the greatest SNR from each 
channel, the visual field is better represented in terms o f its true functional capacity 
(Hood DC. et al. 2002).
The topographical correspondence o f  area VI with the visual field is symmetrical in the 
right and left eyes o f an individual. Thus, the mtVEP obtained from the right and left 
eyes in normal individuals are essentially identical (Graham SL. et al. 2000. Hood DC
2000. Hood DC. et al. 2000). This observation, as mentioned earlier, has given rise to 
inter-ocular mfVEP symmetry analysis as a means o f identifying unilateral or 
asymmetrical visual abnormality (Graham SL. et al. 2000. Hood DC. et al. 2000). One of 
the drawbacks o f this method is the possibility that bilateral damage will not be detected. 
In other words, defects in the same part o f the field in both eyes (e.g.. inferotemporal in 
one eye and inferonasal in the other eye) will not be detected. The mfVEP can be used to 
detect functional abnormality by comparing the response amplitude, in any given sector, 
with the statistical confidence interval o f the VEP amplitude with the distribution o f 
normal values from the normal population (monocular test) (Goldberg I. et al. 2002, 
Hood DC 2003. Hood DC. et al. 2003). By combining monocular and interocular 
methods, the mfVEP exhibits good agreement with SAP in OAG (Goldberg I, et al. 2002. 
Hood DC and Greenstein VC 2003. Hood DC. et al. 2002. Hood DC, et al. 2004).
The relationship between mfVEP and visual field loss by SAP is difficult to elucidate 
given that there are clear differences between the techniques. Firstly. mfVEP sectors and
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the stimulus locations for Program 30-2 and 24-2. for example, do not correspond 
spatially. Secondly, the stimulus locations are spaced evenly throughout the visual field, 
whereas the mfVEP employs a larger proportion of sectors in the regions close to 
fixation. Finally, there is large variability in the mfVEP RMS SNR even between normal 
individuals, thus the quantitative relationship with the differential light sensitivity 
recorded by SAP is difficult to expound especially where RMS SNR is low (Hood DC. et 
al. 2002).
However, the mfVEP has steadily gained acceptance as an objective method for 
topographical assessment o f visual function in OAG. Multifocal VEP abnormalities have 
been found in 20% of glaucoma suspects and in 16% of patients with ocular hypertension 
(Thienprasiddhi P. et al. 2006). In addition. mfVEP abnormalities were found in the non­
affected hemifield in 37.5% o f eyes (n=16) with glaucomatous SAP abnormality in 
hemifields. which appeared normal (Thienprasiddhi P. et al. 2003). These observations, 
combined with the widely accepted consensus that considerable glaucomatous damage 
occurs prior to visual field loss by SAP supports the use o f the mfVEP for the detection 
o f pre-perimetric OAG.
The test-retest variability o f the mfVEP has not been widely investigated: One study 
showed that the between-test variability o f mfVEP amplitudes (SD +1.63-4.3dB) was less 
than o f the between-test variability for SAP (SD +2.4-8.9dB) in normal individuals 
(Fortune B. et al. 2006). However, in OAG the mfVEP amplitude exhibits greater 
variability (SD ± 13.39dB) than for SAP (SD ±  9.88dB) (Chen CS. et al. 2003. Fortune 
B. et al. 2006). Two important factors, which affect the test-retest variability of the
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mfVEP are the SNR (Fortune B. et al. 2006) and location of the mfVEP within the visual 
field. The improvement o f SNR over repeated visits is also postulated (Bjerre A. et al. 
2004). The precision in repositioning the recording electrodes from one examination to 
the next will also play a major role in the between-test variability o f the mfVEP 
technique. In addition, it is almost impossible to re-position the recording electrodes on 
the same person at exactly the same locations on two separate occasions, especially 
where two different technicians/clinicians conduct the examinations.
Since inter-ocular comparison o f mfVEPs is the standard method to detect glaucomatous 
functional abnormality, it is important to understand how the relationship between the 
ratio o f signal amplitudes from the right and left eyes changes over time. This 
characteristic o f the mfVEP technique has yet to be determined. Standardisation of test 
procedures will be an important step in optimising the quality/SNR o f mfVEP recordings 
and reducing test-retest variability.
Studies are required to determine the full clinical utility o f the mfVEP technique in the 
identification o f progressive functional damage in OAG.
/. 7.3 The Electroretinogram (ERG)
The electroretinogram (ERG) is an examination used to assess the functional integrity 
both o f neuronal and non-neuronal components o f the retina. The ERG represents the 
light-evoked changes to the electrical and chemical gradients within the retina that occur 
following phototransduction.
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Published guidelines classify the standard ERG into 5 subtypes (Marmour MF. et al. 
2004): the rod ERG. the standard combined ERG. the oscillatory potentials, the single- 
flash cone ERG and the 30Hz flicker ERG.
The precise waveform for each ERG subtype is governed by a number of parameters 
(Marmour MF. et al. 2004). For example, the rod ERG. standard combined ERG and the 
oscillatory potentials are evoked under scotopic conditions from the dark-adapted retina. 
Conversely, the single-flash cone ERG and the 30Hz flicker ERG are evoked under 
photopic conditions from the light adapted retina. With the exception o f the oscillatory 
potentials and the 30FIz flicker ERG. the ERG consists o f two principal components, 
namely the a- and b- waves. The retinal origins o f these waves have been widely 
investigated (Friedburg C. et al. 2004. Friedburg C. et al. 2001. Paupoo AA. et al. 2000. 
Rager G 1979). The a-wave is a small deflection in the ERG waveform and has a latency 
o f around 25ms (Marmour MF. et al. 2004). The a-wave represents photoreceptoral 
activity and occurs due to the photoreceptor outer segments becoming hyperpolarised as 
sodium ions enter the cells during phototransduction. In accordance with the published 
International Society for Clinical Electrophysiology o f  Vision (ISCEV) guidelines, an 
ERG a-wave can be obtained that is representative o f rod cell activity (rod ERG), cone 
cell (single flash ‘cone ERG') activity, or both (standard combined ERG) (Marmour MF, 
et al. 2004).
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The ERG b-wave is a large positive deflection in the waveform that occurs immediately 
after the a-wave. The b-wave arises from light-induced changes to the photoreceptors, 
and the subsequent reduction in neurotransmitter release at their synaptic terminals. This 
results in an increase in extra-cellular potassium levels in the outer-plexiform layers 
causing depolarisation o f the Muller cells and a transretinal current that is responsible for 
the b-wave (Newman EA and Odette LL 1984).
The ISCEV standard ERGs are dominated by activity in the outer retinal layers. Since the 
ERG has limited representation o f inner retinal function, their application in OAG is 
limited; however, several specialised ERGs are described in the literature that are 
believed to represent inner retinal function, specifically retinal ganglion cells. A number 
o f these specialised ERGs. namely the pattern ERG (PERG) and the photopic negative 
response (PHNR) have been suggested to be o f use for the detection o f OAG and are 
described in the following sections.
1.7.4 The Pattern Electroretinogram (PERG)
The pattern electroretinogram (PERG) evaluates the activity in the retina that is induced 
when an achromatic chequered stimulus reverses in contrast (Berninger T and 
Schuurmans RP 1985). The PERG stimulus has equal numbers o f light and dark checks, 
which enables the total luminous flux entering the eye to be kept constant. The PERG is 
not a response to the pattern element o f  the stimulus, per se, but rather the local increase 
or decrease in retinal luminance that occurs when the stimulus polarity reverses. For this
reason, intra-ocular light scatter must be minimised during the procedure (Bach M and 
Mathieu M 2004).
The PERG is characterised by a prominent positive deflection known as P I. or. P-50. 
which occurs approximately 50ms after polarity reversal. The PI/P-50 is followed by a 
negative deflection known as N l. or. N-95 which occurs approximately 95ms after 
polarity reversal (Berninger T and Schuurmans RP 1985). The PERG is believed to have 
an inner-retinal source since it is diminished in primate retinas following intravitreal 
injection o f tetrodotoxin (TTX) (a selective blocker o f inner retinal spiking activity) 
(Viswanathan S. et al. 2000); in laser induced OAG (Viswanathan S. et al. 2000); and in 
primate and cat retinas following optic nerve transection (Maffei L and Fiorentini A 
1981). In human retina, the N-95 is diminished in OAG (Harrison JM. et al. 1987. 
Kirkham TH and Coupland SG 1983. Trick GL and W intermeyer DH 1982) whilst the P- 
50 remains relatively unaffected (Porrello G and Falsini B 1999. Toffoli G. et al. 2002. 
Wanger P and Persson HE 1987). The N-95 also exhibits a contrast dependency and 
spatial tuning; thus a retinal ganglion cell origin is widely accepted (Bach M 2001. 
Berninger T and Schuurmans RP 1985, Holder GE 2001. 1987. Schuurmans RP and 
Berninger T 1985. Thompson DA and Drasdo N 1987. Viswanathan S, et al. 2000). The 
PERG has demonstrated clinically useful levels o f  diagnostic precision in correctly 
identifying OAG (sensitivity and specificity o f 92%) (Bayer AU, et al. 2002). PERG 
abnormalities have also been found in patients with OHT who later develop OAG (Bach 
M. et al. 1998, Panagachis E and Moschos M 1998, Pfeifer N. et al. 1993, Ruben ST, et 
al. 2004). Despite these findings, the PERG will not replace current clinical examinations
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for the identification o f OAG due to the inherently high between-test variability (up to 
between 30% and 67% of the mean value) (Holopigian K. et al. 1988). The very small 
magnitude o f the PERG also necessitates experienced specialist technicians to derive an 
adequate SNR for clinical use.
1.7.5 The Photopic Negative Response (PhNR)
The photopic negative response is recorded under specialised conditions and is a slow 
negative potential following the ERG b-wave. The retinal generators of this component 
o f the ERG are believed to be the retinal ganglion cells (Bui BV and Fortune B 2004. 
Gotoh Y. et al. 2004. Viswanathan S. et al. 2001). The PhNR is discernable in the 
conventional achromatic ERG (Colotto A. et al. 2000. Viswanathan S. et al. 2001); 
however, a much greater amplitude occurs in response to chromatic stimuli (Drasdo N, et 
al. 2001. Fortune B. et al. 2004). The short wavelength sensitive cone (S-cone) PhNR is 
derived in response to short duration, blue light (that stimulates S-cone activity) 
presented on a red background (to suppress long- and medium-wavelength cone activity, 
respectively) and yields clinically useful levels o f diagnostic precision in OAG (AROC 
0.86) (Drasdo N. et al. 2001).
The PhNR is believed to arise from the increase in extracellular potassium ions from glial 
cells in the proximal retina that occurs as a direct result o f retinal ganglion cell spiking 
activity in the inner retina (Viswanathan S. et al. 2000). Thus, either damage to the inner 
retina or to the glial cells is capable o f attenuating the response (Viswanathan S. et al. 
2000). In primate models o f  OAG. damage both to retinal ganglion cells and to glial cells
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is hypothesised as the histopathology responsible for reduced PhNR amplitudes 
(Viswanathan S. et al. 2000).
Both in experimental OAG models and in pharmacological dissection studies using TTX 
in primates, attenuation o f the PhNR occurs in the presence of the relative preservation o f 
a- and b-wave amplitudes (Fortune B. et al. 2004. Viswanathan S. et al. 2000. 
Viswanathan S. et al. 1999). Thus in primates, at least, the PhNR appears to solely reflect 
spiking activity o f the retinal ganglion cells and their axons. In humans, the time course 
o f the PhNR is reminiscent o f the N95 component o f the PERG that is reduced in inner 
retinal dysfunction (Holder GE 1987) and suggests that the two responses share a 
common retinal origin. Thus, the PhNR is a viable technique for the identification of 
retinal ganglion cell dysfunction in OAG. In comparison with the PERG. the PhNR has 
the practical advantages that neither refractive correction nor exact foveal positioning is 
required to obtain useful responses. Furthermore, the PhNR is affected to a lesser extent 
by the presence o f media opacity and yields an overall larger response than the PERG. 
However, the PhNR technique is neither new nor has it replaced SAP. This is largely due 
to the need for trained expert technicians to carry out the procedure in addition to a lack 
o f understanding amongst clinicians o f the precise retinal origin o f the response in 
humans.
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1.7.6 The Multifocal Electroretinogram (mfERG)
The multifocal ERG (mfERG) permits topographical assessment o f retinal function 
(Bearse MA and Sutter E 1996. Sutter E and Tran D 1992. Sutter EE 2001). The mfERG 
is an adaptation o f the full field ERG and is analogous to the mfVEP in its method o f 
stimulus delivery and response extraction. Several institutions have derived mfERG 
responses using custom devices; however, several instruments, including the Visual 
Evoked Response Imaging System (VERIS. EDI. San Mateo, CA) and the Retiscan 
(Roland Instruments. Germany), are commercially available.
The guidelines for basic mfERG recording recommend the use o f a stimulus that consists 
o f an array o f alternating black and white hexagonal elements (Marmour MF. et al. 2003) 
(Figure 1.5). The number of hexagonal elements can be varied (typically either 37, 61 or 
103 elements are employed) to control the spatial resolution o f the procedure. However, 
an increase in the spatial resolution o f the stimulus reduces the SNR of each mfERG 
response.
60
Figure 1.5 - The typical multifocal Electroretinogram (mfERG) stimulus.
Achieving accurate recordings at high spatial resolution requires excellent SNR and 
equally good fixation stability by the patient. Several studies have derived adequate SNR 
both using 241 (Heinemann-Vernaleken B. et al. 2001, Sutter E and Tran D 1992) and 
509 (Poloschek CM and Sutter EE 2002) stimulus elements; however, these protocols 
required recording times of up to 1 hour, which is unreasonable for clinical use.
The hexagonal elements o f the mfERG stimulus increase in size from the centre to the 
peripheral visual field in order that they elicit approximately equal size mfERG responses 
in individuals with normal retinal function (Sutter E and Tran D 1992).
As with the conventional ERG. the mfERG is recorded using a corneal electrode and the 
same amplification and filtering procedures. The stimulus delivery system is typically 
either a high-luminance (100 and 200 cd/m2) (Marmour MF. et al. 2003) CRT or LCD 
monitor, or an LED device. The sequence o f stimulus element contrast reversal is 
predetermined by a computer controlled binary m-sequence. The frequency o f contrast 
reversal is governed by the frame rate o f  the stimulus delivery and occurs at constant 
intervals referred to as the base period (bp). For a typical 75Hz CRT monitor, the bp is 
equal to 13.3ms (1 second /75Hz). At the end o f  each bp. each stimulus element has a 
50% chance o f undergoing contrast reversal and the probability o f contrast reversal is 
governed by the m-sequence. Under these conditions, the mfERG waveform bears 
superficial resemblance to the conventional photopic flash ERG waveform; however, 
residual differences arise from the more rapid rate o f contrast reversal for the mfERG and 
the way in which the responses are extracted (Hood DC 2003. Hood DC. et al. 2002).
In its standard form, the first order mfERG (Figure 1.6) is not considered to provide any 
information about inner retinal and/or retinal ganglion cell function (Hood DC, et al. 
2002). However, under non-standard recording and filtering conditions the mfERG can 
be used to identify inner retinal abnormality (Bearse MA, et al. 1995, Fortune B, et al. 
2002. Hood DC. et al. 2001. Hood DC. et al. 2002, Klistorner Al and Graham SL 2000. 
Sutter EE and Bearse MA 1999).
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The first description o f a ‘pure* retinal ganglion cell component o f the human mfERG 
was described over a decade ago (Bearse MA. et al. 1995) and originated within the first 
slice o f the second order response kernel (K2.1) (Figure 1.7). The K2.1 response was 
decomposed into two principal components: the optic nerve head component (ONHC) 
and the retinal component (RC) (Bearse MA. et al. 1995). The latency o f the ONHC 
exhibits nasal-temporal asymmetry whereby the latency o f the waveform increases as a 
function o f the distance between the site o f focal stimulation and the ONH. Since the 
conduction velocity o f action potentials along unmyelinated retinal nerve fibres is slower 
than for myelinated nerve fibres, the response has been attributed to a signal source near 
to the ONH (Bearse MA. et al. 1995. Sutter EE and Bearse MA 1999). The ONHC is also 
exhibited by monkey retina (Hood DC, et al. 2001); however, the response is diminished 
in monkey retinas exposed to TTX (Hood DC, et al. 1999) and to NMDA (Hare WA, et 
al. 2001). This observation supports the notion that the ONHC has an inner retinal origin 
in human (Fortune B. et al. 2002).
The magnitude o f the ONHC is enhanced by reducing the stimulus contrast to 50% 
(Hood DC. et al. 1999): by using DTL recording electrodes (Hood DC. et al. 2002); by 
employing an in situ DTL reference electrode in the contralateral eye (Hood DC. et al.
2001. Sutter EE and Bearse MA 1999); and interleaving blank frames between contrast 
reversals (Fortune B. et al. 2002). When combined, these considerations for optimal 
ONHC recording will help to define a standard protocol for recording the ONHC. 
However, further research as to the precise origin o f the ONHC and ways to extract the 
response is needed before the technique can be considered for clinical use.
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Non-linear it}' and m-sequences
The human visual system is described as a ‘non-linear' system since chemical and 
electrical activity within the retina at any time point is governed by preceding events. 
Thus, the influences o f visual events occurring prior to an ERG stimulus, for example, 
have the power to alter the ERG waveform provided that the event occurs within a finite 
time period (memory) to the stimulus. In a linear system the memory is equal to the 
duration o f  the response. However, in non-linear visual system, visual activity can have a 
considerable effect on subsequent activity if  it falls within the memory of the visual 
system.
The rate o f  contrast reversal of the mfERG stimulus is sufficiently slow for the retina to 
register each contrast reversal as a discrete event; however, the individual responses to 
successive contrast reversals overlap. The effects o f preceding stimuli on the mfERG are 
expressed in a ‘kernel series' for each stimulus element. By analysing mfERGs that occur 
after preceding stimuli, the properties o f non-linear systems, such as adaptive 
mechanisms, can be assessed. The kernels series derived by the mfERG technique permit 
topographical mapping o f non-linear response properties across the central retina. Higher 
order kernels represent increasingly more complex interactions between events occurring 
at each bp interval. An in-depth description o f higher order kernel response derivation is 
beyond the scope o f this review; however, a comprehensive review is provided by Sutter 
(Sutter EE 2000).
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The first order kernel o f the mfERG represents the average retinal response to a focal 
flash (the mean difference between a response to a light and dark stimulus event). In a 
similar way, the second order response reflects the mean difference between responses to 
a flash, which is preceded by a bright stim ulus event, and a flash that is preceded by a 
dark stimulus event (Figure 1.7). This pattern o f data analysis continues for still higher 
response kernels.
Flash Sequence R esponse
Figure 1.6 -  The derivation o f the first order response (K l) based on a CRT stimulus 
projection system.
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Flash Sequence
Figure 1.7 -  The derivation o f the first slice o f the second order response (K2.1) based 
on a CRT stimulus projection system.
The rapid rate, at which the mfERG stimulus reverses in contrast, combined with its high 
luminance, produces a response that is principally mediated by the cones. The first order 
mfERG response typically exhibits an initial negative trough (N l) proceeded by a 
positive peak (P I) and a final negative trough (N2). The N l, PI and N2 components of 
the first order mfERG bear a superficial resemblance to the a-wave, b-wave and PhNR, 
respectively, o f the photopic flash ERG. However, since the stimulus and analysis 
conditions under which the two responses are derived are different, in addition to the fact 
that the mfERG is a mathematical extraction and not a measured electrical potential, the
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waveforms are not described using the same nomenclature (Marmour MF. et al. 2003). 
Slowing down the rate o f stimulus presentation such that at least 7bp intervals (106ms) 
are interleaved between contrast reversals (the average separation being 212ms) further 
enhances the likeness o f the mfERG and flash ERG waveforms (Hood DC. et al. 1999). 
Thus, the two waveforms are likely to share the same retinal source generators.
7. 7.7 The Multifocal Pattern E/ectroretinogram (mfPERG)
The diagnostic ability o f the standard PERG for the detection o f glaucomatous 
abnormality has prompted the development o f  its multifocal PERG counterpart 
(mfPERG) (Klistorner Al. et al. 2000. Steifelmeyer S. et al. 2004). In OAG. the mfPERG 
is attenuated (Klistorner Al. et al. 2000. Steifelmeyer S. et al. 2004) with little/no effect 
on the latency o f the response (Berninger T and Schuurmans RP 1985). unlike the 
standard PERG: However, the location o f  the mfPERG abnormality exhibits poor 
topographical correspondence with the location o f the field loss deemed by SAP 
(Klistorner Al. et al. 2000. Steifelmeyer S. et al. 2004). In OAG, the mfPERG responses 
corresponding to the central visual field are affected to a greater extent than those from 
more peripheral areas, irrespective o f the location o f  the field loss (Klistorner Al, et al. 
2000. Steifelmeyer S. et al. 2004). This observation raises the possibility that inner retinal 
damage in OAG may be more widespread and m ore uniform than SAP suggests and also 
that examinations directed at the macula may be useful in detecting OAG (Greenfield DS, 
et al. 2003. Guedes V. et al. 2003).
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Despite the lack of topographical agreement between mfPERG abnormality and visual 
field loss by SAP. the best predictive parameter o f the mfPERG. the amplitude difference 
between P-50 and N-95. exhibits moderate to good sensitivity (88%) and specificity 
(77%) for the detection o f OAG (Klistorner Al. et al. 2000). The AROC for the mfPERG 
is also marginally better than the standard PERG. being 0.86 (Steifelmeyer S. et al. 2004) 
and 0.78 (Bayer AU. et al. 2002). respectively.
The clinically useful levels o f diagnostic precision exhibited by the mfPERG suggest that 
the technique is clinically useful in discriminating patients with OAG from normal 
individuals. However, recording o f the mfPERG necessitates lengthy testing times and 
excellent acuity and accurate fixation (Klistorner A l. et al. 2000. Steifelmeyer S. et al. 
2004) and renders the technique unsuitable for the typical OAG population. In addition, 
the lack o f topographical correspondence between mfPERG and SAP abnormalities raises 
the question whether in fact the two techniques are assessing two different pathological 
processes. Thus mfPERG technique is not considered to offer improvement over current 
methods used in clinical management o f OAG.
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1.8 Psychophysical approaches to OAG detection
1.8.1 The Humphrey Field Analyzer (HFA)
The Humphrey Field Analyzer II (Carl Zeiss Meditec Inc.. Dublin, CA) is the current 
‘gold standard' perimeter for SAP. The HFA employs predefined, computer-controlled 
examination strategies to rapidly evaluate the differential light sensitivity at a number of 
pre-defined locations throughout the visual field. By employing standardised recording 
conditions, the HFA permits better and faster control o f  the stimulus presentation than 
with the previous ‘gold standard', the Goldmann Perimeter, and reduces the between-test 
variability that arises between different operators (Flam mer J. et al. 1983).
The HFA offers a variety o f screening and threshold stimulus programs that meet most 
clinical needs. Screening tests provide an im portant clinical function by quickly 
surveying the visual field for areas that are highly suspect. Areas flagged as abnormal 
during a screening test warrant re-examination using a threshold strategy. Threshold tests 
more precisely define the sensitivity o f the visual field by calculating the differential light 
sensitivity at each test location.
As with all psychophysical procedures involving the detection o f a ‘signal* embedded in 
‘noise*, the HFA exhibits high within- and between-test variability, referred to as short- 
and long-term variability, respectively (Bebie H. et al. 1976, Flammer J, et al. 1984, 
Flammer J, et al. 1984. 1983).
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The outcome o f any given single visual field examination is influenced by many factors 
including pupil diameter (Blumenthal EZ. et al. 2003. Wood JM. et al. 1988). refractive 
error (Goldstick BJ and Weinreb RN 1987. Heuer DK. et al. 1987). media opacities 
(Dengler-Harles M. et al. 1990. Guthauser U and Flammer J 1988. Wood JM. et al. 
1988). patient learning (Heijl A. et al. 1989. Wild JM. et al. 1989). patient fatigue (Bjerre 
A. et al. 2004. Blumenthal EZ. et al. 2003. Gonzalez de la Rosa M and Pajera A 1997. 
Schmiti RB. et al. 2002. Spry PGD. et al. 2001) and random variations in the 
physiological status o f the patient (Anderson DR 1992). In addition, the long- and short­
term variability o f a visual field outcome is influenced by factors including the severity of 
the disease (Bengtsson B 2000. Chauhan BC. et al. 1993). the eccentricity o f the test 
location (Heijl A. et al. 1987). the age o f the patient (Heijl A. et al. 1988) and the fixation 
stability (Henson DB. et al. 1996).
Unless the effects o f these factors are minimised, they can mask or mimic either visual 
field loss in a single examination or. ‘true* deterioration between successive 
examinations. The major factor governing the short-term fluctuation (STF) is fatigue 
arising from protraction o f the examination duration. The HFA is able to minimize the 
duration o f SAP examination, and reduce the effect o f  the STF. by employing either the 
Swedish Interactive Thresholding Algorithm (SITA) Standard or the SITA Fast 
examination protocols. Both SITA Standard and SITA Fast algorithms are effective 
methods to reduce the duration o f SAP without loss o f sensitivity or specificity for the 
detection o f glaucomatous visual field loss (Artes PH. et al. 2002. Bengtsson B. et al. 
1997. Bjerre A. et al. 2004. Budenz DL. et al. 2002. Wild JM, et al. 1999). The HFA
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statistical software. STATPAC. provides statistical analysis o f the measured differential 
light sensitivity in a summary print-out that details the visual field indices; Mean 
Deviation (MD). Pattern Standard Deviation (PSD) and Corrected Pattern Standard 
Deviation (CPSD). Total Deviation (TD). Pattern Deviation (PD) as well as deriving 
indices for the quality o f examination (e.g. fixation stability, and false-positive and false- 
negative catch trial rates) (Wild JM 1988).
The TD index represents the difference between the observed differential light sensitivity 
and the expected value in an age-matched normal individual. The PD index represents the 
difference between the observed differential light sensitivity and the expected value 
adjusted for the general height o f the visual field. The general height is determined from 
the relative depression o f the 15th percentile o f the TD values. By correcting for diffuse 
changes to the visual field in this way. PD analyses seek to separate visual field loss that 
is due to OAG from that which is due to cataract. On the HFA printout, both the TD and 
PD indices are plotted at points corresponding to the HFA stimulus locations. Total and 
Pattern Deviation values that fall between the 5% and 2%, the 2% and 1%. the 1.0% and 
0.5%. and below the 0.5% prediction limit based upon values expected from a normal 
population are highlighted using an grey scale, which increases in density as the 
prediction limit cut-off reduces.
However, the subjective nature o f SAP. which confers the greatest source o f within- and 
between-variability (Blumenthal EZ. et al. 2003, Spry PGD, et al. 2001). is the major 
limitation o f the technique. The magnitude o f the patient-attributed variability is such that
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SAP is rarely, if ever, interpreted in isolation and without careful consideration o f the 
appearance o f the fundus.
1.8.2 Non-conventional evaluation o f visual function in OAG
The consensus that considerable retinal ganglion cell death occurs prior to the onset of 
detectable functional deficit by conventional SAP (Harwerth RS. et al. 2004. Kerrigan- 
Baumrind LA. et al. 2000. Quigley HA. et al. 1982) has prompted the development of 
alternative psychophysical tests that are designed to exploit the functional deficit specific 
to OAG. These tests employ specialised stimuli that assess the functional integrity sub­
channels within the visual pathway.
1.8.3 Frequency-Doubling Technology (FDT) perimetry
Frequency doubling technology (FDT) perimetry is a specialised visual field examination 
that is designed to detect functional damage specific to OAG (Johnson CA and Samuels 
SJ 1997). The technique is based upon the frequency doubling illusion phenomenon 
(Kelly DH 1981) that is created when a low spatial frequency (<lcyc/deg) sinusoidal 
grating undergoes counterphase flicker at a high temporal frequency (>15Hz). Under 
these conditions the grating appears to be twice the actual spatial frequency (Kelly DH 
1981). Early studies hypothesised that the frequency doubling phenomenon was mediated 
by a particular sub-set o f cells within the magnocellular pathway, namely the My cells 
(Maddess T and Henry GH 1992). Some authors estimate that My cells constitute 
between 3% and 5% o f all retinal ganglion cells (Kaplan E and Shapley RM 1982). whilst
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others have questioned whether they exist at all (Anderson AJ and Johnson CA 2002. 
White AJ. et al. 2002) and have postulated that, at contrast threshold, all magnocellular 
cells are likely to be responsible for the frequency doubling phenomenon (Anderson AJ 
and Johnson CA 2002).
The current FDT perimeter, the Humphrey Matrix (Humphrey Systems. Dublin. CA and 
Welch Allyn. Skaneateles. NY) utilises a number o f examination protocols, namely the 
C-20 (four 10 x 10° stimuli per quadrant plus a 5° diameter central stimulus). N-30 (four 
10 x 10° stimuli per quadrant plus a 5° diameter central stimulus, plus two additional 
stimuli above and below the nasal horizontal midline at 20-30° eccentricity) (Johnson CA 
and Samuels SJ 1997) and four test patterns analogous to Program 30-2 (69 stimuli). 24-2 
(55 stimuli). 10-2 (44 stimuli) and macula (16 stimuli) tests o f  the HFA which utilize 5°x 
5° stimuli to improve the spatial resolution o f the technique. By utilizing smaller stimuli, 
the shape characterisation o f visual field defects is improved (Johnson CA. et al. 1999). 
The Humphrey Matrix software derives summary analyses including the Glaucoma 
Hemifield Test and serial test overview analyses that facilitate evaluation o f the data.
The contrast threshold is measured using a maximum likelihood threshold strategy, ZEST 
(zippy estimation o f sequential thresholds) (King-Smith PE, et al. 1994) and is defined as 
the minimum contrast at which the frequency-doubling phenomenon is perceived. The 
ZEST strategy employs a fixed number o f presentations at each location and a flat prior 
probability density function (PDF) to effectively minimize the test duration (Turpin A, et 
al. 2002. 2002).
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Although FDT perimetry is named after the frequency-doubling phenomenon the 
thresholds measured are in fact contrast detection thresholds, since no direct measure of 
the presence or absence o f frequency-doubling is made. It is thus difficult to ascertain 
what percept patients respond to when performing the test. The original suggestion was 
that the percept o f frequency-doubling did exist at contrast detection threshold (Kelly DH 
1966): however, others propose that at contrast threshold the sinusoidal grating may 
appear close to its actual spatial frequency (Parker A 1983) or. merely as a zone o f 
amorphous flicker (Kulikowski JJ 1975. M addess T and Henry GH 1992. McKendrick 
AM. et al. 2003. Richards W and Felton TB 1973). The importance o f correct patient 
instruction prior to commencing the examination (M addess T and Henry GH 1992, 
McKendrick AM. et al. 2003. Parker A 1983) has undermined the validity o f the FDT 
perimetry normative database (Anderson AJ. et al. 2005). The effect o f whether the 
measured thresholds arise either from detection (critical flicker frequency) or resolution 
(spatial frequency recognition) o f the stimulus, on the diagnostic precision o f FDT for the 
detection o f OAG is unknown. However, differences between the detection and 
resolution thresholds o f up to 6dB have been reported (Bosworth CF. et al. 1998, Flood T 
and Flanagan JG 1998. McKendrick AM. et al. 2003).
Frequency doubling technology perimetry is robust to the effects o f optical defocus 
(Anderson AJ and Johnson CA 2003). Humphrey Matrix Pattern Deviation indices, 
analogous to the PD index o f the HFA. is an effective way to separate change caused by 
glaucoma from that caused by cataract (Kook MS, et al. 2004). A prerequisite for any
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perimetric technique is a short, small and predictable learning curve such that 'true ' 
baseline examinations are offset minimally. The FDT perimetry learning effect is well 
documented (Fujimoto N. et al. 2002. Horani A. et al. 2002. Iester M. et al. 2000. Matsuo
H. et al. 2002) and its magnitude is dependent upon patients' prior experience with SAP 
(Fujimoto N. et al. 2002. Horani A. et al. 2002).
In patients with perimetric or pre-perimetric OAG. FDT perimetry exhibits moderate to 
good levels o f diagnostic precision with AROCs o f 0.93 (Brusini P. et al. 2006). 0.79 
(Sample PA. et al. 2006) and 0.75 (Brusini P. et al. 2006). In addition, visual field loss 
recorded by frequency doubling technology perimetry is a positive predictive factor for 
the subsequent development o f corresponding SAP loss (Boden C. et al. 2005. Cello KE, 
et al. 2000. Kalaboukhova L and Lindblom B 2003. Maddess T. et al. 1999, Medeiros F. 
et al. 2004).
The Humphrey Matrix Program 24-2 performs similar to HFA Program 24-2 SITA Fast 
algorithm both in terms o f the reliability of the tests (i.e. the number of: fixation losses 
and abnormal responses to the false-positive and false-negative catch trials) and the 
duration o f the test (median durations are 316 seconds and 309 seconds for FDT and 
SITA Fast, respectively) (Spry PGD. et al. 2005). However, the STF and LTF o f FDT 
perimetry are less influenced by disease severity and the eccentricity o f the stimulus than 
for SAP (Chauhan BC and Johnson CA 1999. Spry PGD. et al. 2001). Thus, FDT 
perimetry is suggested to be a better means o f identifying progressive functional damage 
than SAP (Chauhan BC and Johnson CA 1999. Spry PGD, et al. 2001). Indeed. FDT
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perimetry can identify progressive functional damage by approximately 12 months before 
SAP (Bayer AU and Erb C 2002. Haymes SA. et al. 2005). although supplementary 
longitudinal data is necessary to determine the validity o f these findings.
Despite their relative merits, neither the first-generation FDT perimeter nor the current 
version, the Humphrey Matrix, has successfully replaced SAP in the routine clinical 
management o f OAG. Further studies are warranted to determine the cross-sectional and 
longitudinal relationship between functional damage differentiated by FDT perimetry in 
OAG and the corresponding structural damage. However, the principal limitations o f 
FDT perimetry are: the uncertainty o f the precise derivation o f the measured threshold 
values and lack o f understanding o f  the retinal mechanisms/pathways exploited by the 
technique.
1.8.4 Short-wavelength Automated Perimetry (SWAP)
Short wavelength automated perimetry (SWAP) is a perimetric technique for evaluating 
the functional integrity o f the short-wavelength sensitive pathway comprising short- 
wavelength sensitive cone cells (S-cones). S-cone bipolar cells and blue-yellow retinal 
ganglion cell (Adams AJ. et al. 1982. Dacey D and Lee B 1994). The technique measures 
detection thresholds for a Goldman size V narrow bandwidth blue stimulus (440nm) 
presented against a bright (100cd/m2). broad bandwidth yellow background (Sample PA 
and Weinreb RN 1990). The processing o f the blue stimulus in SWAP is believed to be 
mediated by small bistratified ganglion cells (Dacey D 1993, Dacey D and Lee B 1994). 
Despite being referred to as 'sm all' bistratified cells, their dendritic field size is
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approximately 50% larger than those retinal ganglion cells serving the medium- and long- 
wavelength sensitive cone cells (M- and L-cones. respectively). The bright yellow 
background employed by SWAP is used to suppress the rod cells and the M- and L-cone 
cells during the examination. Small bistratified ganglion cells have large dendritic field 
size and sparse neural representation (Glovinsky Y. et al. 1991). which may make the 
functional consequences o f their loss in OAG. more apparent than most other retinal 
ganglion cells.
Short-wavelength automated perimetry is commercially available for use with HFA 740 
and 750 instruments (Carl Zeiss. Meditec. Dublin. CA) and the Octopus 101. 301 and 311 
instruments (Interzeag AC. Schlieren. Switzerland). With the exception of the stimulus 
colour, background colour and duration o f the stimulus presentation (200ms) all other 
aspects o f examination are as for SAP. The HFA SWAP yields a dynamic range o f 
approximately 24dB. increasing to approximately 29 dB for SITA versions (Bengtsson B 
2003) and has approximately 13dB o f isolation before the next most sensitive retinal 
mechanism is capable o f detecting the SWAP stimulus (Sample PA. et al. 1996). The 
dynamic range and degree o f isolation (18dB) is slightly better for the Octopus perimeter 
(Wild JM 2001).
The hill o f vision for SWAP, in normal eyes, is generally steeper than that obtained by 
SAP. In addition, the hill o f vision for SW AP in the superior field is generally steeper 
than that o f the inferior field. The age-related decline in SWAP is approximately 
2.2dB/decade. which is up to approxim ately twice that o f the age-related decline by SAP
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(approximately 1.2dB/decade) (Gardiner SK. et al. 2006. Johnson C and Marshall D 
1995. Wild JM. et al. 1998): however, this difference is reduced to only 0.5dB when the 
differential light sensitivity thresholds are corrected for the effect o f ocular media 
absorption (Johnson CA. et al. 1995).
The STF for SWAP is larger than for W-W perimetry; estimates for STF using the 
commercially available SWAP vary between approximately 17% (Wild JM. et al. 1998) 
and approximately 55% (Kwon YH. et al. 1998). The STF is greater for patients with 
glaucoma than with ocular hypertension (Wild JM. et al. 1995).
The LF is greater for SWAP compared to W-W perimetry in normal individuals and in 
patients with glaucoma. In patients with OAG. the LF at each stimulus location was 
greater by about 0.50 dB than that for W-W perimetry (Gardiner SK. et al. 2006. Wild 
JM. et al. 1995) especially in peripheral stimulus locations (Gardiner SK. et al. 2006). In 
clinical terms, the increased STF and the LTF. for SWAP relative to W-W perimetry 
means that the identification o f progressive visual field loss for SWAP between any two 
given examinations will generally be more difficult to identify than that for W-W 
perimetry.
Short wavelength automated perimetry is affected to a greater extent by pre-retinal light 
absorption than SAP (Sample PA. et al. 1988). As a result, differences in lens yellowing, 
light scatter and macular pigmentation between individuals produces wider confidence 
limits for normality for SWAP com pared to SAP (Wild JM, et al. 1998. Wild JM and
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Hudson C 1995). Pattern Deviation Analysis by SWAPPAC effectively reduces the 
adverse influence o f media opacity; however, the between-individual variability remains 
greater for SWAP than for SAP.
Despite these limitations. SWAP offers several distinct clinical advantages over SAP. 
Short-wavelength automated perimetry defects are generally larger/deeper than those 
identified by SAP. and have a greater rate o f progressive damage (Johnson CA. et al. 
1995) Short-wavelength automated perimetry is more sensitive than SAP for the 
detection o f early glaucomatous visual field loss (Demirel S and Johnson CA 2001. 
Johnson CA. et al. 1993. Sample PA 2000. Spry PGD. et al. 2005) and generally precede 
those identified by SAP by as much as 5 years (Demirel S and Johnson CA 2001. 
Johnson CA. et al. 1993. Sample PA 2000. Spry PGD. et al. 2005). In addition. SWAP 
exhibits better sensitivity for identifying patients with progressive disc cupping than SAP 
(72.7% and 59.1%. respectively) (Girkin CA. et al. 2000) and SWAP visual field defects 
are more prevalent, prominent and persistent than those o f SAP abnormalities in OAG 
(Demirel S and Johnson CA 2001. Reus NJ. et al. 2005). As would be expected. SWAP 
visual field defects correlate well with glaucomatous NRR abnormalities (Larrosa JM, et 
al. 2000. Mistelberger A. et al. 2002). RNFL defects (M istelberger A. et al. 2002. Mok 
KH. et al. 2003. Mok KH and Lee VWL 2000. Sanchez-Galeana CA. et al. 2004) and 
ONH damage (Ugurlu S. et al. 2000).
The SITA concept has been applied to SW AP and are available for the HFA 740 and 750 
perimeters (Bengtsson B 2003. Bengtsson B and Heijl A 2003) which have been
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successful in reducing between-individual variability, shortening the test duration, 
improving the dynamic range o f SWAP and reducing the width o f the confidence limits 
o f the normative values compared to the full threshold and FASTPAC algorithm s for 
SWAP (Bengtsson B 2003. Bengtsson B and Heijl A 2003). Despite these advancements. 
SWAP is not recognised as an improvement over SAP for routine clinical management o f 
OAG. The principal limitation o f technique arises from the large within- (STF) (Wild JM. 
et al. 1995) and between-test (LTF) (Gardiner SK. et al. 2006. Wild JM. et al. 1995) 
variability and its subsequent effects on the ability o f the technique to detect progressive 
functional damage.
1.8.5 High-pass Resolution Perimetry (HRP)
High-pass resolution perimetry (HRP) is a psychophysical test that provides an estimate 
o f retinal ganglion cell density. High-pass resolution perimetry employs ring shaped, 
spatially high-pass filtered ‘vanishing* targets to determine resolution acuity at a number 
o f pre-determined locations within the central 30° radius o f  the visual field. The 
commercially available HRP device is the Ophthim us system (Visumetrics and High 
Tech Vision. Goteberg. Sweden). High spatial frequency filtered rings are used to 
determine resolution acuity at 50 predefined locations under photopic conditions. The 
HRP ring stimuli consist o f light core (25cd/m^) and dark (15cd/nT) inner and outer 
borders. The background luminance is 20cd/m 2. The width o f the ring is 1 /5th of the 
diameter. The stimulus ‘value* is defined in term s o f  its angular size in accordance with 
conventional resolution acuity tests. If  a given target cannot be resolved, it cannot be seen
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since the ring 's constituents blend imperceptibly into the background i.e. the concept o f 
‘vanishing optotypes' (Frisen L 1986).
The ring values vary between presentations and the patient responds by pushing a button 
when the stimulus is perceptible. A moving fixation target is used to indicate to the 
patient approximately when a target can be expected. The test takes approximately 5 to 6 
minutes per eye to complete. Fixation stability is monitored by the Heijl-Krakau 
technique as employed by SAP and SWAP.
The patient views the monitor at a working distance o f 16.7cm and wears the appropriate 
near vision refractive correction. The FIRP utilizes 14 different stimuli sizes. The scale 
factor between consecutive sizes is approximately ldB. The smallest ring is designated a 
value o f 0. The software automatically scales the rings for constant angular dimensions, 
irrespective o f their actual location on the display screen, i.e. the software corrects for 
screen curvature and thickness.
Removal o f the low spatial frequency information from the HRP stimulus, i.e. high-pass 
spatial frequency filtering, affects visual perception by narrowing the interval between 
detection and resolution thresholds. This has im portant advantages in the perimetric 
situation: firstly, the perception task is made much easier, and secondly, the result can be 
interpreted in terms of numbers o f  functional neural channels. The ease o f deciding 
whether or not a given target is invisible allows a uniquely rapid bracketing o f the
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threshold level. The measurement probes more complex visual functions than the simple 
differential light sensitivity measurement employed by SAP.
Several o f the summary statistics generated by the HRP are similar to those used in 
conventional automated perimeters. However, because o f the many technical differences, 
results cannot be compared numerically. A typical HRP printout displays the thresholds 
at each stimulus location and generates the following indices useful for the detection of 
OAG. including; global deviation (GD. equivalent to MD with SAP), local deviation 
(LD. equivalent to PSD with SAP). Combined Deviation (the sum o f Global and local 
deviations, calculated from the standard deviation o f the former plus the mean o f the 
latter) and Neural Capacity (NC. based upon the proportional relationship between 
resolution thresholds, and the spatial separation retinal ganglion cells).
Open angle glaucoma results in an increased separation between remaining, functional 
retinal ganglion cells. This raises the resolution threshold in the corresponding region o f 
the visual field. Neural Capacity is expressed as a percentage o f the average normal 
whereby the normal average equals 100% (Frisen L and Frisen M 1976). The SD o f the 
NC is approximately ±18%; thus, patients who perform better than average yield results 
which are greater than 100%.
Other indices produced by HRP provide the observer with information about the validity 
o f a test and o f follow-up tests and include: Mean Retest Change, Retest Standard 
Deviation. Relative Criterion Level (C). Relative Dispersion, Blur Index, elapsed time
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(normally 5.5 minutes for a full test), the number o f Fixation Losses, and the number o f 
incorrect responses to the false-positive and false-negative catch trials.
High-pass resolution perimetry indices exhibit a statistically significant (P<0.001) 
correlation with those obtained by SAP (r2=0.76) (Chauhan BC. et al. 1993. Iester M. et 
al. 2003). However, unlike SAP. the variability o f  the HRP resolution threshold is 
relatively uniform across the entire visual field and is less affected by the age o f  the 
patient (Chauhan BC and House PH 1991. Wall M. et al. 2004. Wall M. et al. 1991). As a 
result, current evidence suggests that HRP can detect progressive functional damage in 
OAG by up to 12 months prior to SAP (Chauhan BC. et al. 1993). A high level o f 
concordance is reported between FDT screening and HRP tests (87.7%) in the 
classification o f normal individuals and patients with OAG (Kalaboukhova L and 
Lindblom B 2003).
Despite being in use for over 14 years, the technique has failed to receive widespread 
acceptance amongst clinicians and has not replaced SAP as the clinical standard 
technique for evaluating functional vision in OAG. The principal disadvantage o f HRP is 
attributable to the difficulty in standardising monitor outputs (luminance, homogeneity o f 
output, stability o f contrast etc). Consequently, the validity o f  the normative data is put in 
question and results obtained from different centres may not be directly comparable.
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1.9 Summary
Within the last decade, new and evolving o f technology has changed the ways in which 
OAG is managed clinically. Such advancement has enabled clinicians to currently detect 
OAG and progressive damage at an earlier stage than previously possible. Future 
advancements will undoubtedly improve these abilities even further. Currently, 
stereoscopic ONH-imaging is the recommended ‘gold standard" technique to detect 
OAG. Due to the increased versatility o f digital media versus film media, digital 
stereoscopic ONH-imaging (DSI) will follow-on as the ‘gold standard" technique. 
However, an optimal standard technique for the identification o f progressive damage in 
OAG has yet to be described.
Since the consensus that, in OAG. considerable structural damage occurs prior to visual 
field loss by SAP. a number o f quantitative ocular imaging techniques for detecting OAG 
have been developed. The two techniques exhibiting the greatest promise for clinical 
application are based on CSLO and OCT and are the HRT III and CirrusOCT. 
respectively. In patients with OAG. CSLO and OCT exhibit high repeatability o f 
measurements and suggests that they may be useful for identifying progressive structural 
damage. CSLO and OCT exhibit high diagnostic precision for the detection o f perimetric 
OAG. However, the clinical utility o f CSLO and OCT in detecting OAG. irrespective o f 
any visual field loss is unknown.
Several psychophysical tests, which are designed to exploit specific retinal ganglion cell 
functional properties, are described in the literature, including; SWAP. FDT and HRP.
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D espite yielding generally useful levels o f diagnostic precision, these techniques have not 
replaced SAP as the clinical standard perimetric examination. This is due to poor 
threshold repeatability and/or uncertainty regarding the physiological basis o f the tests. 
A s  yet. an optimal psychophysical stimulus for the detection o f OAG and progressive 
functional damage has not been found.
T h e  current-most promising electrophysiology technique for the investigation o f OAG is 
th e  mfVEP. The appeal o f the technique lies in its ability to objectively map visual field 
loss prior to SAP. Whilst the relative infancy o f the technique limits the amount o f 
longitudinal data currently available, the high reproducibility o f the mfVEP suggests a 
ro le  for the technique in detecting progressive functional damage. There is a compelling 
need for further studies investigating the clinical potential o f the mfVEP in OAG 
management.
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Chapter 2: Rationale for the research
2.1 Introduction to OAG management
As described in the previous chapter there is an abundance of examination techniques 
currently available that facilitate the management o f OAG. The ‘ideal' examination 
would rapidly obtain results, which are highly repeatable: exhibit high sensitivity and 
specificity: and are consistent between diagnosticians and between institutions.
The detection o f OAG and o f progressive damage at the earliest possible stage is the 
principal aim o f any new or evolving investigative technique for OAG. Currently, the 
most effective method to detect OAG and/or progressive damage is dependent upon the 
characteristics and severity o f the damage. In the earliest stages o f the disease, 
stereoscopic ONH imaging is currently the most effective method to detect OAG 
(Gordon MO and Kass MA - The Ocular Hypertension Treatment Study Group 1999. 
Greaney MJ. et al. 2002. Leske CM. et al. 1999. Musch DC. et al. 1997). However, 
stereoscopic ONH imaging is confounded by the variation in the ONH size and shape: the 
number and size o f optic nerve fibres: and the related neuroretinal rim (NRR) area, that 
exists in the normal population. In addition, structural alterations to the ONH that are due 
to OAG must be accurately differentiated from those that are due to normal ageing (Moya 
FJ. et al. 1999).
Whilst stereoscopic ONH imaging exhibits the highest sensitivity for early damage, the 
precise level o f diagnostic precision achieved is dependent upon the experience and
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expertise o f the individual clinician. Objective techniques, which incorporate large 
databases o f age-adjusted normative values, are more favourable for standardising the 
diagnosis o f OAG.
Detection o f progressive damage in OAG can generally be identified by retrospective 
analysis o f  data over many visits, but is dependent upon the repeatability o f 
measurements obtained both within- and between-visits.
Several objective structural and functional tests stand out on merit as having the greatest 
clinical utility for use in the management o f OAG. These techniques include: the HRT III 
(Burgansky-Eliash Z. et al. 2007); the StratusOCT (Jeoung JW. et al. 2005. Parikh RS. et 
al. 2007. Wollstein G. et al. 2005): and the mfVEP (Fortune B. et al. 2007. Graham SL. et 
al. 2005. Hood DC. et al. 2004. Thienprasiddhi P. et al. 2006). The HRT III and 
StratusOCT represent the latest generation o f established technology: however, the 
mfVEP is at a much earlier stage o f development. Despite the relative infancy o f the 
mfVEP. the literature suggests that the technique represents one of the most promising 
techniques developed within the last 10 years (Bjerre A. et al. 2004, Fortune B. et al. 
2006. Fortune B. et al. 2007. Thienprasiddhi P. et al. 2006). However, none o f these 
techniques have been compared to/validated against the emerging clinical 'gold 
standard'. DSI.
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2.2 Previous work
This thesis is a continuation o f studies previously undertaken within the School of 
Optometry and Vision Sciences. Cardiff University. Cardiff and. previously, in the 
Department o f Vision Sciences. Aston University. Birmingham. The studies described in 
this thesis are the natural development o f the previous research concerned with 
longitudinal and cross-sectional evaluation o f OAG. This subject is a constant evolving 
entity because o f technological advancements.
The study described in Chapter 3. investigated the prevalence and concordance o f 
structural and functional progressive damage determined by HRT II and SAP. 
respectively, in patients with OAG and in patients with ‘high risk' OHT. The analysis 
described in this thesis was with particular respect to ‘dissociating factors' between 
structural and functional progressive damage.
The study described in Chapter 4 investigated the ability o f the current most sophisticated 
and promising novel investigative techniques for identification of abnormality in OAG in 
patients diagnosed solely using DSI. These techniques include: CSLO (using the HRT II 
and the HRT III). Optical Coherence Tomography (using StratusOCT). the mfVEP 
technique and the HFA. This study was an extension o f previous work by the Group 
evaluating the use o f retinal imaging techniques to determine early changes in structure 
o f the ONH in patients with OAG and with OHT (Morgan JE. et al. 2005). The study 
particularly investigated potential combination o f techniques for the identification o f 
abnormality; the agreement between techniques; and the topographical relationship o f
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abnormality between RNFL thickness, neuroretinal rim area. mfVEP RMS amplitude and 
SAP differential light sensitivity.
The study described in Chapter 5 evolved from the study described in Chapter 4 and was 
prompted owing to the observed frequency o f erroneous RNFL thickness measurements 
yielded by the standard StratusOCT in patients with OAG. This study validated a novel 
method for measuring RNFL thickness (OCTAnalyse) against measurements obtained 
using the commercially available StratusOCT software.
2.3 Rationale
2.3.1 Some dissociating factors in the analysis of structural and functional progressive 
damage in OAG
Detection o f progressive damage in OAG enables clinicians to determine/predict the 
prognostic outcome for patients receiving a given treatment regimens. Where the rate o f 
progressive damage is deemed to exceed the normal rate o f decline expected due to 
ageing, the treatment strategies are reviewed in an attempt to preserve the remaining 
vision. Since OAG causes an irreversible loss o f vision, the early detection o f progressive 
damage is important in reducing the number o f patients who become legally or 
functionally blind from the disease. Whilst structural changes are believed to precede 
functional changes in the early stages o f OAG the temporal relationship between 
structure and function is currently unknown.
Specialised computer algorithms for the Heidelberg Retina Tomograph and Humphrey 
Field Analyzer, namely the Topographic Change Analysis (TCA) and Glaucoma 
Probability Analysis (GPA). respectively, represent the current-most sophisticated 
methods to detect progressive structural and functional damage, respectively (Artes PH 
and Chauhan BC 2005. Bengtsson B. et al. 1997. Chauhan BC. et al. 2000. Chauhan BC. 
et al. 2001). Both o f these algorithms employ complex statistical analyses to determine 
whether temporal changes to the ONH and visual field, respectively, are statistically 
significantly different from those expected in normal individuals. Both the HRT and HFA 
exhibit sensitivity for progressive damage in OAG (Strouthidis NG, et al. 2006); 
however, poor agreement between the techniques is attributed to one or more unnamed 
dissociating factors (Artes PH and Chauhan BC 2005. Chauhan BC, et al. 2000. Chauhan 
BC, et al. 2001). The sensitivity o f the latest progression analyses, namely TCA and 
GPA, for progressive structural and functional damage, respectively, is currently 
unknown.
This prospective longitudinal study investigated the topographical and temporal 
relationship between structure and function in progressive OAG. The study identified 
several dissociating factors, which are largely responsible for the poor level of agreement 
between the TCA and the GPA in progressive OAG.
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2.3.2 Novel approaches to glaucoma detection
Currently. OAG is diagnosed based on subjective evaluation o f the ONH appearance. 
This is most commonly assessed using binocular indirect ophthalmoscopy; however, 
digital stereoscopic ONH imaging (DSI) is the emerging ‘gold standard' technique. The 
images can be viewed retrospectively, archived and used to derive stereometric data 
(Morgan JE. et al. 2005. Morgan JE. et al. 2005).
Modern digital stereoscopic ONH imaging instruments can detect glaucomatous 
abnormalities before conventional psychophysical tests, such as SAP (Morgan JE, et al. 
2005).
In recent years, several objective diagnostic techniques have shown promise in 
glaucomatous structural or functional abnormalities during the early stages o f the disease. 
These techniques include the HRT I, II and III (Burgansky-Eliash Z, et al. 2007, Uchida 
H. et al. 1996, Wollstein G, et al. 1998), the StratusOCT (Wollstein G, et al. 2004, 
Wollstein G, et al. 2005) and the mfVEP technique (Goldberg I, et al. 2002, Graham SL, 
et al. 2005, Hood DC, et al. 2004). In the majority o f studies to date, the diagnostic 
precision o f these techniques has been determined in patients with OAG who are 
diagnosed on the basis o f glaucomatous visual field loss.
Currently, the diagnostic precision o f these novel techniques has not been referenced to 
the emerging ‘gold standard* technique for assessing ONH abnormality, DSI.
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The study was designed to determ ine the diagnostic performance o f the current novel 
structural and functional investigative techniques in early OAG and/or 
moderate/advanced OAG diagnosed on the basis o f abnormal ONH appearance by DSI. 
alone. The use of techniques in com bination was also investigated since this can improve 
the sensitivity and specificity o f OAG detection (Shah NN. et al. 2006). The agreement in 
the clinical diagnosis, false-positive rates and topographic correspondence o f abnormality 
between techniques was also determined.
2.3.3 Novel estimation of retinal nerve fibre layer thickness (RNFL) thickness based on 
subjective evaluation of StratusOCT scan data.
Optical coherence tomography (OCT) is a standard optical imaging technique that 
exhibits high sensitivity and specificity for the detection o f RNFL attenuation in OAG 
(Budenz DL, et al. 2005. De Leon-Ortega JE. et al. 2006, Jeoung JW. et al. 2005, Leung 
CK, et al. 2005. Sihota R. et al. 2006). The third generation OCT, namely StratusOCT, 
has recently been superceded by the fourth generation OCT.
StratusOCT yields highly reproducible, cross-sectional images o f the retinal 
cytoarctitecture to an axial resolution typically between 8 and 10pm. The high 
reproducibility o f scans suggests that the StratusOCT will be suitable for the 
identification o f progressive structural damage.
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The commericially available StratusOCT software incorporates several scan and analysis 
protocols. The standard scan and analysis protocols for the detection of OAG are the 
RNFL thickness (3.4) and RNFL thickness average protocols, respectively.
StratusOCT is also a standard procedure for the investigation o f macula abnormalities, 
including; macula cysts, macula holes, age-related macula degeneration (AMD), diabetic 
maculopathy and central serous retinopathy. However, several studies have reported 
instances where StratusOCT yields erroneous retinal thickness measurements (Ishikawa 
H. et al. 2002. Ray R. et al. 2005. Sadda SR. et al. 2006). Such measurement error can be 
found in as many as 92% o f scans in eyes w ith subretinal abnormalities (Ray R, et al. 
2005) and most commonly occurs due to m isalignm ent o f the individual a-scans (Ray R, 
et al. 2005. Sadda SR. et al. 2006) and/or misplacem ent o f the retinal inteface markers 
(Ray R, et al. 2005. Sadda SR. et al. 2006).
Clearly there is compelling need to determ ine whether measurement errors by 
StratusOCT occur with the same or similar frequency for RNFL thickness measurement 
ptotocols. It is important to determine the source o f the errors and whether any patient- 
induced factors increase the likelihood o f  encountering such errors. Also, alternative 
methods to obtain RNFL thickness m easurem ents are desireable in instances where the 
standard StratusOCT analysis procedure yields erroneous RNFL thickness measurements.
The study was designed to evaluate the relationship between RNFL thickness 
measurements obtained by the RNFL thickness average analysis protocol and by a
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custom designed program for measuring RNFL thicknes based on StratusOCT scans, 
namely OCTAnalyse. The two methods were compared in terms o f their within-test 
repeatability o f measurements and their agreement. Several factors which seemingly 
increase the likelihood o f encountering erroneous RNFL thickness measurments by the 
standard StratusOCT procedure were also determined.
2.4 Logistics
2.4.1 Some dissociating factors in the analysis o f structural and functional progressive 
damage in open-angle glaucoma
The data collection for the study had been undertaken at the Department of 
Ophthalmology at Birmingham Heartlands Hospital with ethical approval being provided 
by the Birmingham Heartlands Research and Ethics Committee
Patients with “high risk* ocular hypertension and patients with OAG who were enrolled 
in an on-going prospective longitudinal investigation o f structural and functional 
progressive damage who had five years o f follow-up, or more, and who conformed to the 
inclusion criteria o f the study were included. O f the original 24 patients with OAG and 27 
patients with ‘high-risk* OHT, the search, carried out by Cameron Hudson (CH), 
revealed 14 and 9 patients, respectively, who were eligible. The remaining patients had 
been either lost to follow-up. had withdrawn from the study or had died.
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Some delays were encountered whilst several o f the patients were recalled to their final 
HRT and HFA examinations. The influence o f progressive cataract on the study data was 
retrospectively analysed by re-examination o f  the clinical notes. Small delays were 
encountered in retrieving the clinical notes from the hospital archive.
2.4.2 Novel approaches to glaucoma detection
The data collection for the study was undertaken at the Cardiff Eye Unit at the University 
o f Wales Hospital. Cardiff, and the School o f  Optometry and Vision Sciences. Cardiff. 
Ethical approval for the study was provided by the Central Office for Research and Ethics 
Committee.
Patients with OAG attending the Glaucoma Outpatients Clinic at the Cardiff Eye Unit, 
who conformed to the inclusion criteria, were provided with a general outline o f the 
study. Friends, family and partners o f the participants with OAG were encourage to take 
part in the study as normal individuals and were recruited following a full ophthalmic 
investigation to confirm their suitability. Further normal individuals were also recruited 
from the staff at Cardiff University and at the University Hospital o f Wales. Informed 
written consent was obtained from all participants, following a full explanation, verbally 
and in writing, o f the nature o f the study.
Patients with OAG were required to attend for a total o f 6 visits. The normal individuals 
attended for one extra pre-study session in order to undergo ophthalmic examination 
including visual field examination.
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Prior to recruitment o f the participants, a period o f approximately 12 months was spent 
becoming proficient in the technical aspects o f  mfVEP recording as well as compiling a 
database of normative mfVEP records from normal individuals o f different ages. During 
this time, advice and guidance was sought from experienced technicians at the 
Department o f Clinical Electrophysiology at the Queens Medical Centre, Nottingham. 
Experts in the mfVEP technique were also consulted during the 2006 ISCEV and 2007 
BRISCEV meetings at Glasgow Caledonian University and Stoke Mandeville Hospital, 
respectively.
Some difficulties in recruiting participants were encountered, as the inclusion criteria 
were quite restrictive. The presence o f moderate/dense cataracts, common in older 
individuals who are considered to be more likely to develop OAG, can degrade the 
results from ocular imaging.
Major delays in obtaining mfVEPs occurred due to technical problems with the colour 
microdisplay stimulus projection system. Replacem ent hardware was not available until 
approximately 10 months after the initial problems were reported. Replies from the 
technical advisers at Electro-Diagnostic Industries (EDI), San Mateo, California, USA, to 
queries relating to the use o f the monitor stimulus projection system were delayed by 
several months on a number o f  occasions. In addition, the StratusOCT was only available 
for use at various times during the working week due to its use in routine Hospital 
outpatients clinics.
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Longer delays, o f approximately 6 months, were encountered in obtaining the clinical 
diagnoses o f participants by the expert clinical observers who were located at different 
centres around the UK.
A total o f approximately 600 hours was required to analyse the data; o f which 
approximately half was spent analysing the mfVEP data alone.
2.4.3 Novel estimation o f RNFL thickness based on subjective evaluation of 
StratusOCT scan data
StratusOCT data from 21 patients with OAG and 20 normal individuals, who had taken 
part in the study described in Chapter 4 were used in the study.
Delays o f approximately 6 months were encountered in analysing the data as the 
OCTAnalyse software was developed and revised. However, the persistence and 
expertise o f professional colleagues ensured that a fully operational version o f the 
software was available for use by the time that most o f the OCT data had been collected.
StratusOCT data was obtained over a 20 month period, with approximately 41 hours o f 
data acquisition and approximately 200 hours o f data analysis.
Despite the delays encountered during the study, the patience and cooperation shown by 
participants and professional colleagues ensured that a wealth o f valuable information
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was collected and could be presented in this study.
A period o f 17 months was required to achieve the cohort described in Chapters 4 and 5. 
In total. 45 volunteers provided 90 SAP visual fields. 90 HRT images. 90 StratusOCT 
scans. 45 mfVEPs and 45 digital stereoscopic ONH images. In total, over 270 separate 
visits were attended, each visit lasting on average one hour.
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Chapter 3: Some dissociating factors in the analysis of 
structural and functional progressive damage in OAG
3.1 Introduction
When progressive glaucomatous damage becomes apparent, the given treatment regimens 
must be re-assessed in order to arrest the deterioration.
In early OAG. changes to the ONH morphology are believed to provide a more sensitive 
marker o f progressive damage than standard automated perimetry (SAP) (Harwerth RS, 
et al. 2004. Martus P. et al. 2005. M edeiros FA. et al. 2005. Quigley HA. et al. 1980) 
whilst in advanced cases o f OAG. SAP is believed to provide a more sensitive measure of 
progressive damage than structural assessment o f the ONH by biomicroscopic evaluation 
(Jonas JB and Grundler AE 1997. Jonas JB. et al. 2004). Although this summary o f the 
temporal relationship between progressive structural and functional damage in OAG is 
useful clinically, the precise relationship is unknown and is currently receiving much 
attention.
The two digital techniques in longest clinical use for assessment o f structural and 
functional damage and. thus, the current ‘gold* standard techniques for the identification 
o f progressive in OAG. are confocal scanning laser ophthalmoscopy (CSLO) and SAP, 
respectively.
3.1.1 Detecting progressive structural damage with Confocal Scanning Laser 
Ophthalmoscopy (CSLO)
Confocal scanning laser ophthalmoscopy with the HRT is an accurate and repeatable 
technique that obtains quantitative topographical information o f the ONH and 
peripapillary retina. The HRT has been widely employed both in research and clinically 
for the assessment o f ONH morphometry in OAG (Balachandran C. et al. 2006, Danesh- 
Meyer HV. et al. 2006. Iester M. et al. 2006. Janknecht P and Funk J 1994. Jayasundera 
T. et al. 2005. Pueyo V. et al. 2007. Rohschneider K. et al. 1994. Weinreb RN, et al. 
1993). The HRT has shown good test-retest repeatability o f measurements in stable OAG 
both for individual retinal surface height measurements (Chauhan BC, et al. 1994, 
Strouthidis NG. et al. 2005. W einreb RN. et al. 1993) and for the automated software 
derived stereometric parameters (Rohschneider K. et al. 1994). The HRT can thus 
identify statistically significant changes in the ONH morphology that occur in 
progressive OAG. The variability o f the HRT measurements, and thus its sensitivity to 
identify True' change, has been shown to be greater in regions o f  the ONH where the 
topographic gradient is steep and in regions o f the ONH/retina underlying the retinal 
vasculature (Brigatti L. et al. 1995, Chauhan BC, et al. 1994). Thus, variability o f the 
HRT measurements is dependent on the region o f  the ONH under scrutiny.
An in-depth description o f the instrument can be found in Chapter 1. Section 1.4.1.
The Topographic Change Analysis (TCA) o f the HRT II and III identifies statistically 
significant changes in the topographic height o f the ONH and o f the peripapillary retina
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(Chauhan BC. et al. 2000). The TCA identifies changes in the mean retinal height from 
two baseline examinations that reach statistical significance (p<0.05). and is independent 
o f  the reference plane and ONH contour. The technique requires a minimum o f two 
baseline and three follow-up examinations in order to fulfil the criterion for ‘definite* 
structural progression. The TCA software corrects the images acquired at baseline and at 
follow-up for differences in magnification, rotation and tilt. Clusters o f 4x4 adjacent 
pixels are then combined to create super-pixels allowing more sophisticated statistical 
treatment o f  the topography data. Height measurements within each superpixel are used 
to perform  an F-statistic. which tests the variances o f  the local height measurements 
between baseline and follow-up examinations at each pixel within the image. The 
resultant value indicates the probability that a measured height change at a given location 
occurred by chance, alone. If  the error probability is less than 5%. a local surface height 
change is deemed to have occurred. Probability maps display those regions o f the ONH 
that are either elevated or reduced in mean topographic height from baseline, by the 
superimposition o f green or magenta super-pixels, respectively, in the corresponding 
region o f  the reflectance image (Chauhan BC. et al. 2001). Since OAG manifests as a loss 
o f  neural tissue, this technique assumes that a reduction in topographic height from 
baseline is descriptive o f the disease process. The criterion for topographic height change 
is a change at the p<0.05 within a given superpixel, present over three consecutive sets of 
follow-up images. This criterion was determined by computer simulation (Chauhan BC, 
et al. 2000). This criterion has since become the established standard to detect 
progressive structural damage in OAG (Chauhan BC. et al. 2000. Chauhan BC, et al. 
2001 ).
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3.1.2 Delecting progressive functional damage with Standard Automated Perimetry 
(SAP)
Standard automated perimetry is the current method used to identify progressive 
functional damage to the visual field in OAG. The subjective nature o f  SAP yields 
suboptimal levels o f within-test variability o f  the differential light sensitivity, making 
‘true* change to the visual field difficult to differentiate from the between-test variability 
associated with the procedure. Most clinicians em ploying SAP are reliant upon the visual 
comparison o f printouts over the follow-up period to identify progressive damage to the 
visual field. However, this method o f subjective clinical judgement is inconsistent and 
even expert observers show considerable within- and between-test variability in their 
judgement as to whether the results o f a given series o f  visual field examinations exhibit 
progressive loss. or. are stable (Viswanathan AC. et al. 2003). This stems from the lack of 
accepted guidelines as to what constitutes a clinically significant progression o f the visual 
field.
Several analytical methods for identifying progressive functional damage have been 
proposed. However, at present there is no general agreement as to which o f these 
techniques identifies progressive visual field loss with the greatest levels o f sensitivity 
and specificity (Katz J. et al. 1999. Nouri-M ahdavi K. et al. 2004. Spry PGD. et al. 2002, 
Wild JM. et al. 1993). Several large scale randomized trials, namely the Early Manifest 
Glaucoma Trial (EMGT) (Bengtsson B. et al. 1997), the Advanced Glaucoma 
Intervention Study (AGIS) (The AGIS Investigators 1994) and the Collaborative Initial 
Glaucoma Treatment Study (CIGTS) (Katz J 1999, Musch DC, et al. 1997), for which a
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worsening o f the visual field has been the primary outcome measure, have developed 
statistical criteria for the identification o f  progressive visual field loss. The methods used 
by these trials for identifying progressive functional damage to the visual field are each 
based upon different principles. W hilst a standardised criterion for progressive visual 
field loss is clinically appealing, the justification for using any one technique over 
another is equivocal.
The prevalence o f visual field progression with the EM GT and CIGTS methods is twice 
that o f the  AGIS method, being 23%. 22% and 11%. respectively (Katz J. et al. 1999). 
Due to the lack o f a standard for comparison, it cannot be established which o f these 
techniques is the most sensitive for identifying True’ progressive loss. In addition, a poor 
level o f  concordance was observed between those patients deemed as ‘progressive’ by 
each method. However, the earlier time to progression and the greater prevalence o f 
improvement with the EMGT criterion compared to the other two approaches suggests 
that this method may be more sensitive to progressive damage, earlier (Katz J, et al. 
1999).
The principal difference between the EMGT criterion and the CIGTS and AGIS criteria 
is the utilisation o f the Pattern Deviation (PD) values to identify visual field progression 
as opposed to the Total Deviation (TD) values, respectively. As described in Chapter 1, 
Section 1.8.1. the HFA printout for an individual visual field examination displays both 
TD and PD probability maps (Heijl A, et al. 1989). The PD probability map indicates the 
statistical significance o f the difference between the measured threshold values and the
103
age-specific normal threshold values at each location o f the visual field after correcting 
for any generalized depression or elevation o f sensitivity.
The rationale for this approach is. that the PD values remove the influence o f 
homogeneous diffuse loss o f sensitivity e.g., that caused by cataract (Bengtsson B. et al. 
1997).
Studies o f the ability o f PD compared to TD based criteria to identify progressive visual 
field damage indicate a lower prevalence o f progressive loss for PD based criteria than 
for TD based criteria (Artes PH, et al. 2005. Katz J 2000). The discrepancy has been 
attributed to the separation o f progressive OAG from progressive cataract (Katz J 2000). 
However, the prevalence o f PD based progressive loss is lower than TD based 
progressive loss in the presence o f stable cataract (Artes PH. et al. 2005).
3.1.3 Temporal relationship between structural and functional progressive damage
Two studies have investigated the temporal relationship between structural and functional 
progressive damage, assessed using HRT and SAP, respectively (Artes PH and Chauhan 
BC 2005. Chauhan BC. et al. 2001). Both studies find a lack o f concordance between 
structural and functional progression (Artes PH and Chauhan BC 2005, Chauhan BC, et 
al. 2001). Whilst this lack o f  agreement may be a genuine reflection o f the temporal 
relationship between structural and functional abnormality in OAG, it has been proposed 
that ‘dissociating factors' inherent to the test procedures, themselves, may mask the true
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relationship (Artes PH and Chauhan BC 2005. Chauhan BC, et al. 2001). Such 
dissociating factors have yet to be described.
3.2 Study Aims
The purpose o f this study was to investigate the prevalence and concordance o f structural 
and functional progressive damage in patients with OAG and in patients with 4high risk' 
OHT with particular reference to the presence o f  dissociating factors.
3.3 M aterials/ Methods
The material for the study was obtained from an on-going prospective longitudinal 
investigation o f structural and functional progressive damage in OAG undertaken at the 
Glaucoma Out-patients Clinic at Birmingham Heartlands Hospital, Birmingham.
3.3.1 Cohort
A search o f the database for patients who had been followed-up for five years, or more, 
with the HRT and HFA revealed 14 patients with OAG and 9 patients with 4 high-risk’ 
OHT. The mean period o f follow-up was 78.4 months (SD +9.5 months, range 60-101 
months). The mean age o f the group with OAG was 69.3 years (SD +9.4, range 51-80) 
and o f the group with OHT was 63.8 years (SD +12.2, range 46-85).
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The combined cohort had undergone a mean o f 5.5 (SD +0.8, range 4-7) examinations 
with the HRT and a mean o f  7.4 (SD +1.4. range 5-10) examinations with the HFA 
during the follow-up.
The study had approval from the Research and Ethics Committee o f Birmingham 
Heartlands and Solihull (Teaching) NHS Trust and all patients had given written 
informed consent. The group mean age. mean duration o f follow-up, mean number o f 
examinations with the HRT and HFA. respectively, and mean interval between 
examinations for each o f the two groups are specified in Table 3.1
OAG (n=14) OHT (n=9)
Mean Age ±  SD 69.0 + 9.5 6 3 .8 +  12.2
(Range) (51-80) (46-85)
Mean duration o f  follow-up (m onths) ±  SD 7 7 .2 +  10.0 80.0 ±  9.0
Mean number o f  exams ± SD HRT 5.6 ± 0 .8 5.3 ± 0 .9
HFA 7 .5 +  1.3 6 .9 +  1.3
Mean interval between exam s (m onths) HRT 13.8 + 3.1 15.0 + 2.7
HFA 10.3 + 6.0 11.6 + 7.0
Table 3.1 - Demographic characteristics o f the study cohort.
The mean ONH area for those with OAG. derived by the HRT II, was 2.1mm2 (SD +0.4; 
range 1.7-2.9mm2) and for those with OHT 2.2mm2 (SD +0.4; range 1.7-2.8mm2). Seven 
o f the 14 patients with OAG exhibited a small (<1.99mm2) (Schuerle AF and Schmidt E 
2004) and 7 a normal sized (2.0-3.0mm2) ONH. Four o f the 9 patients with OHT had a
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small and 5 a normal sized ONH. The vertical CD ratio in the 4 patients with OHT and a 
small ONH ranged from 0.5 to 0.7.
3.3.2 Inclusion criteria
Inclusion criteria on entry into the longitudinal study confirmed a best-corrected visual 
acuity o f 6/9 or better; a distance refractive error within the range ±6.00 DS and ±2.50 
DC; a crystalline lens appearance, graded according to the Lens Opacity Classification 
System (LOCS) III (Chylack LT. et al. 1993). was not greater than nuclear colour (NC) 
3.0. nuclear opalescence (NO) 3.0. cortical (C) 1.0. or posterior subcapsular (P) 1.0; no 
systemic medication known to affect the visual field; and no history o f diabetes mellitus.
Two patients, one with OAG and one with OHT were pseudophakic at the time of 
enrolment.
Open angle glaucoma (OA G)
Open angle glaucoma was defined as a characteristic ONH appearance with, or without, a 
characteristic visual field defect by SAP and with, or without, elevated IOP. A 
characteristic ONH appearance was considered as one or more o f the following; an 
increase in cup size, an increase in cup to disc (CD) ratio, disc asymmetry, changes in the 
lamina cribrosa. loss o f neuro-retinal rim. pallor, evidence o f peripapillary atrophy, vessel 
changes or ONH haemorrhage. A visual field defect characteristic o f OAG was 
considered as a cluster o f three or more locations, on the same side o f the horizontal
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midline and in a location typical for OAG. exhibiting abnormality on two successive 
examinations by Pattern Deviation probability analysis at the p<0.05 level with at least 
one location exhibiting abnormality at the p<0.01 level (Hodapp E, et al. 1993).
High risk' ocular hypertension
High-risk OHT was defined as either a presenting IOP >24mmHg; a presenting IOP 
>22mmHg and a vertical cup-to-disc (CD) ratio >0.5; or a presenting IOP >22mmHg, a 
vertical CD ratio < 0.5 and a family history o f OAG. The IOP was not corrected for the 
effects of central corneal thickness (CCT).
All had undertaken at least one examination with SAP prior to inclusion in the study.
One eye from each patient had been examined for the study: the eye with the more 
advanced glaucomatous disease or. for the participants with OHT. the eye with the 
greatest risk o f developing OAG.
3.3.3 Heidelberg Retina Tomography (HRT)
The HRT images at the initial/baseline visit were acquired with the HRT Version I, and 
Software Version 1.7. The initial focal plane had been set to the spherical equivalent of 
the refractive error: the scan depth to 2.5mm; the image frame to 10°xl0° and the laser to 
maximum intensity. The camera objective lens had been positioned approximately 15mm 
from the cornea and the laser bean had been directed through the pupil (Schuerle AF and
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Schmidt E 2004). The patient had been instructed to fixate an internal flashing green light 
visible nasally to the eye being examined. The ONH image had been centred on the real­
time monitor using fine adjustment o f  the vertical and horizontal position o f the camera 
and focal plane position to achieve optimal illumination o f the retina and ONH. The 
patient had been asked to refrain from blinking and from excessive head and eye 
movement between each successive scan in order to minimise motion artefacts. A further 
three scans, o f acceptable quality, had been recorded using the same recording settings. 
The three scans had then been combined to generate a mean topographical image, which 
improves the repeatability o f subsequent topographic measurements (Weinreb RN, et al. 
1993).
Once commercially available, the HRT II was used in a similar manner for all subsequent 
follow-up examinations. The recording procedure for the HRT II differed to that o f HRT 
I. in that the scanning variables fine focus, scan depth and sensitivity were determined by 
an automated pre-scanning mode. Also, the HRT II images were obtained using 
automated serial acquisition o f  scans with built-in quality-control measures and an 
automated averaging o f scans to generate the m ean topographical. The images obtained 
using the HRT I had been transferred to the HRT II using the export E2E option o f the 
HRT software (All versions). Export E2E, facilitates the transfer o f HRT data between 
compatible systems.
A third HRT system without image acquisition capability, was used to analyse data 
collected from both the HRT I and the HRT II instruments.
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3.3.4 Humphrey Field Analyzer (HFA)
At the baseline examination, each participant underwent SAP using Program 24-2 and 
either the Full Threshold or SITA Standard algorithm with the HFA 750. The distance 
refractive correction, in the form o f a full aperture trial lens, together with any near 
correction appropriate for the viewing distance o f  the perimeter bowl, was employed for 
all SAP examinations.
The follow-up intervals for HRT and SAP examination were determined in accordance 
w ith the management criteria o f the lead clinician. Mr Ian Cunliffe.
3.3.5 Analysis
HRT progression criterion: Topographic Change Analysis (TCA)
Evidence o f progressive structural damage within the ONH and peripapillary retina was 
assessed using the Topographic Change Analysis (TCA) o f the HRT II (Software Version 
1.7). Structural progression was defined as a cluster o f at least 20 magenta super pixels 
present in each o f 3 consecutive images (Chauhan BC. et al. 2001).
HFA progression criterion: Glaucoma Progression Analysis (GPA)
Evidence o f progressive functional damage to the visual field was assessed using the 
Glaucoma Progression Analysis (GPA) o f the HFA. The GPA defines Tikely’ visual field 
progression when at least three stimulus locations exhibit statistically significant
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reductions (p<0.05) in sensitivity from a baseline comprising the average o f two 
examinations, by Pattern Deviation analysis, on at least each o f three consecutive 
examinations (Heijl A. et al. 2003). This criterion is the same as that employed by the 
Early Manifest Glaucoma Trial (EMGT) (Heijl A. et al. 2003).
3.5 Results
3.5.1 Structural and functional concordance
Six patients (2 with OAG and 4 with OHT) were stable by both TCA and GPA. Four 
patients exhibited progression by both techniques (3 with OAG and 1 with OHT) (Figure
3.1). Topographical correspondence between the visual field progression and the ONH 
progression was present in all four patients (Figure 3.2).
3.5.2 Structural progression, only
Five patients with OAG and two with OHT exhibited progression by TCA only (Figure
3.1). Four o f these 7 patients manifested localised field loss, designated as ‘out of range’ 
by GPA. which corresponded to the region o f structural progression (Figure 3.3). An ‘out 
o f range’ designation indicates that the variability associated with the measured 
sensitivity at the given location lies beyond the maximum stimulus luminance o f the 
HFA. Such locations are excluded by the GPA from the analysis o f progressive field loss.
O f the remaining 3 patients, one exhibited functional progression over the last two visits 
o f the series, and thus did not meet the GPA criterion for ‘likely’ progressive damage;
i l l
and one showed a protracted perimetric learning effect (Figure 3.4). No explanation could 
be found for the lack o f functional progression in the remaining patient.
3.5.3 Functional progression, only
Four patients with OAG and two with OHT exhibited progression by GPA only (Figure
3.1). All 4 o f the patients with OAG exhibited an extensively cupped ONH at baseline 
(one or more HRT sectors exhibiting a neuro-retinal rim area to disc area ratio o f <0.2). 
The attenuated neuro-retinal rim width reduced the available area for assessment of 
reduction in the topographical height within the ONH. Advanced OAG also reduces the 
available height o f the peripapillary retina. Thus, structural progression with the HRT 
seemingly becomes more difficult to identify as the disease advances (Figure 3.5).
In the two patients with OHT. no explanation could be found for the lack o f structural 
progression.
One patient with OAG and one with OHT underwent 4 HRT examinations; both 
exhibited functional progression in the presence o f stable structural damage at each o f the 
two follow-up examinations.
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17% structural 
and functional
progression
(n=4)
31% structural
26% functional 
progression, 
only (n=6)
26% no 
progression 
(n=6)
Figure 3.1 -  The proportions o f patients exhibiting structural and/or functional 
progressive damage.
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Figure 3.2 Topographic correspondence of structural and functional progressive damage
(Male, aged 71 at baseline, Dx OAG).
The baseline TCA images of the ONH and peripapillary region and GPA print-out of the baseline 
visual fields are shown above the dotted line. The most recent visit of a 72 month follow-up is 
shown below the dotted line. Progressive structural damage to the inferior temporal region of the 
ONH is apparent by the TCA (indicated in red) and corresponds to the progressive functional 
damage in the superior temporal visual field apparent by the GPA.
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Greyscale Pattern Deviation HRT Reflectance Image
Baseline 1
Baseline 2
Final Examination
Figure 3.3 Advanced field loss at baseline (Female, aged 68 at baseline, Dx OAG).
The baseline TCA images o f  the ONH and peripapillary region and GPA print-out o f the baseline 
visual fields are shown above the dotted line. The most recent visit o f a 76 month follow-up is 
shown below the dotted line. Progressive structural damage to the superior temporal region o f the 
ONH is apparent by the TCA (indicated in red); however, the corresponding region o f the visual 
field cannot be evaluated by the GPA due to the depth o f the defect (indicated with a cross).
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Figure 3.5 Attenuated neuroretinal rim {Male, aged 74 at baseline, Dx OAG)
The baseline TCA images o f  the ONH and peripapillary region and GPA print-out o f the baseline 
visual fields are shown above the dotted line. The most recent visit o f a 76 month follow-up is 
shown below the dotted line. Progressive visual field loss was identified by GPA (indicated by the 
solid triangles); however, topographic height reduction, although present at the superior disc 
margin (indicated in red), did not fulfill the criteria for structural progression due to the presence 
o f  an attenuated neuroretinal rim.
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3.6 Discussion
This study has demonstrated poor concordance between the current criteria for structural 
and functional progressive dam age assessed using the HRT II and the HFA, respectively. 
This study has also identified three clinical situations in which, either. TCA or GPA are 
limited in their ability to identify progressive damage to the ONH or visual field, 
respectively. These three 'dissociating factors* accounted for 9 o f the 13 patients who 
exhibited a lack o f concordance between structural and functional progressive damage. 
Three patients exhibited an unexplainable lack o f  agreement between the two techniques.
The two other similar studies have also reported discordance between the HRT II TCA 
and the HFA Glaucoma Change Probability (based on Total Deviation) over a similar 
follow-up period (Artes PH and Chauhan BC 2005. Chauhan BC. et al. 2001). The three 
dissociating factors identified in this study may account for some o f the structural and 
functional discordance observed in the latter two studies.
3.6.1 Dissociating factors affecting the Topographical Change analysis (TCA)
The dissociating factor, the severe attenuation o f the NRR, for the analysis o f structural 
progression with the HRT II (Figure 3.5) is in addition to the limitation arising from sub- 
optimal image quality due to such factors as media opacity, fixation instability, and pupil 
miosis which also impair the identification o f  progressive damage (Zangwill L, et al.
1997). It is recommended by the m anufacturer, that the standard deviation o f the height 
measurements for the HRT should not exceed 30pm  to ensure 'high quality images,
(Schuerle AF and Schm idt E 2004). All images in the study were less than the 
recommended value and thus considered to be o f ‘high quality*. However, it would be 
expected that the sensitivity ot the TCA to identify progressive loss would decline with 
reduction in image quality even within the acceptable range o f image quality.
The diagnostic perform ance o f the HRT II is influenced by the ONH size (Medeiros FA, 
et al. 2006). The HRT II. M oorfields regression analysis is associated with an increase in 
diagnostic sensitivity in large ONHs com pared with that o f  smaller ONHs (Medeiros FA, 
et al. 2006). The effect o f  ONH size on the sensitivity o f  the TCA to identify progressive 
structural damage is not know n and cannot be determined from the present study due to 
the small range o f  ONH sizes and to the small cohort size. Optic nerve head size is not a 
predictive factor for the progression o f functional damage (Jonas JB, et al. 2004); 
however, the precise relationship between ONH size and sensitivity o f the TCA to detect 
progressive structural dam age requires further investigation.
3.6.2 Dissociating factors affecting the Glaucoma Progression Analysis (GPA)
The detection o f  functional progression with the HFA is clearly limited by the two 
dissociating factors, nam ely the dynam ic range and the learning effect, are illustrated in 
Figure 3.3 and Figure 3.4. The present version o f the GPA is limited by its inability to 
identify progressive loss in regions o f  the visual field where the variability o f the 
differential light sensitivity is beyond the dynam ic range o f the HFA at the baseline 
examinations. The stim ulus locations corresponding to these regions o f the visual field 
are designated as ‘out o f  range* and excluded from the GPA in subsequent examinations.
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This limitation could conceivably be overcom e by the use o f a size V stimulus. However, 
such an approach would require the developm ent o f a new GPA based upon the larger 
stimulus size.
The second source o f dissociation between the progression analyses arises when evidence 
o f a perimetric learning effect is apparent. Clinicians should exercise caution when 
accepting baseline HFA data for use with GPA. particularly in patients inexperienced in 
SAP. The GPA software alerts the clinician to a significant learning effect between the 
first and second examinations and. in such cases, recommends that the second and third 
examinations be used as the baseline. However, the appropriate baseline visual field 
examination for GPA should only be designated when it is apparent that the learning 
effect is no longer operative. The learning effect is complex in its format (Heijl A, et al. 
1989) and can last beyond the third exam ination and. as illustrated in Figure 3.4, can also 
be associated with large variations in MD.
The time to detection o f progressive functional loss should also, theoretically, be retarded 
by one or more examinations in the series deemed to be unreliable on the basis o f an 
unacceptable number o f incorrect responses to one or more o f the three types o f catch 
trials. However, with the exception o f  those exam inations exhibiting >15% incorrect 
responses to the false-positive catch trials, recorded by either o f the SITA algorithms, 
which are excluded from the baseline, the GPA software incorporates those examinations 
deemed to be unreliable into the analysis o f progressive field loss. The criterion for low 
reliability for any given type o f catch trial is empirically derived and the utility, or
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otherwise, o f  incorporating an unreliable field into the analysis o f progressive loss has yet 
to be determined. In the current study, all patients exhibited reliable responses in terms of 
the incorrect responses to the false-negative (<30%) and false-positive (<15%) catch 
trials across all the examinations. Six patients each exhibited one examination at which 
the incorrect responses to the fixation loss catch trials was beyond 30%. One patient with 
OAG exhibited an unacceptable num ber o f  incorrect responses to the fixation loss trials 
in 7 o f 10 examinations. This was attributed to the difficulty in locating the blind spot, 
which was due. in turn, to the difficulty in fixating as a consequence o f a small focal 
defect close to the macula; however, fixation mediated by the gaze tracker was 
considered to be stable. This patient was not identified as progressing by GPA, due to the 
depth o f the central focal defect lying ‘out o f range*, but showed evidence o f structural 
progression by TCA.
3.6.3 Topographical correspondence o f structural and functional progressive damage
Topographical correspondence o f  the ONH and visual field was present in all four 
patients exhibiting both structural and functional progression, an example o f which is 
given in Figure 3.2. The topographical relationship between structural damage to the 
ONH and functional damage to the visual field has been investigated previously (Anton 
A, et al. 1998. Bowd C. et al. 2006. D anesh-M eyer HV. et al. 2006, Gardiner SK, et al. 
2005, Garway-Heath DF. et al. 2000. Yamagishi N. et al. 1997). The retinotopic 
organization o f the retinal nerve fibres at the ONH is equivocal (Minckler DS 1980, 
Ogden TE 1983. 1974. Radius RL and Anderson DR 1979) and exhibits variability 
between individuals (Garway-Heath DF, et al. 2000, W irtschafter JD, et al. 1982). There
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is an apparent organisation o f the retinal nerve fibres with respect to the circumferential 
origin o f the axons. The course o f  axons above and below the macula show clear, 
mirrored symmetry; however, the position o f  the ONH relative to the horizontal meridian 
governs their precise point o f entry and accounts for the between-individual differences 
in topographical correspondence (G arway-Heath DF. et al. 2000). The organisation o f the 
retinal nerve fibres with respect to the eccentricity o f their origin is less well understood. 
Some studies report that the longer axons, from more peripheral regions tend to lie deeper 
within nerve fibre bundles (M inckler DS 1980. Radius RL and Anderson DR 1979). 
Other studies conclude that the longer axons are intermixed with the shorter ones (Ogden 
TE 1973). or. that the longer axons lie more superficially (Ogden TE 1974). A more 
recent study found no apparent organisation o f  nerve fibres within the nerve fibre bundle 
with respect to the eccentricity o f its origin (Garway-Heath DF, et al. 2000). Whilst the 
findings o f the present study do not further the understanding o f the topographical 
correspondence in progressive OAG. they do serve to corroborate the likelihood o f ‘true’ 
progression having occurred in these four patients.
3.6.4 Identification o f progressive damage and disease severity
Another likely contributor to the discordance between the HRT II TCA and the HFA 
GPA is the failure o f the respective progression analyses to consider the severity o f the 
disease. The reduction in differential light sensitivity, in dBs. for each ganglion cell lost 
in OAG. increases exponentially as the total number o f remaining retinal ganglion cells 
declines (Harwerth RS. et al. 2004). Thus, the amount o f structural damage required to 
produce an equivalent amount o f  functional dam age will vary dependent upon the
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severity o f the condition. Thus, the am ount o f  neuronal damage required to produce a 
given functional deficit is likely to be sm aller in advanced stages o f OAG than in the 
early stages. The current TCA software (HRT Version 3.0) is unlikely to overcome this 
issue, since, like earlier software versions: it em ploys a fixed progression criterion that is 
independent o f disease severity.
Since loss o f the retinal ganglion cells is the prim ary neuronal damage occurring in OAG, 
the ideal study o f structure and function should occur at the level o f the retinal ganglion 
cell and its axon. Currently, this cannot be achieved in vivo and clinicians must rely upon 
surrogate measures o f structural deficit, such as morphom etric assessment o f the ONH, 
and functional deficit, such as m easurement o f  differential light sensitivity. Precisely how 
well these surrogate measures are a true reflection o f  retinal ganglion cell damage in 
OAG is not yet fully understood. Experimental studies on primate have shown that 
despite complete optic nerve transection, the ONH fails to undergo cupping, which is the 
hallmark o f OAG (Agapova OA, et al. 2003, M orrison JC, et al. 1990). Similarly, 
assessment o f the visual field can be affected by many pre- and post-retinal factors that 
are independent o f retinal ganglion cell dysfunction. Thus, the clinical appropriateness of 
CSLO and SAP as surrogate measures o f  retinal ganglion cell integrity is questionable.
In OAG, ONH cupping occurs as a result o f  retinal ganglion cell axonal loss and the 
physical backward compression o f  the connective tissue o f the lamina cribrosa. 
Individuals with OAG. exhibit different am ounts o f  physical tissue alteration and retinal 
ganglion cell loss that, together, constitute the final disc topography. However, only the
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retinal ganglion cell axon loss is correlated directly with functional loss. Since the HRT II 
is unable to differentiate these different types o f structural alteration, this may further add 
to the disparity between the HRT II and HFA progression analyses. It has yet to be 
determined whether imaging technologies that assess progressive damage due to axonal 
integrity by means other than ONH m orphom etry yield better concordance with 
progressive functional damage. It has been proposed that RNFL thickness may be a more 
suitable surrogate for determining retinal ganglion cell integrity (Schlottmann PG, et al. 
2004); however, within- and between-individual variability o f the RNFL thickness 
measurement may ultimately limit the clinical utility o f  this modality. Equally so, a 
psychophysical test that is less dependent on pre-retinal factors may yield a truer 
reflection of retinal ganglion integrity.
3.7 Conclusion
A poor concordance was present between structural and functional progressive damage in 
OAG assessed using the TCA o f the HRT II and the GPA o f  the HFA, respectively. It can 
be speculated that this is due to the three dissociating factors identified in this study. It 
may also arise from the failure o f  the TCA and the GPA criteria for progressive damage 
to account for disease severity and by the inappropriateness o f ONH morphometry and 
measurement o f differential light sensitivity as surrogate measures o f retinal ganglion cell 
integrity. Such factors highlight the potential lim itations o f current techniques, and in 
particular CSLO and SAP, for the identification o f progressive structural and functional 
damage in OAG.
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Chapter 4: Novel approaches to glaucoma detection
4.1 Introduction
Since the widespread consensus that retinal ganglion cell damage precedes detectable 
functional damage, by conventional SAP in the earliest stages o f OAG (Harwerth RS, 
et al. 2004. Kerrigan-Baumrind LA. et al. 2000. Quigley HA, et al. 1989), evaluation 
o f the optic nerve head (ONH) and retinal nerve fiber layer (RNFL) has become the 
core o f OAG management (American Academy o f  Ophthalmology 2000, European 
Glaucoma Prevention Study (EGPS) Group 2002, Gordon MO and Kass MA - The 
Ocular Hypertension Treatment Study Group 1999, Leske CM, et al. 1999, Musch 
DC. et al. 1997).
Subjective evaluation o f  the ONH is ham pered by high within- and between-observer 
variability (Harper R. et al. 2000. Shuttleworth GN, et al. 2000, Tielsch J, et al. 1988, 
Varma R. et al. 1992. Zeyen T. et al. 2003). Similarly, the most widely used 
functional test in the m anagem ent o f  OAG, namely SAP, is fraught with high within- 
and between-test variability and. as mentioned above, is relatively insensitive to early 
glaucomatous damage. Several alternative perimetric techniques, including; 
Frequency Doubling Technology (FDT) perim etry. Short Wavelength Automated 
Perimetry (SWAP) and High-Pass Resolution Perim etry (HRP), have shown promise 
in identifying OAG-specific functional abnormality (Bayer AU and Erb C 2002, 
Johnson CA. et al. 1993. Kalaboukhova L and Lindblom B 2003, Martin L, et al. 
2003. Sample PA 2000, Spry PGD, et al. 2005). However, none o f these tests have 
gained wide spread clinical acceptance.
125
4.1.1 Current clinical standards
With the advent o f newer optical im aging technology, such as confocal scanning laser 
ophthalmoscopy (CSLO) and optical coherence tomography (OCT), assessment o f the 
ONH and peripapillary m orphom etry has becom e more objective and quantitative. 
The current clinical standard for confocal scanning laser ophthalmoscopy, the HRT. is 
capable o f producing highly reproducible, three-dimensional topographic images of 
the ONH (Chauhan BC. et al. 1994. Rohschneider K. et al. 1994. Zangwill L, et al. 
1995). The HRT is clinically useful for the detection o f  OAG (Burgansky-Eliash Z, et 
al. 2007. Uchida H. et al. 1996, W ollstein G, et al. 1998) and progressive structural 
damage (Chauhan BC, et al. 2000. Chauhan BC. et al. 2001).
The current clinical standard for optical coherence tomography, the StratusOCT, 
yields cross-sectional, high-resolution images o f  the retinal cytoarchitecture that are 
highly reproducible (Budenz DL. et al. 2005. Paunescu LA, et al. 2004). The RNFL 
Thickness (3.4) Scan exhibits the highest level o f diagnostic precision for 
glaucomatous damage o f  all o f  the StratusOCT scan protocols and is the current 
clinical standard protocol (W ollstein G. et al. 2004. W ollstein G, et al. 2005).
The multifocal visual evoked potential (mfVEP) has steadily gained acceptance as an 
objective method for topographical assessm ent o f  functional vision (Hasegawa S and 
Abe H 2001. Hood DC 2000. K listorner Al and Graham SL 2000, Klistorner Al, et al.
1998). With refinements to the standard technique, such as inter-ocular comparisons 
(Graham SL. et al. 2000. Hood DC. et al. 2000) and signal-to-noise analyses 
(Klistorner Al and Graham SL 2001. Zhang X, et al. 2002), the mfVEP can accurately 
discriminate glaucomatous visual field loss (Goldberg I, et al. 2002, Graham SL, et al.
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2005. Hood DC. et al. 2004). The mfVEP technique can also detect abnormalities in 
seemingly unaffected regions o f  the glaucom atous visual field (Hood DC. et al. 2004. 
Thienprasiddhi P. et al. 2003) and in persons with suspected OAG who manifest 
normal visual fields by SAP (Goldberg I. et al. 2002. Hood DC. et al. 2004, Klistorner 
Al and Graham SL 2000).
4.1.2 Limitations o f previous studies
Traditionally, the diagnostic performance o f  new and emerging OAG diagnostic tests 
is compared with the most widely used method o f  functional assessment, namely 
SAP. This methodology poses a critical problem since any new test that is capable of 
detecting OAG prior to SAP will appear to yield a high false-positive rate and thus 
exhibit poor specificity for OAG. In addition, all but a few studies are confounded by 
the use o f  SAP as the diagnostic ‘gold standard’ used to define OAG (Bowd C, et al. 
2001). Embracing current perspectives, it is justifiable to define OAG based solely on 
the appearance o f the ONH. using the emerging ‘gold standard’ technique, digital 
stereoscopic imaging (DSI) (M organ JE. et al. 2005).
No single study, to date, has investigated the diagnostic performance o f the most 
promising structural and functional techniques, namely HRT III. StratusOCT and the 
mfVEP. in detecting early OAG in a single cohort, and referenced the outcome to 
DSI.
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4.2 Study Aims
The aims o f this study were fourfold. Firstly, to evaluate the diagnostic utility, in 
terms o f sensitivity and specificity, o f  the current promising techniques to detect early 
OAG based solely on the appearance o f  the ONH using the current diagnostic gold 
standard. DSI. Secondly, to determine whether by combining structural and/or 
functional techniques the diagnostic precision for OAG o f  the promising techniques 
would be improved. Thirdly, to determine the agreement in the diagnostic outcome 
between the structural and/or functional techniques. Fourthly, to investigate the 
topographical relationship between structural and/or functional damage as assessed by 
these techniques.
4.3 M aterials/M ethods
This prospective cross-sectional study took place at the C ardiff Eye Unit in the 
Ophthalmology department at the University Hospital o f Wales (UHW), Cardiff and 
at the School o f Optometry and Vision Sciences at C ardiff University. Cardiff.
4.3.1 Cohort
In total. 23 patients with OAG (12 female. 11 male) and 20 normal individuals (14 
female. 6 male) were recruited to the study. The mean age (+SD) o f the OAG group 
was 67.3 (±11.2) years (range 46-85). The mean age o f the normal individuals was 
66.9 (±9.3) years (range 51-82).
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The study had approval from the Central Office for Research Ethics Committees 
(COREC). London and the C ardiff and Vale NHS Trust, Research and Development 
committee. All participants had given written informed consent.
4.3.2 Inclusion criteria
The suitability o f participants was determined prior to entry into the study in 
accordance with the following inclusion criteria: all participants exhibited a best- 
corrected visual acuity o f 6/9 or better in the designated eye; a distance refractive 
error within the range o f +5.00 DS and +2.50 DC: a crystalline lens appearance, 
graded according to the Lens Opacity Classification System (LOCS) III (Chylack LT, 
et al. 1993). not greater than nuclear colour (NC) 2.0. nuclear opalescence (NO) 2.0, 
cortical (C) 2.0 or posterior subcapsular (P) 1.0: no systemic medication known to 
affect the visual field: no history o f diabetes mellitus and no history o f ocular surgery 
in the designated eye. Patients with pigm ent dispersion symdrome and/or 
pseudoexfoliation syndrome were deemed unsuitable for the study.
Each participant underwent a detailed ophthalm ologic examination including 
measurement o f best-corrected visual acuity. Goldmann applanation tonometry 
(GAT), and measurement o f  central corneal thickness (CCT) and corneal radius with 
the Oculus Pentacam (Oculus, Inc.. Lynwood. WA). All intra-ocular pressure (IOP) 
measurements were corrected for the effects o f  CCT (Ehlers N, et al. 1975). 
Gonioscopy was not performed.
Both eyes from each participant w ere examined. Suitable participants were classified 
either as normal or glaucomatous (early OAG or moderate/advanced OAG) on the
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basis o f their ONH appearance by DSI, alone. This procedure is described in further 
detail in the following section (Section 4.3.3).
In total, 20 normal. Caucasian individuals and 23 patients with OAG (22 Caucasian 
patients and 1 patient o f African origin) were recruited into the study. Fifteen o f the 
23 OAG eyes were from patients with unilateral OAG. The remaining 8 eyes were 
from patients with bilateral OAG. All normal eyes used during the present study were 
obtained from individuals who exhibited a normal ONH appearance in both eyes. 
None o f the patients had undergone laser refractive surgery.
The mean age, mean CCT. Goldmann IOP and cornea corrected IOP (cc-IOP) o f the 
Normal. Early OAG and M oderate/Advanced OAG participants is given in Table 5.1.
Each participant underwent the schedule o f  appointments given in Table 4.2. The 
mean interval (±SD) between visits was 2.4 (±1.8) weeks (range 1-12 weeks). The 
mean duration (±SD) between visit 1 and visit 6 was 12.1 weeks (±4.9) weeks, (range 
6-25 weeks).
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Normal Early OAG Moderate/Advanced
(n=20) (n=l 5) OAG
(n=8)
Gender (M :F) 6:14 9:6 2:6
Mean age ± SD  (range) (years) 6 6 .9 + 9 .3 67 .4+ 11 .3 69.2 ±10.6
(31-82) (46-85) (58-83)
Mean CCT ± S D  (range) (^im) 556.5 +30.6 522 .9+ 27 .2 532.8 ±40.3
(497-615) (477-576) (473-605)
Mean IOP+SD (range) (m m H g) 1 5 .5 + 3 .6 21.8 ±5.2 18.0 ±4.1
(10-19) (11-29) (12-25)
Mean cc-IO P+SD  (range) (m m H g) 14.6+3.1 22.1 ±5.5 19.8 ±4.4
(9-19) (12-30) (14-24)
Mean SAP M D +SD  (range) (dB)
-0.3 + 2 .2  
(-8.3 -2 .2 )
-1 .0±  1.5 
( -3 .6 -0 .8 )
-3.0 ± 6 .6  
(-1 8 .9 -  1.0)
Mean SAP PSD ± S D  (range) (dB)
1.7 ± 0 .8  
(1.1 -4 .7 )
2.3 ± 0 .9  
(1 .3 -3 .9 )
3.5 ± 3 .7  
(1 .7 -  12.7)
Table 4.1 -  Gender, mean age, mean central corneal thickness (CCT), mean intra­
ocular pressure (IOP) and mean cornea corrected IOP (cc-IOP) for the normal 
individuals and for the individuals with early and moderate/advanced OAG, 
repectively. Where appropriate, the IOPs and cc-IOPs indicate treated values.
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Visit 1 V isit 2 Visit 3 Visit 4 Visit 5 Visit 6
Procedures DSI SAP
HRT
CCT
Keratometry
mfVEP OCT SAP
HRT
OCT
Mean duration post 
previous visit ± S D  
(range) (w eeks)
2.7 ±1.5  
(1-6)
2.5 ±1.8  
(1-10)
2.3 ±2.5  
(1-12)
2.7 ±1.8  
(1-8)
1.9 ±1.4  
(1-6)
Table 4.2 -  Visit schedule completed by all study participants 
4.3.3 Digital Stereoscopic ONH-imaging (DSI)
Sequential ONH stereo-photographs were obtained for both eyes o f  each particpant, 
after dilation o f the pupil (Tropicamide, 0.5%), using a digital fundus camera (Topcon 
TRC 50EX, Topcon Medical Systems. Inc. [TMS], Paramus, NJ). During the 
procedure, the patient was seated in front o f the cam era with their chin and forehead 
in contact with the chin rest and forehead strap, respectively. The camera objective 
lens was brought to within approximately 15mm o f the cornea and the patient was 
instructed to look at a fixation target attached to the camera. The image o f the ONH, 
visible through the eyepiece o f  the cam era, was centred and brought into sharp focus 
using the camera joystick. The image brightness was optimised using a rheostat and 
the patient was instructed to refrain from blinking and to keep their eye still for 
approximately 5 seconds. Two images o f  the ONH were captured in rapid succession 
with a small 10° separation in the viewing angle between the first and second images.
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The two images were autom atically transferred to a computer and displayed on a 
monitor using IM A G EnetIM 2000 software (Version 2.1) (Topcon Medical Systems. 
Inc. [TMS]. Paramus. NJ). A subjective assessment o f the image quality was 
performed. Images that appeared out o f  focus, or. were under or over exposed were 
re-taken. Acceptable image pairs were saved to the hard-drive o f the computer and 
copies o f the images were transferred to a custom DSI software program 
(StereoDxResearch) on a stand-alone PC. Using a specialist graphics card (VX1 
graphics card (3Dlabs. M ilpitas. CA). a Z-Screen monitor overlay (StereoGraphics 
Corp.. San Rafael. CA) and passive polarizing eyewear. StereoDxResearch enables an 
observer to view ONH image pairs simultaneously, thereby creating the perception of 
a single, three dimensional ONH stereo-image. The Digital stereo ONH images were 
reviewed by three expert observers (M r James E M organ [JEM], Mr Ian A Cunliffe 
[IAG] and Mr David Garway-Heath [DGH]). each trained to fellowship level in 
OAG. Observers were masked to the individual's identities and diagnoses. All images 
were independently graded by each observer on three separate occasions. An interval 
o f at least one week was interleaved between each grading session. The three 
observers graded the digital stereoscopic ONH im ages as either normal, early OAG or 
moderate/advanced OAG at each o f  the three grading sessions in accordance with the 
following definitions:
A normal ONH appearance was defined as: an ONH exhibiting no evidence o f 
structural abnormality to the neuroretinal rim, peripapillary RNFL and peripapillary 
retina and with no other characteristic associated with OAG.
Early OAG was defined as: an abnorm al ONH appearance which, in the opinion of
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the observer, would not yield corresponding glaucomatous visual field loss by SAP.
Moderate/advanced OAG was defined as: an abnormal ONH appearance which, in the 
opinion o f the observer, would yield corresponding glaucomatous visual field loss by 
SAP. Each observer was also required to indicate the severity (based on an arbitrary 
scale between 1 [early] and 10 [advanced]), and location, o f any apparent abnormality 
for each stereo ONH image designated as glaucomatous. Agreement in the 
topographic location o f abnormality in. at least, two out o f three observers was used 
to construct the final diagnosis (See Figure 4.1).
Summary
E O A G
E OAG
Final Diagnosis
E O A G
Figure 4.1 -  Flow diagram depicting the mechanism for establishing the diagnosis o f  
each ONH (Norm, indicates norm al E.OAG indicates early OAG and OAG indicates 
moderate/advanced OAG).
Norm
Severity grade
Topographic location of damage Session No 
_  2
O bserver 1.
Observer 2.
O bserver 3
ONH sectors
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4.3.4 Standard Automated Perimetry (SAP)
Each individual underwent SAP using Program 24-2 and the SITA Standard 
algorithm o f the Humphrey Field A nalyzer (HFA) 750 (Carl Zeiss Meditec, Dublin. 
CA. USA) on two occasions. The m ean interval (+SD) between SAP examinations 
was 7.5 (±3.4) weeks (range 3-15 weeks). Both eyes o f each participant were 
examined on each occasion. All participants had undertaken at least one visual field 
examination by SAP prior to inclusion in the study. The HFA examination protocol 
was the same as described in Chapter 3. Section 3.3.4. The distance refractive 
correction, in the form o f a full aperture trial lens, together with any near correction 
appropriate for the viewing distance o f  the perim eter bowl, was used during all SAP 
examinations. The non-test eye was occluded with an opaque occluder.
An expert grader. Professor John W ild (JM W ), assessed the first and second visual 
field printouts, simultaneously, for evidence o f repeatable abnormality for each 
participant. The grader was masked to the participant's identity, age and diagnosis by 
DSI. Fellow eyes were graded independently o f  one another. Visual fields were 
graded as: normal, variable normal, variable abnorm al or OAG, in accordance with 
the following criteria:
The criterion for a normal visual field was defined as:
A pair o f fields, each containing few er than 3 non-adjacent locations, excluding 
locations adjacent to the blind spot and the upper locations corresponding to the upper 
lid region in Sectors 4 and 5 o f the G laucom a Hemifield Test (Asman P and Heijl A
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1992) (Figure 4.2), which exhibited abnormality at the p<5% level and/or two or 
fewer non-adjacent locations in either hemifield exhibiting repeatable abnormality at 
the p<5% level.
/ 6 ,
/  \ 
4
2
31 1f : : .
Figure 4.2 -  Distribution o f  sectors in the superior hemifield for the Glaucoma 
Hemifield Test (GHT). The distribution o f  GHT sectors is mirrored in the inferior 
hemifield.
The criterion for a variable normal visual field was defined as:
A pair o f fields, with at least one field containing more than 3 locations (excluding 
locations as above) exhibiting abnormal sensitivity at the p<5% level, or lower; and/or 
with two or fewer non-adjacent locations per hemifield, exhibiting repeatable 
abnormality at the p<5% level, or lower.
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The criteria for a glaucomatous visual field were defined as fields exhibiting:
1). Three, or more, locations with repeatable abnormality at the p<0.05 
level, or lower, in at least one hemifield o f which two locations are 
adjacent.
2). One location situated in the paracentral or nasal step regions 
(corresponding to GHT Sectors 1. 2. or to the three locations closest to 
the midline in GHT Sector 3 [Figure 4.1]) with repeatable abnormality 
at the p<0.5% level.
3). Two or more locations situated in a cluster both with repeatable
abnormality at the p<1.0%  level, or lower; or, one location in the 
cluster with repeatable abnormality at the p<0.05% level and the 
remaining location at p<2%  level, or lower.
4). Two or more locations situated in a cluster exhibiting repeatable
abnormality, one o f  which is at the p<1.0%  level, or lower, by Pattern
Deviation probability analysis in the arcuate regions corresponding to 
the two locations in GHT Sector 3 farthest from the midline, and to the 
locations closest to the midline in GHT Sectors 4 and 5.
5). Three or more locations situated in a cluster exhibiting repeatable
abnormality one o f  w hich is at the p<2.0% level, or lower, in the
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arcuate regions corresponding to the two locations in GHT Sector 3 
farthest from the midline, and to the locations closest to the midline in 
GHT Sectors 4 and 5.
Locations exhibiting apparent abnorm ality arising from the presence o f obvious 
artefacts such as lens rim. upper lid contam ination or seed point (i.e. those at 9°, 9° 
eccentricity) errors: and those locations im mediately adjacent to the blind spot were 
not considered in the evaluation o f  the field.
In all categories, the adjacent locations could vertically straddle the division within 
GHT sector 3 and/or straddle either horizontally or vertically the adjacent sectors, but 
not straddle the horizontal midline.
4.3.5 Corneal curvature and corneal thickness assessment
Each participant underwent Oculus Pentacam assessm ent to determine the radius of 
corneal curvature (keratometry values) and central corneal thickness. The Oculus 
Pentacam uses a rotating Scheimpflug cam era to obtain 3-D images o f  the anterior 
segment o f the eye.
The patient was seated in front o f  the Oculus Pentacam with their chin on the chin rest 
and forehead in contact with the forehead restraint. The instrument was aligned in 
front o f the eye using the joystick. The patient was instructed to fixate the centre o f a 
blue light, visible within the instrum ent and to refrain from blinking for a period o f 
approximately 3 seconds. The live Scheim pflug image, visible on the LCD screen o f
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the instrument assisted in aligning the instrum ent at the correct working distance from 
the anterior apical surface o f  the cornea. Once correctly aligned, the images were 
taken automatically. Image quality was assessed subjectively prior to saving to the 
hard drive. Poor quality images or those containing artifacts were retaken. Central 
corneal thickness measurement was used to calibrate the I OP measurements (Table 
4.1). The corneal curvature m easurem ent was used prior to acquisition o f the HRT 
images (Section 4.3.6).
4.3.6 Confocal Scanning Laser Ophthalmoscopy (CSLO)
Each individual underwent confocal Scanning Laser Ophthalmoscopy (CSLO) using 
the HRT II (Version 1.4.1) on two occasions. The mean interval (±SD) between 
examinations was 7.2 (±4.3) weeks (range 3-20 weeks). Both eyes o f each participant 
were scanned on each occasion.
Heidelberg Retina Tomograph im ages were obtained using the methodology 
described in Chapter 3. Section 3.3.3. In addition, a cylindrical lens correction was 
attached to the condensing lens system for patients with astigmatism >1.00 DC 
(Schuerle AF and Schmidt E 2004). Corneal curvature values obtained by Oculus 
Pentacam were input into the HRT II during the scan preparation (Section 4.3.5). In 
all but one o f the scans, image quality w as considered excellent according to the 
manufacturers guidelines (M ean SD = 17.9pm . SD ±5.8pm, Range 8-30pm). The 
slight reduction in image quality (SD 32pm ) in the one case occurred due to the 
patient having a mild tremor.
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The ONH margin contour line, defined as the inner edge o f the scleral ring, was 
demarcated by a trained observer (CH) for all images used during the study. The 
topographical information from within the ONH margin contour was used to calculate 
the likelihood o f glaucomatous optic neuropathy based upon the Moorfields 
Regression analysis (MRA) (Full description given in Chapter 1, Section 1.6.2). The 
HRT II images were exported to the HRT III analysis software (Version 3.0), when it 
became commercially available, using the export E2E option for analysis. Export 
E2E. facilitates the transfer o f HRT data between compatible systems. The HRT III 
incorporates a larger and ethnicity-specific normative database than the HRT II, and 
comprises a database o f 733 healthy Caucasian eyes and 215 healthy African 
American eyes. The MRA by HRT III is based upon this enlarged database.
Moorfields regression analyses on the first and second HRT scans, both for HRT II 
and III, were evaluated for evidence o f  repeatable abnormality at, or beyond, the 5% 
prediction limit based upon the distribution o f expected values from the respective 
normative databases. Glaucom atous abnormality both by HRT II and HRT II MRAs 
were defined as repeatable abnormality within one or more disc sector/s at or below 
the 5% prediction limit.
4.3.7 Optical Coherence Tomography (OCT)
Each participant underwent RNFL thickness measurement and ONH topographic 
imaging using StratusOCT. Both eyes o f each participant were examined on two 
occasions. The mean interval (±SD) between the first and second examinations was 
7.2 (±3.1) weeks (range 3-17 weeks).
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Each participant received Tropicam ide (0.5%) to dilate the pupil prior to examination. 
Retinal nerve fibre layer thickness m easurements were obtained using a commercially 
available StratusOCT. with the Standard RNFL (3.4) Scan protocol. During the scan 
acquisition, participants were seated with their chin on the chin rest and their forehead 
in contact with the forehead restraint. The scanning module was correctly aligned and 
the StratusOCT objective lens was adjusted for the participant’s refractive error. The 
participant was instructed to fixate a target, which brought the ONH within view o f 
the examiner on the real-time video window. The Z-offset and polarization were 
optimized to bring the OCT scan into view and to maximize the reflectivity o f the 
signal, respectively. The aiming circle was adjusted so that the ONH was in the centre 
o f the scan circumference. All StratusOCT scans were obtained by a single operator 
(CH). All scans used in the analysis were free from blink and eye movement artefacts, 
had a signal to noise ratio (SNR) o f  at least 33dB and had 100% o f A-scans accepted.
Global and quadrant average RNFL thicknesses were automatically calculated for the 
first and second scan using the com mercially available StratusOCT analysis software 
(Version 3.0).
The RNFL thickness data was analyzed using the RNFL thickness average analysis 
protocol o f  the standard StratusOCT software (Version 3.0). For each participant, 
RNFL thickness measurements were com pared with the expected values based upon 
the StratusOCT normative database. Printouts were considered abnormal if  they 
showed evidence o f a repeatable abnormality beyond the 5% and/or 1% prediction 
limit based upon the distribution o f  expected RNFL thickness from a normal 
population.
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4.3.8 Multifocal Visual Evoked Potential (mJVEP)
The Multifocal VEP was obtained using the Visual Evoked Response Imaging System 
(VERIS) Science. Version 5.1 (EDI. San Mateo. CA). Both eyes were examined, 
monocularly and a standard 60-sector dartboard stimulus was used to generate the 
evoked response. The stimulus was displayed on a 22-inch colour monitor (Mitsubishi 
Diamond Pro 2070SB. Mitsubishi Electric & Electronics, Cypress, CA), which had a 
refresh rate o f 75Hz. The mfVEP stimulus consisted o f 60 individual sectors each 
sector containing 16 checks. 8 white (102.0 cd/m2) and 8 black (2.1 cd/m2). The 
luminance o f the stimulus was measured using a M inolta LS-110 luminance meter 
(Konica Minolta, Ramsey. NJ).
A single, vertical midline channel (Bipolar Occipital Straddle, BOS) was recorded for 
each participant. The active and reference electrodes were positioned 3 cm above and 
lcm  below the inion, respectively. The ground electrode was attached to the forehead. 
The skin area for the electrode was prepared with Nuprep (D.O. Weaver & Co, 
Aurora, CO). Disposable, silver chloride coated plastic disc electrodes (Oxford 
Instruments. Surrey, UK) were then fixed in place using Ten20 conductive paste 
(D.O. Weaver & Co. Aurora, CO). Electrode impedance was measured prior to 
recording using a custom-made im pedance meter and was maintained below 5ka.
During the recording, the participant was seated in an armchair and encouraged to 
relax their neck and shoulders. The stim ulus projection monitor was brought towards 
the patient to a working distance o f  52cm. At this distance the stimulus subtended a
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viewing angle o f 25 degrees from fixation to the outermost edge o f the stimulus. The 
distance refractive correction, in the form o f a full aperture trial lens, together with 
any near correction appropriate for the viewing distance, was used during all mfVEP 
examinations. The non-test eye was occluded with an opaque patch. The stimulus was 
viewed through natural pupils. The contrast polarity o f the stimulus was modulated 
temporally and controlled by a com puter-driven binary m-sequence. The mfVEP 
recording was divided 16 segments each segment lasting 27.31 seconds. At the end of 
each segment, participants were allowed a b rief rest period before the recording o f the 
next segment began. On average, the mfVEP recording lasted between 8-10 minutes 
per eye. Signals were amplified (Grass model 15LT), band pass filtered from 3 to 
30Hz. sampled at 1200Hz and notch filtered.
Multifocal VEPs within 16 discrete regions were averaged to improve the amplitude 
o f the signals using the standard VERIS analysis software. The spatial distribution of 
these regions is shown in Figure 4.3. The raw data for the 16 responses was exported 
from VERIS. No spatial smoothing was applied to the data prior to the export. 
Additional data analyses were performed using commercially available software 
(Microsoft Excel; Microsoft Corporation, Redmond, WA). The root-mean-square 
(RMS) amplitude o f a ‘signal’ and ‘noise’ window, between 45 to 150ms and 325 to 
430ms. respectively, was calculated for each mfVEP waveform. The RMS signal-to- 
noise ratio (SNR) was determined by dividing the RMS o f the signal by the RMS of 
the noise.
A standard analysis o f inter-ocular mfVEP signal amplitude was undertaken by 
dividing the log RMS signal in the right eye with the log RMS signal in the left eye.
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The observed values, in each o f  the 16 mfVEP sectors, were compared with the 95% 
confidence limits for the inter-ocular ratio o f signal amplitudes, derived from a 
database o f  mfVEPs obtained both eyes o f  30 normal age-matched individuals (13 
males and 17 females) (mean age [±SD] 65.2 [±9.1] years, range 49-82 years). 
Probability plots, similar to HFA Total Deviation plots, were produced, whereby the 
colour of the mfVEP sector indicated which eye, left (blue) or right (red) was affected 
(see Figure 4.4). The saturation o f  the color indicated the level o f significance of the 
difference between the observed value and value expected from the distribution 
normal values. Lighter colours were used to indicate abnormality, within any given 
sector, between the 5% and 1% prediction limit. Deeper colours were used to indicate 
abnormality, within any given sector, beyond the 1% prediction limit.
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Figure 4.3 -  The spatial distribution o f  mfVEP responses
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Figure 4.4 -  Multifocal VEPprintout showing a nasal step defect in the right eye. The 
deeper colour indicates abnormality beyond the 1% prediction limit and the lighter 
colour indicates abnormality between the 5% and 1% prediction limits.
4.3.9 Topographic correspondence
The topographic relationship between the region o f the visual field and the region of 
the ONH has been the topic o f  several studies (Garway-Heath DF, et al. 2002, 
Yamagishi N, et al. 1997). Based on these studies, the topographic correlation 
between the visual field and the ONH region was estimated. Since the size and spatial 
distribution o f the ONH sectors/visual field locations varied between each 
examination technique, topographic comparison was matched as closely as possible.
On DSI. the final diagnosis plot (Figure 4.1) reports summary findings o f the ONH 
appearance as assessed by three expert observers. The superior-temporal and 
superior-nasal sectors and the inferior-temporal and inferior-nasal sectors were 
combined into superior and inferior quadrants, respectively. These quadrants were 
considered to be abnormal if  either o f  the sectors was classified as abnormal by at 
least two out o f the three observers. The temporal, superior, nasal and inferior 
quadrants were numbered 1 to 4, respectively, as shown in Figure 4.5a.
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The StratusOCT RNFL thickness average analysis protocol displays the RNFL 
thickness for each o f 12 sectors o f  the ONH. The three superior-most sectors were 
combined into one superior quadrant. The three temporal-, nasal- and inferior-most 
sectors were also combined into one temporal, nasal and inferior quadrant, 
respectively. Quadrants were considered to be abnormal if  any of the three sectors 
was classified as abnormal at the 5% or 1 %  confidence limit. The temporal, superior, 
nasal and inferior quadrants were numbered 1 to 4, respectively, as shown in Figure 
4.5b.
The Heidelberg Retina Tom ograph II and III display MRA for each o f 6 sectors o f the 
ONH. The superior-temporal and superior-nasal sectors and the inferior-temporal and 
inferior-nasal sectors were com bined into superior and inferior quadrants respectively. 
These quadrants were considered to be abnormal if  either o f  the sectors was classified 
as abnormal or borderline. The temporal, superior, nasal and inferior quadrants were 
numbered 1 to 4. respectively, as shown in Figure 4.5c.
For the mfVEP print-out, the temporal sector o f the ONH was considered to 
correspond to Sectorsl. 2. 3, 9, 10 and 11 in right eye format and sectors 1, 2, 5, 9, 10 
and 13 in left eye format i.e. the central-m ost 5° o f the visual field and the region 
corresponding to the papillom acular bundle. The nasal quadrant o f the ONH was 
considered to correspond to Sectors 6 and 14 in right eye format and 8 and 16 in left 
eye format. The superior and inferior quadrants o f the ONH were considered to 
correspond to the remaining sectors in the inferior and superior quadrants,
respectively. The mfVEP regions corresponding to the temporal, superior, nasal, and 
inferior ONH were numbered 1 to 4. respectively, and are shown in Figure 4.5d.
For Program 24-2 o f the HFA. the temporal quadrant on the ONH was considered to 
correspond to the stimulus locations, above and below the midline, in GHT Sector 1. 
The nasal quadrant was considered to correspond to the four stimulus locations 
temporal to the blind spot. The superior and inferior quadrants of the ONH were 
considered to correspond to the remaining GHT Sectors in the inferior and superior 
hemifield. respectively. For consistency the upper most locations o f GHT Sectors 4 
and 5 in the superior hemifield. only, were excluded from the analysis (see Section 
4.3.4). The regions o f  the visual field corresponding to the temporal, superior, nasal 
and inferior ONH were numbered 1 to 4, respectively, as shown in Figure 4.5e.
SAP
e.
Region 1 (Temporal ONH) |  Region 3 (Nasal ONH)
Region 2 (Superior ONH) | |  Region 4 (Inferior ONH)
Figure 4.5a-e - The topographic delineation o f  the results fo r  each o f  the 
investigative techniques. DSI denotes digital stereoscopic ONH-imaging, OCT 
denotes Optical coherence Tomography, CSLO denotes Confocal Scanning Laser 
Ophthalmoscopy, mfVEP denotes multifocal Visual Evoked Potential and SAP 
denotes Standard Automated Perimetry.
DSI O CT CSLO  m fVEP
IV _  A \ — y
/
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4.3.10 Analysis
The Sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) were calculated using conventional 2x2 contingency tables (Table 4.3).
DSI
OAG* Normal
Examination OAG True Positive (TP) False Positive (FP) TP
PPV  =
(TP + FP)
Normal False Negative (FN) True Negative (TN) TN
N P V  = 7----------------r(TN  + FN))
TP
Sens. = ---------------
(TP + FN )
77V
PeC' (FP + TN)
OAG* includes participants with early OAG and patients with moderate/advanced OAG
T able 4.3 -  The derivation o f  sensitivity, specificity , positive predictive (PPV) and  
negative predictive (NPV) values.
To evaluate the efficacy o f each technique, for the detection o f abnormality, PPVs and 
NPVs were calculated at assumed disease prevalence levels o f 5%, 10% and 30% (to 
simulate populations at various levels o f  risk).
Positive (LR) and negative (LR) likelihood ratios were also calculated for each 
technique (Deeks JJ and Altman DG 2004). Specifically, the likelihood ratio is the 
probability o f the specific test result in individuals who do have the disease compared 
to the probability o f the specific test result in people who do not, expressed as a ratio. 
A likelihood ratio greater than 1 indicates that the test result is associated with the
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presence o f the disease, whereas a likelihood ratio less than 1 indicates that the test 
result is associated with the absence o f  disease.
4.4 Results
4.4.1 Agreement in clinical diagnosis by DSI
The cohort comprised 19 right eyes and 24 left eyes. Twenty eyes were designated as 
normal, 15 as early OAG and 8 as moderate/advanced OAG. The demographic 
characteristics o f the groups are described in Table 4.1.
The agreement between observers in the clinical diagnosis is given in Table 4.4. A 
moderate level o f  agreement was present between JEM  and DGH (Kappa = 0.61). A 
fair level of agreement was present between I AC and DGH (Kappa = 0.31) and 
between IAC and JEM (Kappa = 0.40).
IAC vs. D G H 1A C  vs. JEM JE M  vs. D G H
Kappa Statistic 0.31 0.40 0.61
Agreement (%) 69.8 73.2 81.4
SE 0.11 0.10 0.09
95% Cl Upper 0.53 0.60 0.78
Lower 0.10 0.20 0.44
Table 4.4 - Agreement vales in clinical diagnosis between the three observers: Mr 
David Garway-Heath (DGH), Mr Ian Cunliffe (IAC) and Mr James Morgan (JEM).
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The distribution o f severity scores o f  the ONH provided by each observer is given in 
Figure 4.6 The mean severity score diagnosed by DGH. IAC and JEM, and was 4.1,
4.5 and 4.2, respectively. The median severity score for abnormal ONHs diagnosed 
by TGH. IAC and JEM was 4. 5 and 4, respectively. A Kolmogorov-Smirnov test of 
the data demonstrated that severity scores did not follow a normal distribution for any 
of the observers, and that no statistically significant difference in the distribution o f 
the severity scores existed between any two observers (Table 4.5).
20
1 2 3 4 5 6 7 8 9  10
OAG Severity
Figure 4.6 -  The distribution o f  severity scores fo r  the three observers: Mr David 
Garway-Heath (DGH), Mr lan Cuniliffe (IAC) and Mr James Morgan (JEM).
IAC vs. D G H IAC vs. JEM JEM  vs. D G H
Maximum difference between  
cum ulative d istributions, D
0.16 (p =0.16) 0.14 (p =0.22) 0.10 (p =0.68)
Table 4.5 -  The results o f the Kolmogorov-Smirnov test to identify differences in the 
distribution o f  severity scores between observers
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The SAP visual field Mean Deviation (M D) and Pattern Standard Deviation (PSD) 
values for the normal, early OAG and moderate/advanced OAG groups are given in 
Table 4.1. A students T-Test revealed that there was no statistically significant 
difference in the MD between the normal group and the group with early OAG 
(p=0.23). for the normal and m oderate/advanced OAG groups (p=0.11) and for the 
early OAG and moderate/advanced OAG (p=0.28) groups. The difference in mean 
PSD statistically significant between the normal and early OAG groups (p=0.046) and 
between the normal and m oderate/advanced OAG groups (p=0.045). However, there 
was no statistically significant difference in PSD between the early OAG and 
moderate/advanced OAG groups (p=0.23).
4.4.2 Diagnostic precision o f techniques
The sensitivity and specificity o f  OCT, CSLO (HRT II and III), mfVEP and SAP for 
the detection o f early OAG, m oderate/advanced OAG and for both groups, combined, 
are shown in Tables 4.6a. 4.6b and 4.6c. respectively.
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Early OAG 
(n=15)
OCT CSLO 11 CSLO III mfVEP SAP
Sensitivity (%) 40.0 73.3 86.7 66.7 40.0
Specificity (%) 95.0 80.0 65.0 60.0 95.0
PPV 0.86 0.73 0.65 0.56 0.86
PPV (5%) 0.26 0.16 0.12 0.08 0.30
PPV (10%) 0.47 0.29 0.22 0.16 0.47
PPV (30%) 0.77 0.61 0.51 0.42 0.77
NPV 0.68 0.80 0.87 0.71 0.68
NPV (5%) 0.08 0.13 0.20 0.09 0.08
NPV (10%) 0.15 0.25 0.35 0.17 0.15
NPV (30%) 0.40 0.56 0.68 0.44 0.40
PLR 8.00 3.67 2.47 1.67 8.00
NLR 0.63 0.33 0.21 0.56 0.63
Table 4.6a -  Sensitivity, specificity, positive predictive value (PPV) (at 5, 10 and 30% 
prevalence), negative predictive value (NPV) (at 5, 10 and 30% prevalence), positive 
likelihood ratio (PLR) and negative likelihood ratio (NLR) fo r  Optical Coherence 
Tomography (OCT), Confocal Scanning Laser Ophthalmoscopy (CSLO II using the 
Heidelberg Retina Tomograph II and CSLO III using the Heidelberg Retina 
Tomograph III), multifocal Visual Evoked Potential (mfVEP) and Standard  
Automated Perimetry (SAP) fo r  the early OAG group (n-15).
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Moderate/Advanced OAG 
(n=8)
OCT CSLO 11 CSLO III mfVEP SAP
Sensitivity (%) 50.0 87.5 100.0 75.0 62.5
Specificity (%) 95.0 80.0 65.0 60.0 95.0
PPV 0.80 0.64 0.53 0.43 0.83
PPV (5%) 0.34 0.19 0.13 0.09 0.40
PPV (10%) 0.53 0.33 0.24 0.17 0.58
PPV (30%) 0.81 0.65 0.55 0.45 0.84
NPV 0.83 0.94 1.00 0.85 0.86
NPV (5%) 0.09 0.25 1.00 0.11 0.12
NPV (10%) 0.17 0.42 1.00 0.21 0.22
NPV (30%) 0.45 0.73 1.00 0.51 0.52
PLR 10.00 4.38 2.86 1.88 12.5
NLR 0.52 0.16 0 0.41 0.39
Table 4.6b -  Sensitivity, specificity, positive predictive value (PPV) (at 5, 10 and  
30% prevalence), negative predictive value (NPV) (at 5, 10 and 30% prevalence), 
positive likelihood ratio (PLR) and negative likelihood ratio (NLR) for Optical 
Coherence Tomography (OCT), Confocal Scanning Laser Ophthalmoscopy (CSLO II 
using the Heidelberg Retina Tomograph II  and CSLO 111 using the Heidelberg Retina 
Tomograph III), multifocal Visual Evoked Potential (mfVEP) and Standard 
Automated Perimetry (SAP) fo r  the moderate/advanced OAG group (n=8).
153
Combined OAG Groups 
(n=23)
OCT CSLO II CSLO III mfVEP SAP
Sensitivity (%) 43.5 78.2 91.3 69.6 47.8
Specificity (%) 95.0 80.0 65.0 60.0 95.0
PPV 0.91 0.82 0.75 0.67 0.92
PPV (5%) 0.31 0.17 0.12 0.08 0.29
PPV (10%) 0.49 0.30 0.22 0.16 0.47
PPV (30%) 0.79 0.63 0.53 0.43 0.77
NPV 0.59 0.76 0.86 0.63 0.61
NPV (5%) 0.08 0.16 0.28 0.37 0.07
NPV (10%) 0.16 0.29 0.45 0.18 0.15
NPV (30%) 0.42 0.61 0.76 0.46 0.40
PLR 8.70 3.91 2.61 1.74 7.83
NLR 0.59 0.27 0.13 0.51 0.55
Table 4.6c -  Sensitivity, specificity, positive predictive value (PPV) (at 5, 10 and 30%  
prevalence), negative predictive value (NPV) (at 5, 10 and 30% prevalence), positive 
likelihood ratio (PLR) and negative likelihood ratio (NLR) for Optical Coherence 
Tomography (OCT), Confocal Scanning Laser Ophthalmoscopy (CSLO II using the 
Heidelberg Retina Tomograph II  and CSLO III using the Heidelberg Retina 
Tomograph III), multifocal Visual Evoked Potential (mfVEP) and Standard 
Automated Perimetry (SAP) fo r  the early and moderate/advanced OAG groups 
combined (n=23).
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Optical Coherence Tomography with the StratusOCT detected abnormality in early 
OAG eyes w ith a sensitivity and specificity o f  40.0% and 95.0%. respectively (Table 
4.6a). It detected abnormality in m oderate/advanced OAG eyes with a sensitivity and 
specificity o f  50.0%  and 95.0%. respectively (Table 4.6b). When the early OAG and 
moderate/advance OAG groups w ere com bined, the sensitivity and specificity was 
43.5% and 95.0% . respectively (Table 4.6c).
Confocal Scanning Laser Ophthalm oscopy with the HRT II detected abnormality in 
early OAG eyes with a sensitivity and specificity o f 73.0% and 80.0%, respectively 
(Table 4.6a). It detected abnorm ality in moderate/advanced OAG eyes with a 
sensitivity and specificity o f  87.5%  and 80.0%, respectively (Table 4.6b). When the 
early OAG and m oderate/advanced OAG groups were combined, the sensitivity and 
specificity was 78.2%  and 80.0%, respectively (Table 4.6c).
Confocal Scanning Laser O phthalm oscopy with the HRT III detected abnormality in 
early OAG eyes with a sensitivity and specificity o f 86.6% and 65.0%, respectively 
(Table 4.6a). It detected abnorm ality in moderate/advanced OAG eyes with a 
sensitivity and specificity o f  100.0% and 65.0%, respectively (Table 4.6b). When the 
early OAG and m oderate/advanced OAG groups were combined, the sensitivity and 
specificity was 91.3%  and 65.0%. respectively (Table 4.6c).
The mfVEP w ith the VERIS detected abnormality in early OAG eyes with a 
sensitivity and specificity o f  66.7%  and 60.0%. respectively (Table 4.6a). It detected 
abnormality in m oderate/advanced OAG eyes with a sensitivity and specificity o f 
75.0% and 60.0% , respectively (Table 4.6b). When the early OAG and
155
moderate/advanced OAG groups w ere combined, the sensitivity and specificity was 
69.6% and 60.0%. respectively (Table 4.6c).
Standard Automated Perimetry with the HFA detected abnormality in early OAG eyes 
with a sensitivity and specificity o f  40%  and 95%. respectively (Table 4.6a). It 
detected abnormality in moderate/advanced OAG eyes with a sensitivity and 
specificity o f 62.5% and 95.0%. respectively (Table 4.6b). When the early OAG and 
moderate/advanced OAG groups were com bined, the sensitivity and specificity was 
47.8% and 95%. respectively (Table 4.6c).
The highest PPV was achieved by SAP (0.92) for the early OAG and 
moderate/advanced OAG groups (Table 4.6c). The lowest PPV was achieved by 
mfVEP (0.43) in individuals with m oderate/advanced OAG (Table 4.6b). The highest 
NPV was achieved with the CSLO (1.00) in individuals with moderate/advanced 
OAG (Table 4.6b). The lowest PPV was achieved by OCT (0.43) for the group with 
early OAG or moderate/advanced OAG (Table 4.6c).
The highest PLR was achieved by SAP for the moderate/advanced OAG group 
whereby a positive SAP result (i.e. visual field loss) increase the odds o f having OAG 
by 12.5 times (Table 4.6b). The lowest PLR was achieved by mfVEP for the early 
OAG group whereby an abnormal m fVEP response increases the odds o f having 
OAG by 1.67 times. The lowest (best) NLR was achieved by CSLO using HRT III for 
the moderate/advanced OAG group whereby a negative result seemingly excludes the 
disease. The highest (worst) N LR  was achieved by SAP and OCT equally, for the
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early OAG group, such that a negative test result reduced the odds o f having OAG by 
only 0.63 times.
4.4.3 Combining techniques
The diagnostic precision o f  two tests com bined, when a positive result by both tests 
was required to detect abnorm ality, is given in Table 4.7a. Under these conditions, the 
specificity for the detection o f OAG is generally higher; however, the observed levels 
o f  sensitivity are lower. T he best overall com bination o f tests was observed using the 
HRT II MRA and the H R T III MRA. In cases w here either o f these tests yielded an 
abnormal result the sensitivity and specificity for OAG was 78.3% (in early and 
moderate/advanced groups com bined) and 85%, respectively.
The diagnostic precision o f  two tests com bined, when a positive result by either test 
was required to detect abnorm ality, is given in Table 4.7b. Under these conditions the 
sensitivity for the detection o f  OAG is generally higher; however, the observed levels 
o f  specificity are lower. T he best overall com bination o f tests was OCT and CSLO 
with the StratusOCT and the HRT II MRA, respectively. In cases where either o f 
these tests yielded an abnorm al result the sensitivity and specificity for OAG was 
82.6% (in early and m oderate/advanced groups combined) and 80.0%, respectively.
157
Abnormal by test 1 AND test 2 Specificity
(%)
Sensitivity (%)
Early
OAG
(n-15 )
Moderate/
Advanced
OAG
(n=8)
Combined
OAG
groups
(n=23)
OCT and CSLO II 95.0 40.0 37.5 39.1
OCT and CSLO III 100.0 40.0 50.0 43.5
OCT and mfVEP 100.0 20.0 37.5 26.1
OCT and SAP 100.0 26.7 25.0 26.1
CSLO II and CSLO III 85.0 73.3 87.5 78.3
CSLO II and mfVEP 95.0 46.7 62.5 52.2
CSLO II and SAP 100.0 33.3 37.5 34.8
CSLO III and mfVEP 90.0 60.0 75.0 65.2
CSLO III and SAP 95.0 33.3 37.5 34.8
mfVEP and SAP 100.0 26.7 25.0 26.1
Table 4.7a — The sensitivity and specificity o f  combinations o f  two techniques in OAG 
based upon an abnormal result w ith both tests.
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Abnormal by test 1 OR test 2 Specificity
(%)
Sensitivity (%)
Early
OAG
(n=15)
Moderate/
Advanced
OAG
(N=8)
Combined
OAG
groups
(N=23)
OCT and CSLO 11 80.0 73.3 100.0 82.6
OCT and CSLO III 60.0 86.7 100.0 91.3
OCT and mfVEP 55.0 86.7 87.5 87.0
OCT and SAP 90.0 53.3 75.0 60.9
CSLO 11 and CSLO III 60.0 86.7 100.0 91.3
CSLO II and mfVEP 45.0 93.3 100.0 95.7
CSLO II and SAP 75.0 80.0 87.5 82.6
CSLO III and mfVEP 35.0 93.3 100.0 95.7
CSLO III and SAP 65.0 93.3 100.0 95.7
MfVEP and SAP 55.0 80.0 87.5 82.6
Table 4.7b -  The sensitivity and specificity o f  combinations o f  two techniques in OAG 
based upon an abnormal result by one o f  the two tests.
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4.4.4 Rates o f agreement between tests
The agreement between tests in detecting abnormality in normal individuals (false- 
positives), in early OAG and in moderate/advanced OAG are shown in Figure 4.7, 
Figure 4.8 and Figure 4.9. respectively. The percentage agreement. Kappa statistic 
and standard error between test outcomes in normal individuals and in early OAG, in 
moderate/advanced OAG and in the two groups OAG, combined, are given in Tables 
4.8a, 4.8b. 4.8c and 4.8d, respectively.
Normal
MRA (HRT II) MRA (HRT III)
RNFL
Thickness
(StratusOCT) mfVEP
Figure 4.7 -  The number o f  the 20 normal individuals exhibiting abnormality with the 
given investigative technique.
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Early OAG
MRA (HRT II) MRA (HRT III)
RNFL
Thickness
(StratusOCT) mfVEP
Figure 4 .8 -  The number o f  the 15 individuals with early OAG exhibiting abnormality 
with the given investigative technique.
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Moderate/advanced OAG
MRA (HRT II) MRA (HRT III)
RNFL
Thickness
(StratusOCT) mfVEP
Figure 4.9 -  The number o f  the 8 individuals with moderate/advanced OAG 
exhibiting abnormality w ith the given investigative technique.
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Normal
(n=20)
OCT CSLO II CSLO III mfVEP
CSLO II 85%
0.35 (0.26)
- - -
CSLO III 60%
-0 .1 0 (0 .0 9 )
75%
0 .3 9 (0 .2 1 )
- -
mfVEP 55%
-0 .1 0 (0 .0 9 )
50%
-0 .1 4 (0 .1 9 )
45%
-0 .17 (0 .21 )
-
SAP 90%
-0.05 (0.04)
75%
-0.09 (0.07)
70%
0 .18 (0 .1 6 )
55%
-0 .10(0 .09)
Table 4.8a -  Level o f  agreement (bold [%]). Kappa statistic and standard error (in 
parentheses) between diagnostic tests in normal individuals.
E.OAG
(n=15)
OCT CSLO II CSLO III mfVEP
CSLO 11 67%
0 .3 9 (0 .1 8 )
- - -
CSLO III 53%
0 .1 9 (0 .1 3 )
87%
0.60 (0.24)
- -
mfVEP 33%
-0.25 (0.23)
53%
-0 .1 0 (0 .2 4 )
67%
0.12 (0.24)
-
SAP 73% 53% 40% 47%
0.44 (0.24) 0.15 (0.20) -0.05 (0.16) 0 (0.22)
Table 4.8b -  The level o f  agreement (bold [%]). Kappa statistic and Standard Error 
(inparentheses) between diagnostic tests in the individuals with early OAG.
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M/A. OAG
(n=8)
OCT CSLO II CSLO III mfVEP
CSLO II 38%
-0.25 (0.23)
- - -
CSLO III 50%
0.00 (0.00)
88%
0.00 (0.00)
- -
mfVEP 50%
0.00 (0.31)
75%
0.33 (0.38)
75%
0.00 (0.00)
-
SAP 63%
0.25 (0.33)
50%
0 .1 6 (0 .1 6 )
38%
0.00 (0.00)
33%
-0.13 (0.24)
Table 4.8c -  The level o f  agreement (bold [%]), Kappa statistic and Standard Error 
(in parentheses) between diagnostic tests in the individuals with moderate/advanced  
(M/A.) OAG.
OAG
Combined
(n=23)
OCT CSLO II CSLO III mfVEP
CSLO II 57%
0 .1 9 (0 .1 5 )
- - -
CSLO III 52%
0 .1 4 (0 .1 0 )
87%
0.51 (0.23)
- -
mfVEP 39%
-0 .1 6 (0 .1 8 )
61%
0.04 (0.21)
70%
0 .1 0 (0 .1 8 )
-
SAP 70%
0.37 (0.20)
52%
0 .1 5 (0 .1 4 )
39%
-0.03 (0.10)
42%
-0.06 (0.17)
Table 4.8d -  The level o f  agreement (bold [%]), Kappa statistic and Standard Error 
(inparentheses) between diagnostic tests in all individuals with OAG.
4.4.5 Topographic correspondence o f abnormality
The topographic correspondence o f abnormality was determined between each o f the 
diagnostic techniques for individuals classified as early OAG and for individuals 
classified as moderate/advanced OAG and for both groups o f patients combined. The 
rates of agreement between techniques are given in Table 4.9
In eyes with early OAG. the best topographic correspondence with the diagnostic 
standard DSI was achieved by CSLO using the HRT III (80%). The worst 
topographic correspondence was for SAP using the HFA (13.3%) and the mfVEP 
using VERIS (13.3%). equally.
In eyes with moderate/advanced OAG. the best topographic correspondence with the 
diagnostic standard DSI was achieved by CSLO using the HRT III (100%). The worst 
topographic correspondence was for SAP using the HFA (25%).
In eyes with early OAG or moderate/advanced OAG, combined, the best topographic 
correspondence o f abnormality with the diagnostic standard DSI was achieved by 
CSLO using the HRT III (87%). The worst topographic correspondence was for SAP 
using the HFA (17.4%).
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Agreement between: E.OAG (%)
( n = l 5)
M/A. OAG (%)
(n=8)
Combined (%)
(n=23)
DSI and OCT 33.3 37.5 34.8
DSI and CSLO II 66.7 87.5 73.9
DSI and CSLO III 80.0 100.0 87.0
DSI and mfVEP 13.3 37.5 21.7
DSI and SAP 13.3 25.0 17.4
OCT and CSLO II 40.0 37.5 39.1
OCT and CSLO III 40.0 37.5 39.1
OCT and mfVEP 13.3 0 8.7
OCT and SAP 20.0 12.5 17.4
CSLO 11 and CSLO 111 73.3 87.5 78.3
CSLO II and mfVEP 26.7 12.5 21.7
CSLO II and SAP 26.7 37.5 30.4
CSLO III and mfVEP 26.7 12.5 21.7
CSLO III and SAP 26.7 37.5 30.4
mfVEP and SAP 13.3 12.5 13.0
Table 4.9 — The agreement in the topographical location of abnormality betw een the 
4 techniques in individuals with early OAG, in individuals with moderate/advanced 
OAG and fo r  the two groups combined.
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4.5 Discussion
Subjective evaluation o f  stereoscopic ONH im ages is the ‘gold standard' technique 
for detecting structural dam age (Am erican A cadem y o f Ophthalmology 2000. 
European Glaucoma Prevention Study (EGPS) G roup 2002, Gordon MO and Kass 
MA - The Ocular Hypertension Treatm ent Study Group 1999). The natural 
development o f stereoscopic ONH im aging and thus the emerging ‘gold standard’ is 
digital stereoscopic ONH im aging (DSI) (M organ JE, et al. 2005). Since the 
consensus, that in OAG structural damage precedes functional damage by SAP 
(Harwerth RS, et al. 2004. Kerrigan-Baum rind LA . et al. 2000, Quigley HA, et al. 
1989). several techniques that are sensitive to structural changes to the ONH and 
peripapillary retina have shown promise in the detection o f  the disease. Two o f the 
most promising o f these techniques, namely CSLO  and OCT, that measure structural 
aspects of ONH morphometry and RNFL thickness, respectively, have been shown to 
detect structural abnormalities in glaucom atous patien ts with visual field loss by SAP 
(Burgansky-Eliash Z. et al. 2007, Danesh-M eyer HV, et al. 2006, Naithani P, et al. 
2007, Pueyo V, et al. 2007, Sihota R, et al. 2006). However, the detection o f OAG in 
patients without visual field loss presents a much greater diagnostic challenge and the 
use o f these imaging techniques in this type o f  O A G  is less well documented. The 
mfVEP technique has also dem onstrated clinical utility  in detecting functional deficits 
in patients with OAG manifesting visual field loss by SAP (Graham SL, et al. 2005, 
Hood DC. et al. 2000, Hood DC, et al. 2004) and in patients with OAG without visual 
field loss (Hood DC, et al. 2003, Thienprasiddhi P. et al. 2003).
This study is the first to determ ine the diagnostic perform ance o f the current state-of- 
the-art techniques for detecting OAG in a single study cohort who were classified
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solely according to the em erging ‘gold standard’ technique. DSI. The results o f this 
study demonstrate the various diagnostic performances o f OCT. CSLO, mfVEP and 
SAP in their respective ability to detect OAG.
This study has also dem onstrated the various diagnostic capabilities o f techniques 
used in combination, as well as the levels o f  agreement between tests and the level 
topographical correspondence o f abnormality.
4.5.1 Diagnostic Precision
Sensitivity
In early OAG. in moderate/advanced OAG and for both groups combined. CSLO 
using the HRT III MRA exhibited the highest levels o f  sensitivity for OAG. In early 
OAG. moderate/advanced OAG and combined groups HRT III MRA yielded 
sensitivities o f 86.7%, 100% and 91.3%. respectively, with a specificity o f 95% in all 
groups. The lowest sensitivity was OCT o f the RNFL using the StratusOCT (40%) 
and for SAP using the HFA (40% ) in the early OAG group. In the combined group, 
the HRT II MRA (78.2%). the HRT III MRA (91.3%) and the mfVEP (69.6%) 
technique each exhibited sensitivity for glaucomatous abnormality exceeding that o f 
the HFA (47.8%). This finding may indicate that these techniques are capable o f 
detecting glaucomatous damage before it can be detected as visual field loss by SAP.
The sensitivity o f StratusOCT RNFL thickness measurements to detect OAG is lower 
than reported in other studies (Balachandran C, et al. 2006, Hougaard JL, et al. 2007, 
Medeiros FA, et al. 2006, Naithani P, et al. 2007). However, this discrepancy can be
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explained in one o f two ways. Firstly, since the analysis o f StratusOCT RNFL 
thickness measurements in this study was based solely on the normative database of 
RNFL thickness values employed by the commercially available StratusOCT, rather 
than using a LDF o f the best diagnostic parameters, it may be the case that, due to the 
wide inherent variation in RNFL thickness, the confidence intervals yielded by the 
StratusOCT normative data are, in fact, too wide to detect OAG accurately. In 
addition, the fact that the StratusOCT RNFL thickness average protocol takes no 
account o f the between individual differences in ONH size, which has been shown to 
result in relative under- and overestimation o f  RNFL thickness in small and large 
ONHs. respectively (M edeiros FA. et al. 2006) may be a confounding limitation of 
the StratusOCT RNFL thickness average analysis protocol. A second explanation 
relates to the fact that all diagnostic tests tend to be more sensitive in advanced stages 
of the disease and that measures o f  diagnostic precision obtained from studies that 
include patients with moderate or severe OAG may not be applicable to patients in the 
early stages o f the OAG or OAG suspects (M edeiros FA, et al. 2006, Ransohoff DF 
and Feinstein AR 1978). In the present study, a relatively large proportion o f patients 
(15 o f 23) presented with what are believed to be the ‘earliest’ detectable signs o f 
OAG according to the emerging ‘gold standard’, DSL Thus, the relatively low 
sensitivity o f StratusOCT to detect OAG may represent differences in the distribution 
of OAG severity between the present study and other recent studies (Hougaard JL, et 
al. 2007, Medeiros FA. et al. 2006, Parikh RS. et al. 2007, Pueyo V, et al. 2007). A 
recent study investigating the diagnostic capability o f StratusOCT based on RNFL 
thickness in patients with OAG w ithout visual field loss (Kim TW, et al. 2007), 
showed sensitivity and specificity o f  <40.8%  and <100%, which is more consistent 
with the values observed in this study.
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Despite yielding only moderately levels o f  sensitivity (69.6%. in early and 
moderate/advanced groups com bined), the mfVEP technique appeared to be more 
sensitive for OAG than SAP (47.8% . in early and moderate/advanced groups 
combined). Previous studies investigating the mfVEP have reported sensitivities of 
29% (Fortune B. et al. 2007) and 80.9%  (Graham SL, et al. 2005) in patients with 
OAG without visual field loss. Thus, the observed sensitivity o f the mfVEP is in 
agreement with these earlier reports. The low sensitivity o f SAP (47.8%, in early and 
moderate/advanced groups combined) is not surprising considering the stage o f OAG 
exhibited by a majority o f the individuals.
It has been speculated that the mfVEP and SAP may be detecting slightly different 
functional deficits in OAG (Fortune B. et al. 2007). This may, in part, be responsible 
for the poor level o f agreement (33-55%) shown between the mfVEP and SAP in the 
present study. The fact that the mfVEP outperformed SAP, in terms o f sensitivity, and 
that the two techniques agreed in only 33% to 55% o f cases, suggests that the mfVEP 
detects abnormality that SAP is m issing and vice versa. This may arise due to 
differences in the spatial sampling o f the visual field used by each technique or due to 
the variability in SNR that exists between patients and within the visual field.
Specificity
In all analyses (early OAG. moderate/advance OAG and the two groups combined), 
RNFL thickness by OCT and differential light sensitivity by SAP exhibited joint 
highest specificity (95%) for OAG o f  all o f the techniques used. The lowest 
specificity was exhibited by the m fV EP using VERIS (60%) and the CSLO using the 
HRT III MRA (65%) (Figure 4.6). An explanation for the apparent lack o f specificity
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of mfVEP is presented later; however, the lack o f specificity exhibited by HRT III 
MRA is also noteworthy since the MRA represents one o f the most sophisticated 
analysis techniques for the detection o f  OAG.
The HRT III MRA outperformed the HRT II MRA with respect to sensitivity for 
OAG. although the HRT II MRA exhibited better specificity for the disease. A good 
level o f agreement was between the HRT II MRA and the HRT III MRA outcomes. 
Recent studies comparing the HRT II MRA and HRT III MRA report similar findings 
(Burgansky-Eliash Z. et al. 2007. Ferreras A. et al. 2007). In both studies, a higher 
degree of abnormality is shown by the HRT III MRA than by the HRT II MRA, 
which has the effect o f increasing sensitivity and reducing specificity for the newer 
analysis (Burgansky-Eliash Z, et al. 2007, Ferreras A, et al. 2007). It can be 
speculated that this might be due to the narrower confidence interval in the enlarged 
normative database and consequently the tendency to yield a greater proportion o f 
abnormal classifications.
Another point, worthy o f note, is that all individuals in the normal group were 
recruited as normal i.e. none o f the individuals had been falsely classified in terms of 
the ONH appearance using DSI. Considering the deliberate exclusion o f normal 
individuals who had risk factors for OAG, the normal individuals classified as 
abnormal by the techniques in this study would appear to be ‘true’ false-positive 
classifications.
Seeking to explain the low specificity yielded by the CSLO, a retrospective analysis 
of the HRT images in the false-positive cases revealed no evidence o f a tilted, small
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(<1.9mrrr) or large (>3mm2) ONHs. which are known to affect the accuracy of MRA 
classifications (Medeiros FA. et al. 2006. Schuerle AF and Schmidt E 2004). 
However, a longitudinal follow-up o f  these patients will be required to identify if  any 
of these individuals subsequently go on to develop OAG.
4.5.2 Combining techniques
The use o f diagnostic tests in com bination can improve the sensitivity and specificity 
for the detection of OAG than if  the same techniques were used, alone (Shah NN, et 
al. 2006). In addition, the severity o f  OAG may have an influence on the diagnostic 
capability o f each test but to different extents (Hougaard JL. et al. 2007). Hence, 
combining techniques that exploit different diagnostic parameters to quantify 
glaucomatous damage may improve the diagnostic precision over a broader range of 
severity.
This study has demonstrated that by using tests in combination the clinical utility of 
the tests and diagnostic precision for OAG is improved. This is achieved by 
stipulating either that both or one o f the tests must be abnormal in order to yield a 
glaucomatous classification.
The combination o f RNFL thickness by StratusOCT and the HRT II MRA, using an 
abnormal result by one or other o f the tests to designate OAG, exhibited the most 
clinically useful diagnostic precision o f  all the possible combinations o f techniques, 
yielding a sensitivity and specificity o f  82.6% (in early and moderate/advanced 
groups combined) and 80%, respectively.
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The combination o f the HRT II MRA and the HRT III MRA performed similarly well 
using an abnormal result by both tests to confirm OAG, yielding a sensitivity and a 
specificity o f 78.3% (in early and moderate/advanced groups combined) and 85%, 
respectively. However, since both versions o f the HRT MRA employ the same 
diagnostic parameter to detect OAG i.e. normalised rim area measurements, it is 
speculated that this combination o f  tests may be less effective in detecting OAG over 
a broader spectrum o f disease severity than for other combinations o f investigative 
techniques that offer different diagnostic parameters.
This is the first study that has examined the com bined diagnostic precision for the 
detection o f OAG. in terms o f  any two o f the following diagnostic parameters: RNFL 
thickness (OCT); neuroretinal rim area (CSLO); the mfVEP; and differential light 
sensitivity (SAP).
The combined use o f tests to detect OAG has been investigated previously in terms o f 
visual function-specific perimetry with optical imaging (Shah NN, et al. 2006), early- 
generation photographic ONH image analysis and SAP (Caprioli J 1992) and early- 
generation HRT. OCT and stereoscopic image analysis (Greaney MJ, et al. 2002). 
Each o f these studies demonstrated superior level o f diagnostic precision for OAG by 
combining one or more tests than if  tests were used in isolation (Caprioli J 1992, 
Greaney MJ, et al. 2002. Shah NN. et al. 2006).
4.5.4 Agreement between techniques
It is important to determine the agreem ent between the glaucomatous ONH 
appearance (DSI) and tests for RNFL thickness (OCT) and neuroretinal rim area
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(CSLO) and visual sensitivity (m fVEP and SAP) since it provides an indication o f the 
relationship between structural and functional parameters in OAG.
The best levels agreement between structural tests and functional tests were observed 
between the OCT RNFL thickness analysis and SAP differential light sensitivity (63- 
90%) and between the HRT II MRA and the mfVEP (45-75%). Better agreement 
between SAP and OCT than between SAP and CSLO has been previously reported 
(Bowd C. et al. 2006).
In this study, the diagnostic agreement between techniques varied considerably in 
normal individuals, and in individuals with either early OAG or with 
moderate/advanced OAG. Much o f  the agreement that occurred between the tests 
seemingly occurred by chance alone i.e. tests agreed only because the diagnostic 
precision was similar between tests. As might be expected, the best level o f 
agreement was seen between the two versions o f  the MRA o f the HRT II and the 
HRT II; however, even still only a poor to moderate likelihood existed that the 
observed agreement occurred by chance alone (Kappa, 0.0 to 0.6). The generally poor 
Kappa values observed in this study may be, in part, due to the relatively small cohort 
size.
This, and several other studies, provide evidence that the temporal onset o f structural 
and functional defects, using the current state-of-the art technology, is different based 
on different diagnostic parameters (Kass MA, et al. 2002. Miglior S, et al. 2005). In 
some eyes, glaucomatous structural deficits precede functional deficits and in some
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cases the opposite is true (Kass MA. et al. 2002, Miglior S, et al. 2005). Thus, the 
characterisation o f structural and functional damage in terms of the agreement 
between tests will depend upon the type o f  OAG and the temporal lag/severity of the 
disease.
Whilst the levels o f agreement between techniques demonstrated by the present study 
reflect patterns in predominantly early OAG, the precise level o f agreement between 
any two o f the techniques will vary depending upon to diagnostic performance of the 
technique at a given level o f OAG severity (M edeiros FA, et al. 2006, Zangwill LM, 
et al. 2007).
4.5.5 Topographical correspondence
Topographic correspondence between two different tests serves to corroborate the 
likelihood that ‘true* damage has occurred. This is especially the case when 
topographical agreement occurs between two types o f test that utilize different 
diagnostic parameters (Greaney MJ. et al. 2002. Hoh ST, et al. 2000, Iester M, et al. 
2006, Sihota R, et al. 2006).
The topographical correspondence between structure and function has been 
investigated previously (Ajtony C, et al. 2007, Bowd C, et al. 2006, Gardiner SK, et 
al. 2005, Garway-Heath DF, et al. 2000. Strouthidis NG, et al. 2006). In this study, 
the greatest level o f topographical correspondence was observed between two 
structural tests, namely the HRT III MRA and DSI in patients with
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moderate/advanced OAG (100%). The HRT II MRA corresponded only slightly less 
well with DSI in this group o f  patients (87.5%). The correspondence with DSI for the 
remaining 3 methods was 34.8%. 21.8%  and 17.4% for the StratusOCT, the mfVEP 
and the HFA. respectively.
The level o f topographical agreement between structural and functional tests was 
generally poor (less than approximately 30%). This finding may be because the cohort 
consisted predominantly o f patients with early OAG who perhaps had not undergone 
sufficient functional deficits. However, it is also interesting to note that a higher rate 
o f topographical agreement was observed between the SAP and the CSLO than 
between the SAP and DSI.
Another possible explanation for the weak structure-function associations observed in 
this study is that the structure-function topography map upon which the analysis was 
based (Garway-Heath DF. et al. 2000) is not optimal and/or, due to the inherent 
variation in the RNFL between individuals, devising a ‘true’ structure-function map is 
not possible.
A recent study demonstrated that although predicted topographical agreements occur, 
unpredicted topographical agreements also occur (Gardiner SK, et al. 2005). This 
latter study investigators showed that although topographical agreement was present 
between the outcomes o f the CSLO and SAP, some degree of topographical 
inconsistency was also present (Gardiner SK. et al. 2005).
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4.5.6 Limitations o f the study
A key limitation o f this study, and o f  any method comparison study, is that the 
different diagnostic techniques are at different stages o f development. In general, 
more established techniques, like the CSLO and OCT, benefit from more robust 
normative databases and more sophisticated statistical analyses than newer techniques 
such as the mfVEP.
In this study, the mfVEP analysis did not need to be corrected for the effects o f ageing 
since an interocular comparison was undertaken. This analysis was possible due to the 
inclusion in the study o f patients without cataracts. However, the technique may be 
limited in patients with a marked difference in the severity o f the cataract between the 
right and left eyes.
The criterion for glaucomatous abnormality by mfVEP was less stringent (operative at 
a p<0.05 level) compared with the criteria used for the other techniques. However, 
this did not correspond with a relatively higher level o f  sensitivity by the mfVEP, as 
may be expected. Recent refinements to the m fV EP technique, which may yield 
improved diagnostic ability for OAG include: multi-channel recording and use o f ‘the 
best array* i.e. the best responses from the six channels available for each eye 
(Fortune B. et al. 2007. Hood DC and Greenstein VC 2003, Hood DC, et al. 2002); 
probability based cluster analysis (Fortune B, et al. 2007, Fortune B, et al. 2004); and 
combining monocular and interocular mfVEP responses (Hood DC, et al. 2004).
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Several reports have suggested that the latency o f the mfVEP may be useful in 
detecting OAG (Bach M 2006. Hood DC. et al. 2006. Rodarte C, et al. 2006). 
However, these delays in the mfVEP are small (<2ms) (Rodarte C. et al. 2006), even 
based on the most sophisticated recording methods, and are not specific to OAG 
(Hood DC. et al. 2006).
Due to the rate o f technological advancements concerning structural and functional 
associations in OAG, this area o f research is constantly evolving. Cross-sectional and 
longitudinal studies, which employ state-of-the-art techniques at the study outset, are 
often out of date by the time the study is complete and/or published.
In the present study, and inherent in all studies evaluating the diagnostic performance 
of various techniques, there exists no perfect gold standard for diagnosis. Although 
DSI is derived from the current ‘gold standard' technique, it is possible that newly 
developed instruments are better at detecting OAG. Thus, estimates o f diagnostic 
precision are reliant on the quality o f the gold standard applied. The greatest 
limitation o f DSI as a gold standard technique is the lack o f  an established diagnostic 
standard o f what constitutes a glaucomatous ONH appearance. Diagnoses by DSI are 
subjective and based upon the gestalt appearance o f the disc by the observer. Expert 
observers using DSI achieved fair to moderate levels o f  agreement in their clinical 
diagnoses (Kappa 0.31-0.61). This outcome is also consistent with that for non-digital 
stereoscopic ONH-imaging (Harper R. et al. 2000, Shuttleworth GN, et al. 2000, 
Tielsch J, et al. 1988, Varma R. et al. 1992. Zeyen T, et al. 2003). Thus the diagnostic 
precision o f the technique, clinically, will vary with each individual clinician. This
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finding highlights the importance that, in research, diagnoses by DSI should be made 
by consensus agreement and not by one diagnostician, alone.
Longitudinal studies are justified to evaluate whether one. or a combination o f the 
techniques, used in this study, are useful in predicting those patients in a clinical 
situation likely to convert to OAG over time and also which patients with OAG are 
most likely to undergo progressive damage.
4.6 Conclusion
This is the first cross-sectional study to compare the diagnostic performance o f the 3 
most promising techniques (OCT. CSLO and mfVEP) for detection o f OAG in a 
single cohort o f individuals classified solely using the emerging ‘gold-standard’ 
technique, DSL The main outcomes o f  this study are that the CSLO using the HRT III 
MRA exhibited the highest level o f sensitivity for OAG o f all the techniques 
investigated in this study. Thus, the HRT III MRA seemingly identifies OAG at an 
earlier stage than any other o f  the techniques. However, along with the mfVEP using 
VERIS, CSLO using the HRT III MRA exhibited one o f  the lowest levels o f 
specificity. The greatest levels o f specificity were exhibited by for OCT using the 
StratusOCT and SAP using the HFA.
Based on the results o f this study, the precise utility o f each o f these technologies 
remains an issue o f clinical judgement. The clinical diagnoses made by different 
observers based on DSL will govern the precise level o f diagnostic precision achieved 
by each technique.
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Combining diagnostic techniques can improve the detection o f OAG (Shah NN, et al. 
2006). The combination o f techniques yielding the greatest diagnostic performance 
was the OCT (StratusOCT) with the CSLO (HRT II MRA). Based upon a diagnostic 
criteria o f abnormality by either one o f  the techniques sensitivity and specificity for 
the detection o f OAG of 82.6% and 80%. respectively, was achieved.
The best levels o f agreement between structure and function were present between 
StratusOCT and the HFA and between the HRT and the mfVEP. However, due to the 
similarities in the diagnostic precision between these pairs o f tests, combined with a 
relatively small cohort size it was difficult to determine whether the observed 
agreement was due more than just to chance alone.
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Chapter 5: Novel estim ation o f RNFL thickness based on 
subjective evaluation o f StratusOCT scan data
5.1 Introduction
Measurement o f  RNFL thickness by optical coherence tomography (OCT) is 
becoming an established standard procedure in the detection and management of 
patients with OAG (Budenz DL. et al. 2005. De Leon-Ortega JE, et al. 2006, Jeoung 
JW, et al. 2005. Leung CK. et al. 2005, Sihota R, et al. 2006).
The current clinical standard for OCT, the StratusOCT, defines the anterior and 
posterior borders o f  the RNFL as the two points along the A-scan reflectivity profile 
where the amount o f  reflectivity just exceeds and just falls below, respectively, a 
specified threshold. The axial distance between these two points is taken as the 
measure o f the RNFL thickness. A similar approach is adopted for the measurement 
o f macular and retinal thicknesses.
5.1.1 Erroneous RNFL thickness measurement by StratusOCT
In a number o f instances, the StratusOCT analysis yields erroneous measurements o f 
RNFL and retinal thickness (Ishikawa H. et al. 2002, Ray R, et al. 2005, Sadda SR, et 
al. 2006). In these instances an alternative means to obtain RNFL thickness 
measurements, based on standard StratusOCT data, would add clinical value to the 
technique.
In eyes with sub-macula and/or sub-retinal disease, erroneous retinal thickness 
measurements are commonplace in StratusOCT scans (Ishikawa H, et al. 2002, Ray 
R, et al. 2005. Sadda SR. et al. 2006). Some errors are operator dependent, such as 
eye movement and blink artefacts (Ray R, et al. 2005), whilst others are operator 
independent, such as m isidentification o f the outer/inner retina (Leung CK, et al. 
2007. Sadda SR. et al. 2006) and misalignment o f adjacent A-scans (Leung CK, et al. 
2007. Ray R. et al. 2005. Sadda SR, et al. 2006).
The likelihood o f encountering erroneous retinal/RNFL thickness measurements is 
greater for scans exhibiting low to poor SNR (Ishikawa H, et al. 2002), for an 
attenuated RNFL (Ishikawa H. et al. 2002), for a poorly reflective RNFL (Ishikawa H, 
et al. 2002), for a detached internal limiting membrane (ILM) (Ray R, et al. 2005) 
and/or where abnormalities o f the subretinal tissues are apparent, for example, the 
presence o f subretinal fluid (Sadda SR, et al. 2006). Operator independent 
measurement errors most commonly occur either due to misplacement o f the RNFL 
interface boundary, or due to misalignment o f adjacent a-scans by the StratusOCT 
automated analysis software (Leung CK. et al. 2007, Sadda SR, et al. 2006). Such 
operator independent errors occur during automated analysis o f scan data by 
StratusOCT and have been identified in individuals undergoing macula thickness 
scans. The influence o f such errors in individuals undergoing RNFL thickness 
measurement is unknown.
As was described in Chapter 4. the StratusOCT RNFL thickness (3.4) scan, averages 
the 512 independent measurements from around the ONH to yield one global, 4 
quadrant and 12 clock hour averaged RNFL thickness values. Under optimal
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recording conditions. S tratusO C T RNFL thickness measurements exhibit high within- 
test repeatability (ICC 0.92-0 .97) (Budenz DL, et al. 2005, De Leon-Ortega JE, et al. 
2007. Paunescu LA. et al. 2004).
In some cases, erroneous m easurem ents can be rectified, simply by re-scanning the 
patient. However, where th is is not immediately possible and/or where patients 
consistently yield erroneous RNFL thickness measurements, the application of 
StratusOCT to detect O A G . or progressive structural damage due to OAG, is limited.
5.1.2 Justification fo r  alternative RNFL thickness measurement methods
During the study described in Chapter 4, it became apparent that a relatively high 
proportion o f the first acquisition StratusOCT RNFL thickness measurements 
contained errors, which, i f  persistent, could have led to the exclusion o f participants 
due to unusable RNFL thickness measurements by StratusOCT. As a consequence, 
novel software was developed to permit the measurement o f RNFL thickness in such 
instances. The basic program , OCTAnalyse, was written by a computer programmer, 
Gavin Powell (GP). who. in collaboration with two o f the study investigators (JEM 
and CJH), refined the basic software to yield a user-friendly subjective technique for 
obtaining peripapillary RNFL thickness measurements based on the standard 
StratusOCT procedure.
The validity o f O CTA nalyse needed to be established in terms o f the level o f 
agreement between O CTA nalyse and the StratusOCT. The repeatability o f 
OCTAnalyse RNFL thickness measurements governs the clinical utility in cross- 
sectional and longitudinal evaluation o f OAG.
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5.2 Study Aims
The purpose o f the study was: to determ ine the level o f agreement o f RNFL thickness 
measurements obtained by OCTAnalyse with those obtained by StratusOCT; to 
determine the test-retest repeatability o f  RNFL thickness measurements obtained by 
OCTAnalyse and by StratusOCT; and to investigate the presence and likely cause o f 
measurement errors in RNFL thickness obtained by StratusOCT.
5.3 M aterials/ M ethods
A retrospective study was undertaken using 21 o f  the patients described in Chapter 4 
and all 20 normal individuals. The inclusion criteria were as described in Chapter 4, 
Section 4.3.2.
5.3.1 Digital stereoscopic ONH-imaging (DSI)
The classification o f eyes as normal or glaucomatous (OAG) was based solely on the 
appearance o f the ONH by subjective grading using DSI in accordance with the 
procedure described in Chapter 4, Section 4.3.3.
Although both eyes o f each participant were assessed with the novel techniques, the 
results o f one randomly chosen eye for each individual are reported in Chapter 4. The 
eye chosen for the present study was also selected at random but on a separate 
occasion.
Twelve eyes were classified by DSI as OAG and 29 o f  the eyes were normal. Nine o f 
the 29 normal eyes had a fellow eye which had OAG. These 9 eyes, defined as
184
suspect eyes, were analysed alongside, but independently of, the remaining 20 eyes in 
the normal group. The 12 eyes w ith OAG were derived from 8 patients with bilateral 
OAG and 4 patients with unilateral OAG.
One suspect eye was receiving topical anti-glaucom a drugs; all other suspect eyes 
were not receiving medical therapy o f  any kind. All o f the eyes with OAG were 
receiving topical anti-glaucom a drugs with the exception o f one patient who had 
undergone a trabeculectomy 30 m onths prior to entry into the study.
All o f the normal and suspect eyes exhibited a normal visual field by SAP. Nine of 
the 12 OAG eyes exhibited a repeatable visual field defect, characteristic o f OAG, by 
SAP. The remaining 3 OAG eyes exhibited a normal visual field by SAP. In all cases, 
visual field printouts were interpreted by an expert (JMW). The definitions o f a 
normal and abnormal visual field used in the present study were as described in 
Chapter 4. Section 4.3.4.
The gender, mean age. mean central corneal thickness (CCT), mean Goldmann intra­
ocular pressure (IOP) and m ean corneal corrected IOP (cc-IOP) o f the Normal, 
Suspect and OAG participants is given in Table 1.
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Group Gender Mean age +SD. Mean CCT +SD. IOP +SD. cc-IOP +SD,
(M:F) years (range) pm (range) mmHg mmHg
(range) (range)
Normal 6:14 65.3 + 11.2 559.6 + 28.4 16.4 + 3.1 14.4 + 3.5
(n=20) (31-82) (508-615) (9-20) (9-18)
Suspect 4:5 72.4 + 7.2 531.4 + 16.8 15.9 + 3.2 16.4 + 3.3
(n=9) (59-83) (502-554) (10-18) (10-19)
OAG 7:5 65.6 ±  12.2 521.5 + 35.5 19.5 ± 5 .6 21.2 + 5.4
(n=12) (46-85) (480-552) (8-26) (9-26)
Table 5.1 - Gender, mean age, mean central corneal thickness (CCT), mean intra­
ocular pressure (IOP) and mean cornea corrected IOP (cc-IOP) fo r  normal and 
suspect individuals and individuals with OA G. Where appropriate, the IOPs and cc- 
IOPs are treated values.
5.3.2 StratusOCT
StratusOCT scans were obtained in accordance w ith the same methodology described 
in Chapter 4, Section 4.3.7. After the first scan, the patient was instructed to sit back 
from the instrument for a m om ent to rest. The patient was then asked to resume their 
position in preparation for a second scan. The z-offset and polarization were re­
optimized for second scan. The position o f  the scan circle, relative to the ONH was 
adjusted, if  necessary, to account for any difference in head/eye position between the 
first and second scans. Both the first and second scan were analysed in the same way 
using the RNFL thickness average analysis protocol.
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5.3.3 OCTAnalyse
The OCTAnalyse software was created in Delphi utilizing the OpenGL application- 
programming interface (API) (Figure 4.1). The OCTAnalyse software allowed an 
observer to view StratusOCT scan data, and to subjectively measure RNFL thickness, 
via a stand-alone PC. The software was designed to allow the data to be viewed in a 
consistent manner whatever the resolution o f  the scan (512 or 256 A-scans). 
StratusOCT data files were imported via a memory stick to OCTAnalyse for each 
participant. The OCTAnalyse software included a thresholding algorithm that enabled 
the observer to view the detail within the image analogous to the typical scan pattern 
seen on the StratusOCT. An independent viewing window, which allowed the 
observer to visualise any single A-scan reflectivity profile was also incorporated into 
the program.
ThicknessThreshold
A-scan reflectivity profile window
Ant. calliper scroll
Ant. RNFL border
Post. RNFL border
Post, calliper scroll
Horizontal r o w o n
|0 08333333333
StratusOCT analysis RNFL thickness output
NR Thickness | 97 65j j
OCTAnalyse RNFL thickness output
Figure 5.1 -  The display generated by the OCTAnalyse software
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The software permitted manual delineation, with a caliper, of the anterior and 
posterior RNFL borders based upon specific landmarks in the A-scan reflectivity 
profile. The axial location o f the anterior RNFL border was defined as the base o f the 
first major peak in reflectivity along the A-scan reflectivity profile (Figure 5.2). In 
several cases, the first reflectivity peak corresponded to a detached inner limiting 
membrane (ILM). In these instances, the anterior RNFL border was defined at the 
base o f the second major deflection in reflectance intensity on the A-scan reflectivity 
profile (Figure 5.3). The axial location o f  the posterior RNFL border was defined as 
the mid-point along the descending limb o f the first reflectance spike. In the presence 
o f a detached ILM, the posterior RNFL border was defined as the mid-point along the 
descending limb o f the second reflectance spike. The distance between the two 
cursors provided a direct measurement o f  RNFL thickness.
 Ant. RNFL border
Post. RNFL border
Figure 5.2 -  The axial definition o f  the anterior and posterior retinal nerve fibre  
layer (RNFL) borders on the A-scan reflectivity profile (right) corresponding to the 
highlighted A-scan (left).
A -scan
Figure 5.3 -The axial definition o f  the anterior and posterior retinal nerve fibre layer 
(RNFL) borders on the A-scan reflectivity profile in the presence o f  a detatched 
internal limiting membrane (ILM) (*) (right) corresponding to the highlighted A-scan 
(left).
5.3.4 RNFL thickness measurement
Retinal nerve fibre layer thickness measurements by OCTAnalyse were made with the 
caliper at 24 predetermined and equally spaced A-scans throughout the entire scan 
length. The six measurements obtained within each quadrant (temporal, superior, 
nasal and inferior) were averaged to give a quadrant mean RNFL thickness value. In 
order that the sampling density o f the manual and automated measurements was 
equal, 24 thickness measurements were obtained at the corresponding A-scan 
locations to those from the automated StratusOCT analysis. This number o f 
measurements represented an optimum trade-off between sampling density and the 
length o f time taken to obtain measurements from the entire length o f the scan. The 
quadrant mean RNFL thickness corresponding to the StratusOCT analysis was
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similarly derived from the mean o f  the 6 manual measurements taken from each 
quadrant.
5.3.5 Analysis
Within-session repeatability
The repeatability o f the RNFL thickness measurements was assessed using an 
established method (Bland JM and Altman DG 1999). The difference between the 
first and second measurements was plotted against the mean o f the two values for 
both the manual (OCTAnalyse) and the automated (StratusOCT) measurements. The 
95% confidence intervals for the difference the first and second measurement for both 
the manual and the automated RNFL thickness measurements were separately 
determined (Bland JM and Altman DG 1999, 1986). Differences in measurements 
within particular quadrants and between patient groups were also determined in the 
same way both for the manual (OCTAnalyse) and for the automated (StratusOCT) 
measurement methods.
The test-retest repeatability w ithin a session o f  the RNFL thickness measurements for 
both the StratusOCT and OCTAnalyse measurements was also assessed using a 
second method, namely the intraclass correlation coefficient (ICC). Intraclass 
correlation coefficients were calculated for global average, quadrant average and 
group average measurements.
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Agreement (repeated measures)
The level o f agreement between the manual and automated measurements was 
analyzed in a pair-wise manner. Sim ilar to the first analysis, plots were produced 
which related the difference between the mean manual and mean automated 
measurements with the mean o f the two values. The SD o f the differences from these 
pairs o f means was corrected for the effect o f  repeated measurement error. The 
agreement between the methods was quantified by calculating the 95% limits of 
agreement (LOA) between the methods. The standard error (SE) and 95% confidence 
interval (Cl) for the LOA were also determined.
5.4 Results
5.4.1 With in-test repeatability o f measurements by OCTAnalyse and StratusOCT
The difference between the first and second m easurem ents against the mean o f the 
two measurements for OCTAnalyse and for StratusOCT is given in Figures 5.4a-h for 
each quadrant for all 41 individuals. The corresponding differences for the groups, 
normal, suspect and OAG are given in Figures 5.5a-d.
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Figure 5.4e-h. -  The difference between the first and second measurements against 
the mean o f  the two values in the Temporal (A and E), Superior (B and F), Nasal (C 
and G) and Inferior (D and H) quadrants fo r  manual (OCTAnalyse) (A-D) (left) and 
automated (StratusOCT) (E-H) (right) measurement methods for all 41 individuals.
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Figure 5.5a-d. -  The difference behveen the firs t and second measurements against 
the mean o f  the two values for normal and suspect individuals (A and C) and patients 
with OAG (B and D) fo r  manual (OCTAnalyse) (A-B) (left) and automated 
(StratusOCT) (C-D) (right) measurement methods.
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Variable Mean. Mean SD SE, 95% Cl (± 1 .7 1  SE). ICC
pm Difference (Difference). pm pm
Manual 1 - 2. 
pm
pm Upper Lower
Temporal
78.70  
±  16.04
3.1 1 7.31 1.14
17.44 ±  
1.95
-1 1.22 ±  
1.95
0.90
Superior
113.66  
± 2 1 .8 8
1.84 14.15 2.21
29.57 ±  
3.78
-25.89 ±  
3.78
0.81
Nasal
81.67
± 2 2 .0 6
-1.05 13.12 2.05
24.67 ±  
3.50
-26.77 ±  
3.50
0.84
Inferior
114.74  
+ 22.23
0.70 9.50 1.49
19.32 ±  
2.54
-17.92 ±  
2.54
0.91
Global
97.19  
± 16.86
1.15 6.74 1.05
14.36 ±  
1.80
-12.06 ±  
1.80
0.92
Normal
102.48
± 2 6 .5 9
1.04 12.26 1.14
25.06 ±  
1.95
-22.98 ±  
1.95
0.90
Suspect
98.67
± 2 7 .3 2
-1.81 14.07 2.34
25.76 ±  
4.01
-29.38 ±  
4.01
0.85
OAG
84.42
± 2 2 .5 6
1.41 8.92 1.29
18.89 ±  
2.20
-16.07 ±  
2.20
0.93
Table 5.2 - The mean , m ean d ifference, standard  deviation (SD) o f  the difference, 
standard error (SE) o f  the d ifference, the upper and  lower 95% confidence interval 
(Cl) and intraclass correlation coeffic ient (ICC) fo r  repeated RNFL thickness 
measurments obtained by O C TA nalyse for the 43 individuals (above the double line) 
and for each diagnostic ca tegory (below  the double line).
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Variable Mean. Mean SD SE. 95% Cl (±  1.71 SE), pm ICC
pm Difference 
Automated  
1 -2. pm
(Difference).
pm
pm Upper Lower
Temporal
67.63  
±  14.62
0.42 5.37 0.84 10.94 ±  1.43
-10.11 ±  
1.43
0.94
Superior
107.73
± 2 1 .9 7
0.72 6.47 1.01 13.40 ±  1.73
-11.96 ±  
1.73
0.96
Nasal
71.11 
±  17.18
0.17 6.92 1.08 13.73 ±  1.85
-13.39 ±  
1.85
0.92
Inferior
108.76
± 2 1 .9 0
-0.49 6.20 0.97 11.66 ±  1.66
-12.64 ±  
1.66
0.96
Global
88.81 
±  15.01
0.21 2.74 0.73
5.58 ±  
0.73
-5.16 ±  
0.73
0.98
Normal
94.05  
±  13.14
0.06 6.30 0.43 12.40 ±  1.00
-12.29 ±  
1.00
0.97
Suspect
89.62
^ 1 4 .6 2
0.33 5.15 0.86 10.44 ±  1.47
-9.78 ±  
1.47
0.98
OAG
76.13
± 2 0 .7 7
0.57 6.09 0.88 12.5 ±  1.50
-11.37 ±  
1.50
0.96
Table 5.3 - The mean, mean difference, standard deviation (SD) o f  the difference, 
standard error (SE) o f  the difference, the upper and lower 95% confidence interval 
(Cl) and intraclass correlation coefficient (ICC) fo r  repeated RNFL thickness 
measurmenls obtained by StratusO C T for the 43 individuals (above the double line) 
and for each diagnostic category (below the double line).
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Table 5.2 and Table 5.3 show summary statistics for RNFL thickness measurements 
obtained by OCTAnalyse and StratusOCT, respectively. Intraclass correlation 
coefficients (ICCs) w ere excellent (>0.80) and were higher for measurements 
obtained by StratusOCT in all cases. The highest ICC was obtained for the global 
average RNFL thickness m easurem ents by automated StratusOCT analysis (0.98). 
The lowest ICC obtained was for superior quadrant mean RNFL thickness 
measurements by O CTA nalyse (0.81).
The within-test repeatability (95% Cl) o f RNFL thickness measurements obtained by 
OCTAnalyse ranged between +13.6 pm  (global average) and +28.5 pm (Superior 
quadrant). The w ithin-test repeatability (95% Cl) o f RNFL thickness measurements 
obtained by StratusOCT ranged between +5.5 pm (global average) and +13.9 pm 
(Nasal quadrant). Retinal nerve fibre layer thickness measurements obtained by 
OCTAnalyse exhibited greatest w ithin-test repeatability in the temporal quadrant 
(95% Cl, +14.3 pm) followed by the inferior (95% Cl, +18.6 pm), nasal (95% Cl, 
+23.6 pm) and superior (95%  Cl, +27.7 pm) quadrants, respectively. The 
repeatability o f m easurem ents obtained by StratusOCT was greatest in the temporal 
quadrant (95% CL +10.5 pm ) followed by the inferior (95% Cl, +12.2 pm), superior 
(95% CL +12.7 pm ) and nasal (95%  Cl, +13.6 pm ) quadrants, respectively. In all 
quadrants, w ithin-test repeatability o f  RNFL thickness measurements was greater for 
automated StratusOCT analysis than for manual OCTAnalyse measurements.
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5.4.2 Agreement between OCTAnlayse and StratusOCT
The difference between the mean manual (OCTAnalyse) and mean automated 
(StratusOCT) measurements against the mean o f the two measurements, are given in 
Figure 5.6a-d for quadrant average data and Figure 5.7a and 5.7b for all quadrants for 
the normal, suspect and OAG groups. Table 5.3 provides summary statistics for the 
agreement between OCTAnalyse and StratusOCT RNFL thickness measurements.
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Variable Mean.
pm
Difference. 
(Manual -  
Automated) 
pm
S DCora.ctetl
Difference.
pm
SE.
pm
95% Cl 
Upper
, pm
Lower
Temporal 73.17 11.07 8.29 1.30
27.32 ±  
2.22
-5.18 ±  
2.22
Superior 110.70 5.93 13.74 2.16
32.87 + 
3.67
-21.01 + 
3.67
Nasal 76.39 10.56 17.58 2.74
45.01 ±  
4.69
-23.90 + 
4.69
Inferior 111.75 5.98 9.64 1.50
24.87 ±  
2.57
-12.91 + 
2.57
Global 93.00 8.38 8.01 1.25
24.09 ±  
2.14
-7.32 ±  
2.14
Normal 98.27 8.42 13.10 2.04
34.10 + 
3.49
-17.26 ±  
3.49
Suspect 94.15 9.01 10.00 1.67
28.67 ±  
2.75
-10.75 + 
2.75
OAG 80.27 8.29 12.81 2.00
33.40 + 
3.42
-16.82 + 
3.42
Table 5.4 - The mean, mean difference, corrected standard deviation (SDcorrected), 
standard error (SE) and upper and lower 95% confidence interval (Cl) fo r  the 
agreement betw een manual and autom ated RNFL thickness measurement techniques.
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Figure 5.6a-d. -  The difference between OCTAnalyse and StratusOCT measurements 
against the mean o f  the tw>o values obtained fo r  the Temporal (A), Superior (B), 
Inferior (C) and Nasal (D) quadrants.
199
so
40
30
20 •  •  •
10
0
•10
•30
O AG
-10
-20
-3 0
-4 0
Mean(iim)
•—i
~s
norm al and su sp ect
100 125 ISO 175
95% LOA
Mean
S uspect
Figure 5.7a and 5.7b -  The difference between OCTAnalyse and StratusOCT 
measurements against the mean o f  the 1m >o  values obtained fo r  patients with OAG (A) 
and normal/ suspect individuals (B).
In all quadrants, RNFL thickness measurements obtained by OCTAnalyse were 
statistically significantly greater than those obtained by StratusOCT (PO .O l). The 
difference between the techniques was greatest for the temporal quadrant RNFL 
thickness (11.07 pm ) followed by the nasal (10.56 pm), inferior (5.98 pm) and 
superior (5.93 pm) quadrant measurements.
Retinal nerve fibre layer thickness measurements obtained by OCTAnalyse were 
greater than those obtained by StratusOCT in normal (8.42 pm), suspect (9.05 pm) 
and OAG (8.29 pm) groups, which in all cases was statistically significant (p<0.01).
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5.4.3 Erroneous RNFL thickness measurements by StratusOCT
Seven of the 41 participants produced Stratus O CT scans which, when analysed using 
the RNFL thickness average protocol, yielded erroneous RNFL thickness 
measurements. In all o f  these cases, reacquisition o f the scan eliminated these 
artefacts; however, should these errors have persisted the StratusOCT data would 
have been deemed to be un-useable.
Several examples o f  erroneous RNFL thickness measurements are given below. 
Seemingly, the origin o f  these errors is consistent with the literature (Ray R, et al. 
2005. Sadda SR, et al. 2006) and in all cases arose either due to detachment of the 
internal limiting membrane (ILM) (Figure 5.8a and Figure 5.8b) or due to a localised 
area o f reduced a-scan reflectivity (Figure 5.9a and Figure 5.9b).
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Figure 5.8a -Erroneous retinal nerve fib re  layer (RNFL) thickness measurment due 
to a detached ILM  in a 59 year o ld  male patient with OAG. The red arrow indicates 
the affected region.
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Figure 5.8b - Erroneous retinal nerve fib re  layer (RNFL) thickness measurment due 
to a detached ILM  in a 64 year o ld  female patient with OAG. The red arrow’ indicates 
the affected region.
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Figure 5.9a - Erroneous retinal nerve fib re  layer (RNFL) thickness measurment due 
to low RNFL reflectivity in a 52 year o ld  male patient with OAG. The red arrow’ 
indicates the affected region.
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Figure 5.9b - Erroneous retinal nerve fib re  layer (RNFL) thickness measurement due 
to low RNFL reflectivity in a 55 year old fem ale patien t with OAG. The red arrow 
indicates the affected region.
5.5 Discussion
Errors in macula thickness by StratusOCT are reported to affect up to 92% of scans 
(Ray R, et al. 2005, Sadda SR, et al. 2006). Currently, the prevalence o f erroneous 
RNFL thickness measurements is unknown; however, this study observed in RNFL 
thickness measurements in 17% (7 o f  41) o f individuals who underwent scanning 
with the StratusOCT. Thus there is a com pelling need to identify the causes o f such 
measurement error and develop ways to overcome such errors in order that the 
clinical utility o f StratusOCT can be improved.
In this study, new and novel software (OCTAnalyse) was developed that permits 
subjective measurement o f RNFL thickness based on data obtained during the
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standard StratusOCT procedure. O CTAnalyse RNFL thickness measurements were 
validated in terms o f their agreem ent w ith those obtained using StratusOCT. The 
within-session repeatability o f m easurem ents was also determined for each technique.
5.5.1 Within-session repeatability
The within-session repeatability o f  StratusOCT RNFL measurements has been 
investigated previously (Budenz DL. et al. 2005. Paunescu LA, et al. 2004). The 
levels of within-session repeatability o f StratusOCT RNFL thickness measurements 
are consistent with previous values (Budenz DL, et al. 2005, Paunescu LA, et al. 
2004). In this study, both the StratusOCT and OCTAnalyse yielded the best within- 
session repeatability in the temporal quadrant, with 95% LOA o f +10.5 pm and +14.3 
pm. respectively. StratusOCT yielded lowest within-session repeatability for mean 
RNFL thickness in the nasal quadrant followed by the superior, inferior and temporal 
quadrants, which is consistent with an earlier study (Budenz DL, et al. 2005). 
OCTAnalyse. however, yielded lowest within-session repeatability for mean RNFL 
thickness in the superior quadrant followed by the nasal, inferior and temporal 
quadrants.
In previous studies, the repeatability o f  StratusOCT RNFL thickness measurements is 
greater in normal individuals than in patients with OAG (Budenz DL, et al. 2005, De 
Leon-Ortega JE, et al. 2007). However, there was no statistically significant 
difference in the repeatability o f  RNFL thickness measurements between normal, 
suspect and OAG eyes, either by OCTA nalyse or StratusOCT.
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5.5.2 Agreement between StratusOCT and OCTAnalyse
The level of agreement between tw o measurem ent techniques provides an indication 
of how well the given techniques can be used interchangeably.
The validity o f OCT RNFL m easurements in providing a clinically reliable estimate 
of RNFL thickness has been reported in a number o f  previous studies (Jones AL, et al. 
2001. Schuman JS. et al. 1996. Skaf M, et al. 2006, Toth CA, et al. 1997). This 
relationship is important since it serves to validate imaging-derived data, as well as 
help improve our understanding o f  RNFL loss in OAG. Optical coherence 
tomography RNFL thickness m easurements have been evaluated against histological 
measurements obtained using ex vivo retinal sections (Blumenthal EZ, et al. 2007, 
Skaf M, et al. 2006, Toth CA, et al. 1997) as well as against RNFL thickness 
measurements obtained by other imaging techniques (Blumenthal EZ, et al. 2007, 
Greaney MJ. et al. 2002, Leung CK, et al. 2005). In general, StratusOCT RNFL 
thickness measurements appear qualitatively similar when compared to the 
histologically derived data (Blum enthal EZ, et al. 2007, Greaney MJ, et al. 2002, 
Leung CK. et al. 2005). Quantitative differences have been attributed either to scaling 
differences or histological artifacts related to cell shrinkage and dehydration o f tissues 
post mortem (Blumenthal EZ, et al. 2007, Skaf M, et al. 2006).
This study observed a consistent tendency for OCTAnalyse to yield statistically 
significantly greater RNFL thickness (p<0.01) measurements than those obtained by 
StratusOCT. Based on quadrant averaged RNFL thickness measurements across the 
three groups, this discrepancy was greatest in the temporal and nasal quadrants than in 
the superior and inferior quadrants.
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Similarly. RNFL thickness m easurements obtained using OCTAnalyse were 
statistically significantly greater (p<0.01) than those obtained by StratusOCT in 
normal and suspect individuals and in patients with OAG.
Since the measurement scaling factors used by OCTAnalyse and StratusOCT were 
equal, the consistent tendency for OCTAnalyse to yield thicker values is most likely 
to be due to the criteria used to define the axial location o f the anterior and posterior 
RNFL borders on the a-scan reflectivity profile with OCTAnalyse (see Section 5.3.4). 
Whilst alternative criteria could theoretically be applied to improve the agreement 
between the techniques, the current criteria utilise points on the a-scan reflectivity 
profile that are easy to distinguish in order to reduce the influence o f  between- 
observer effects on measurement variability.
The magnitude o f the difference in the measured RNFL thickness between the two 
techniques constitutes a caveat when implementing the OCTAnalyse clinically.
5.5.3 Erroneous RNFL thickness measurements
OCTAnalyse was designed to overcom e the clinical situation where the standard 
StratusOCT procedure yields erroneous RNFL thickness measurements. Where errors 
persist upon re-scanning and/or where re-scanning o f the patient is not immediately 
possible, as in many clinical situations, OCTAnalyse offers an alternative method to 
obtain RNFL thickness measurements. OCTAnalyse reduces the amount o f lost 
clinical time and resources due to erroneous RNFL thickness measurements by 
StratusOCT. Erroneous RNFL thickness measurements, by StratusOCT, were present
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in 17% of individuals who underwent imaging; however, some reports suggest that a 
much greater proportion scans may be affected (Ray R, et al. 2005. Sadda SR. et al. 
2006).
The erroneous RNFL thickness m easurem ents seen in this study arose either due to 
mislocation o f the retinal interface borders arising from a detachment o f the ILM 
(Figure 5.8a and b) or due to a localised reduction in a-scan reflectivity within the 
scan profile (Figure 5.9a and b).
Thus, there is a clear clinical need for alternative methods to measure RNFL thickness 
based on StratusOCT data. In view o f its w ider potential, OCTAnalyse is also capable 
of measuring retinal thickness from macula scans where a higher proportion of 
erroneous measurements are reported to arise (Ray R, et al. 2005, Sadda SR, et al. 
2006). Thus OCTAnalyse is a clinically useful tool, which can be applied to a wide 
range retinal and macula abnormalities.
However, despite yielding high ICCs (>0.80) for repeated measurements, the 95% 
LOA for OCTAnalyse were large, and ranged between +13.2 pm and +27.7 pm. It 
can be speculated that these limits o f  agreement may in fact be too wide to accurately 
detect longitudinal changes in RNFL thickness, although further investigation is 
warranted.
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5.6 Conclusion
This study has dem onstrated the clinical utility o f novel computer software 
(OCTAnalyse) that permits subjective quantification o f RNFL thickness, based on 
data obtained from the standard StratusOCT procedure. OCTAnalyse was designed 
for clinical use in instances w here standard StratusOCT yields erroneous RNFL 
thickness measurements, although the software can be used with StratusOCT scans 
which yield erroneous m acula/retinal thickness measurements.
Retinal nerve fibre layer thickness measurements obtained by OCTAnalyse are 
statistically significantly thicker (p<0.01) than those obtained by standard 
StratusOCT. The within-session repeatability o f OCTAnalyse was, in all analyses, 
greater for StratusOCT.
In its current form, OCTAnalyse seems unlikely to offer clincians the ability to 
accurately detect progressive damage due to OAG due to the wide 95% LOA o f the 
technique although further studies are warranted. With refinements to the current 
OCTAnalyse software, such as the development o f  an intuitive (semi-automated) 
algorithm for retinal interface recognition, the longitudinal clinical utility of the 
technique could potentially be improved. The fourth generation OCT, CirrusOCT, 
which images the retina with greater resolution, may further improve the repeatability, 
and thus clinical utility, o f OCTAnalyse.
208
Chapter 6: C onclusions and proposals for future work
6.1 C onclusions
6.1.1 Some dissociating factors in the analysis o f structural and functional 
progressive dam age in OAG
The longitudinal study  dem onstrated poor concordance between two o f the current- 
most sophisticated techniques for the identification o f structural and functional 
progressive d am ag e  in OAG namely, the HRT II TCA and the HFA GPA, 
respectively. S even teen  out o f  23 patients with OAG or with ‘high risk’ ONH 
exhibited p rogressive  damage by TCA and/or by GPA; however, only 4 patients 
exhibited p rogressive  damage by both techniques. In a majority (70%) o f the eyes 
progressing by o n ly  one o f the techniques, one o f  three dissociating factors were, at 
least in part, to  b e  responsible for the poor concordance. These dissociating factors 
were: the p erim etric  learning effect; the inability o f GPA to detect progressive 
functional dam age in regions o f  the visual field where the variability o f the 
differential light sensitivity is beyond the dynamic range o f the HFA at the baseline 
examinations; and  the inability o f TCA to detect progressive structural damage where 
the neuroretinal r im  is markedly attenuated, as in advanced OAG.
6.1.2 Novel approaches to glaucoma detection
The cross-sectional study investigated the diagnostic precision o f the current-most 
promising techn iques for the detection o f  OAG, namely; Optical Coherence 
Tomography (O C T ), Confocal Scanning Laser Ophthalmoscopy (CSLO), and the 
Multifocal V isual Evoked Potential (mfVEP), in participants classified solely
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according to the emerging ‘gold standard' technique, DSI. Confocal Scanning Laser 
Ophthalmoscopy, using the Heidelberg Retina Tomograph (HRT) III Moorfields 
Regression Analysis (MRA), yielded the highest sensitivity for OAG (86.7% to 
100%). Optical Coherence Tomography, using the StratusOCT, and SAP using the 
Humphrey Field Analyzer (HFA) yielded the highest specificity for OAG (95%). The 
combined use o f the StratusOCT and the HRT II MRA yielded the best overall 
diagnostic precision for OAG (sensitivity. 82.6% and specificity, 80%) o f all possible 
combinations o f tests and was higher than if  any o f the techniques were used alone. 
The relationship between techniques was determined in terms o f  their agreement in 
diagnostic outcome and their topographic correspondence o f abnormality. The best 
agreement between structural and functional techniques was observed between the 
StratusOCT and the HFA and between the HRT II/III and the mfVEP, although 
because o f the co-variance the observed values are likely to be inflated.
The best topographical concordance was observed between DSI and HRT III (up to 
100%) and serves to strengthen the qualitative relationship between the two 
techniques. The techniques that is the ‘best’ for detecting OAG is a matter o f clinical 
judgement, which based upon the most promising techniques, inevitably, involves a 
trade-off between sensitivity and specificity.
6.1.3 Novel estimation of RNFL thickness based on subjective evaluation of 
StratusOCT scan data
The study investigated the validity o f a novel clinical tool (OCTAnalyse) that permits 
subjective measurement o f RNFL thickness based on information obtained from the 
commercially available StratusOCT. The development o f the software was prompted
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by observations o f erroneous RNFL thickness measurements by the standard 
StratusOCT analysis procedure during the study described in Chapter 4. OCTAnalyse 
was designed to overcome this lim itation where errors persist on re-scanning and/or 
where re-scanning is not immediately possible.
The results o f the study indicate that both automated (StratusOCT) and manual 
(OCTAnalyse) exhibit excellent within-test repeatability o f measurements, (ICC 0.81- 
0.98). although measurements obtained by StratusOCT were more repeatable than 
those obtained using OCT Analyse. In addition, measurements obtained by 
OCTAnalyse were statistically significantly greater than those obtained by 
StratusOCT.
Erroneous measurement o f RNFL thickness were present from 7 o f 41 patients 
examined with the StratusOCT. In all o f these cases, the measurement errors were due 
to mislocation o f the retinal interface borders and occurred either due to a detached 
internal limiting membrane or localised diminution in retinal reflectivity.
The study demonstrated the utility and caveats for the use o f OCTAnalyse in a 
clinical setting. In its current form, OCTAnalyse can improve the ability of 
StratusOCT to detect OAG. W ith refinements to the current OCTAnalyse, as 
suggested in Section 6.2.3, the software is likely to be a useful add-on to the 
commercially available StratusOCT for both cross-sectional and longitudinal use in 
patients exhibiting persistant errors in RNFL thickness measurement by the standard 
technique.
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6.2 Proposals for future w ork
6.2.1 Some dissociating factors in the analysis o f structural and functional 
progressive damage in OAG
The failure o f the TCA and the GPA to account for disease severity is an important 
clinical issue, which limits the ability o f  the both techniques to identify structural and 
functional progressive damage, respectively. The development o f progression criteria 
for use with the HRT and HFA instruments, which account for both the severity and 
characteristics o f  the disease, would enhance the ability to detect progressive damage 
throughout the entire course o f  the disease process than is presently possible. This 
may involve: scaling the number o f  magenta super-pixels that are necessary in follow- 
up scans to confirm progressive structural damage with the available neuroretinal rim 
area for a given ONH, or em ploying a Size V stimulus to measure differential light 
sensitivity at visual field locations exhibiting variability beyond the dynamic range of 
the HFA.
More longitudinal studies, involving large numbers o f participants, are required to 
determine the appropriateness o f retinal surface height (TCA) and differential light 
sensitivity (GPA) as surrogate measures o f progressive RGC damage. The ability of 
other promising techniques, such as OCT and the mfVEP, has yet to be determined as 
part of a longitudinal investigation.
The first step in corroborating the validity o f new and evolving methods, as clinically 
reliable techniques for detecting progressive damage, will be improving the level of 
concordance between structural and functional tests for OAG.
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6.2.2 Novel approaches to glaucoma detection
Based on the outcomes o f  the study, future work involving further development o f the 
statistical analyses employed by each o f  the techniques. For example, this may 
involve determining how the diagnostic precision o f the StratusOCT RNFL thickness 
measurements is affected when measurem ents are corrected for between-individual 
differences in ONH size; determ ining how  the diagnostic precision o f the HRT III 
MRA is affected when additional stereometric parameters, such as RNFL thickness, 
are incorporated into the algorithm ; determining the clinical utility o f interocular 
differences in the RNFL thickness and ONH topography using the StratusOCT and 
the HRT III, respectively, as means to detect glaucomatous structural damage; 
enlargement o f  the mfVEP norm ative database appropriate for the local recording 
environment and the developm ent o f  more sophisticated analysis methods for mfVEP, 
analogous to Statpac for the HFA.
A longitudinal follow-up o f  the normal participants classified as abnormal by one, or 
more, o f the techniques should be undertaken to determine whether any o f these 
individuals developed OAG at a later date.
The ‘ideal’ diagnostic technique for OAG would provide objective, reproducible and 
rapid measurements that are a direct representation o f ganglion cell injury/death and 
thus exhibit high diagnostic precision for the disease at the earliest stage. The current 
promising techniques for the detection o f  OAG, including the emerging ‘gold 
standard’, DSI, provide a surrogate assessm ent o f the structural or functional integrity 
in OAG. It is speculated that a m ore appropriate evaluation for glaucomatous damage
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would involve direct assessment o f  RGC function. One emerging technology, namely 
functional ultra-high resolution OCT (Optophysiology), represents perhaps the most 
promising techniques for directly assessing RGC function (Bizheva K, et al. 2006). 
Further studies are necessary to determ ine whether this and/or other new techniques 
are capable o f advancing the ability to detect OAG to an earlier stage than is currently 
possible.
6.2.3 Novel estimation of RNFL thickness based on subjective evaluation of 
StratusOCT scan data
Based on the findings in this study, it will be important to determine the ‘true’ 
prevalence o f erroneous RNFL thickness measurements in the population since this is 
currently unknown and has the potential to affect the longitudinal utility of OCT 
RNFL thickness measurements. It is possible that other artefacts, in addition to those 
described in this study, may be responsible for measurement errors. Thus a cross- 
sectional study involving a larger cohort o f individuals will be necessary to determine 
the prevalence o f erroneous m easurements and whether, or nor, other types of 
artefacts exist.
Whether, or not, the fourth generation OCT will overcome the limitation o f erroneous 
measurements is also grounds for future work. However, unless the interface 
recognition software for the new device is more intuitive to the artefacts described in 
this study, it can be speculated that measurement errors will persist even with the 
fourth generation instrument.
With respect to the current version  o f OCTAnalyse software, it is o f interest to 
determine the between-observer and  between-test effects on repeatability o f RNFL 
thickness measurements. H ow ever, w ith  a view to improving the overall repeatability 
of the technique, future developm ents o f  the OCTAnalyse software should involve 
removing the subjective com ponent o f  the measurement procedure, for example, by 
incorporating a fully/sem i-autom ated and intuitive interface recognition algorithm. 
This would provide a m ore standardised criteria for retinal interface recognition and 
also permit more rapid m easurem ent and use o f information from all o f the 512 A- 
scans, rather than 24 A-scans as at present.
There is a clear role for softw are such  as revised versions o f OCTAnalyse in routine 
clinical management o f  patients w ith  OAG. With the suggested refinements to the 
current OCTAnalyse software, it is feasible that the RNFL thickness measurements 
obtained by this technique could be  superior to those obtained using the automated 
OCT analysis, in term s o f  few er erroneous measurements and greater within- and 
between-test repeatability, and could  becom e the analysis method o f choice for all 
individuals with OAG.
6.3 Overall conclusions
The overall findings from the th ree  studies provide important information for 
clinicians implementing the prom ising  techniques for the routine management o f 
patients with OAG. Interestingly, each  o f  the techniques has shown major limitations 
for their use clinically.
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In the case o f  OCT. which in the cross-sectional study (Chapter 4) exhibited high 
specificity for OAG (95.0% ). the technique exhibited poor sensitivity for OAG 
(43.5%. for OAG using the StratusO CT). A proportion o f the participants (7 of 41) 
yielded StratusOCT scans w hich occurred due to mis-location o f the anterior or 
posterior RNFL interface. An investigation into the validity o f  an alternative method 
to measure RNFL thickness was prom pted by this finding (Chapter 5). However, the 
new method, namely O CTAnalyse. w hilst permitting measurement o f RNFL 
thickness in scans containing m easurem ent errors, yielded measurements which were 
statistically significantly thicker than those obtained by the standard technique and 
exhibited poorer w ithin-session repeatability o f  measurements.
In the case o f the m fVEP. the cross-sectional study (Chapter 4) showed that this 
technique exhibited sub-optim al diagnostic precision, both in terms o f sensitivity 
(69.6%. for OAG using VERIS) and specificity (60.0%), for clinical use in detecting 
OAG. It should, however, be noted that the mfVEP technique is at a much earlier 
stage in its development than other m ore established promising techniques such as 
CSLO using the HRT and OCT using the StratusOCT.
In the case o f CSLO. which in the cross-sectional study (Chapter 4), exhibited high 
sensitivity for OAG (91.3% , for OAG using the HRT III MRA), the technique 
exhibited poor specificity for O AG (65.0%. using HRT III MRA and 80.0%, using the 
HRT II MRA). In the longitudinal study (Chapter 3), whilst demonstrating the ability 
to detect progressive structural dam age (HRT II Topographical Change Analysis 
[TCA]), CSLO was limited in its ability to detect progressive damage in individuals
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with marked attenuation o f  the neuroretinal rim and exhibited poor concordance with 
progressive functional damage by SAP.
Whilst not considered as a promising technique for the detection o f OAG, SAP also 
showed several inherent limitations. In the cross-sectional study (Chapter 5), whilst 
exhibiting high specificity for OAG (95.0%), the sensitivity o f SAP was below a level 
now deemed acceptable for clinical use (47.8%, for OAG using the HFA). In the 
longitudinal study (Chapter 3). SAP was able to detect progressive functional 
damage; however, the technique failed to detect progressive damage in the presence 
o f the perimetric learning effect and/or where regions o f the visual field loss exhibit 
variability o f the threshold response beyond the dynamic range o f the HFA during the 
baseline examinations.
In the cross-sectional study (Chapter 4), the standard technique used to determine the 
diagnostic performance o f  all other techniques was DSI. Digital stereoscopic ONH- 
imaging was able to correctly classified 100% o f individuals originally recruited 
either as normal or glaucom atous on the basis o f consensus agreement; however, there 
was some overlap in agreem ent between observers in several participants. The Gestalt 
principles used by a clinician to define OAG using digital and/or standard 
stereoscopic ONH-im aging are the same as those employed when using conventional 
ophthalmoscopy, which was devised over 100 years ago. Thus, despite providing 
clinicians with the state-of-the-art means to quantify the structural and functional 
status in OAG, there is little evidence to support the use o f any o f the promising 
techniques as the ‘com plete’ technique in OAG management.
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